date generated: 2021-04-20
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Here is the first few lines of the input profile.
## x
## A1BG 0.23019048
## A1BG-AS1 0.62211022
## A1CF 0.68373998
## A2M -0.03980079
## A2M-AS1 -0.04056761
## A2ML1 0.91485083
Here are some metrics about the input data profile:
Profile metrics | |
---|---|
num_genesets | 2408 |
num_genes_in_profile | 21631 |
duplicated_genes_present | 0 |
num_profile_genes_in_sets | 8410 |
num_profile_genes_not_in_sets | 13221 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Here are some metrics about the gene sets used: GMT file of genesets: ReactomePathways.gmt
Gene sets metrics | |
---|---|
num_genesets | 2408 |
num_genesets_excluded | 1045 |
num_genesets_included | 1363 |
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
Top N= 100 gene sets
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
IRAK4 deficiency (TLR2/4) | 10 | 6.62e-06 | 0.823 | 1.14e-04 |
MyD88 deficiency (TLR2/4) | 10 | 6.62e-06 | 0.823 | 1.14e-04 |
Peptide chain elongation | 88 | 2.46e-30 | -0.705 | 3.72e-28 |
Eukaryotic Translation Elongation | 93 | 7.89e-32 | -0.703 | 1.34e-29 |
Selenocysteine synthesis | 92 | 9.58e-30 | -0.682 | 1.10e-27 |
Viral mRNA Translation | 88 | 1.67e-28 | -0.682 | 1.62e-26 |
Formation of a pool of free 40S subunits | 100 | 5.67e-32 | -0.680 | 1.10e-29 |
Eukaryotic Translation Termination | 92 | 2.59e-29 | -0.677 | 2.72e-27 |
Translocation of ZAP-70 to Immunological synapse | 24 | 1.86e-08 | -0.663 | 5.90e-07 |
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 94 | 3.69e-28 | -0.656 | 3.35e-26 |
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | 12 | 1.31e-04 | 0.637 | 1.52e-03 |
alpha-linolenic acid (ALA) metabolism | 12 | 1.31e-04 | 0.637 | 1.52e-03 |
Response of EIF2AK4 (GCN2) to amino acid deficiency | 100 | 9.21e-28 | -0.631 | 6.61e-26 |
L13a-mediated translational silencing of Ceruloplasmin expression | 110 | 9.65e-30 | -0.624 | 1.10e-27 |
Regulation of TLR by endogenous ligand | 11 | 3.45e-04 | 0.623 | 3.13e-03 |
GTP hydrolysis and joining of the 60S ribosomal subunit | 111 | 8.89e-30 | -0.622 | 1.10e-27 |
Unwinding of DNA | 12 | 2.11e-04 | -0.618 | 2.15e-03 |
Formation of the ternary complex, and subsequently, the 43S complex | 51 | 2.80e-14 | -0.615 | 1.31e-12 |
Major pathway of rRNA processing in the nucleolus and cytosol | 180 | 3.41e-43 | -0.594 | 1.16e-40 |
rRNA processing in the nucleus and cytosol | 190 | 6.06e-45 | -0.590 | 8.26e-42 |
Cap-dependent Translation Initiation | 118 | 5.14e-28 | -0.584 | 3.89e-26 |
Eukaryotic Translation Initiation | 118 | 5.14e-28 | -0.584 | 3.89e-26 |
Activation of the pre-replicative complex | 32 | 1.20e-08 | -0.582 | 3.89e-07 |
WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | 11 | 1.04e-03 | 0.571 | 7.86e-03 |
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 114 | 1.01e-25 | -0.568 | 5.96e-24 |
Nonsense-Mediated Decay (NMD) | 114 | 1.01e-25 | -0.568 | 5.96e-24 |
SRP-dependent cotranslational protein targeting to membrane | 111 | 1.26e-24 | -0.562 | 6.59e-23 |
rRNA modification in the nucleus and cytosol | 59 | 1.02e-13 | -0.560 | 4.48e-12 |
Selenoamino acid metabolism | 114 | 1.10e-24 | -0.555 | 6.01e-23 |
rRNA processing | 217 | 4.38e-44 | -0.547 | 2.99e-41 |
Influenza Viral RNA Transcription and Replication | 135 | 4.19e-28 | -0.547 | 3.57e-26 |
NOTCH4 Activation and Transmission of Signal to the Nucleus | 10 | 2.84e-03 | 0.545 | 1.73e-02 |
Translation initiation complex formation | 58 | 6.84e-13 | -0.545 | 2.91e-11 |
Ribosomal scanning and start codon recognition | 58 | 1.10e-12 | -0.540 | 4.39e-11 |
DNA strand elongation | 32 | 1.35e-07 | -0.538 | 3.40e-06 |
Hyaluronan uptake and degradation | 12 | 1.32e-03 | 0.535 | 9.29e-03 |
Heme degradation | 10 | 3.64e-03 | 0.531 | 2.12e-02 |
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | 59 | 2.07e-12 | -0.529 | 8.07e-11 |
PD-1 signaling | 28 | 1.37e-06 | -0.527 | 2.92e-05 |
VLDLR internalisation and degradation | 12 | 1.78e-03 | 0.521 | 1.16e-02 |
Telomere C-strand synthesis initiation | 13 | 1.36e-03 | -0.513 | 9.36e-03 |
Nucleobase biosynthesis | 13 | 1.45e-03 | -0.510 | 9.89e-03 |
MET activates RAP1 and RAC1 | 10 | 5.25e-03 | 0.510 | 2.86e-02 |
Influenza Infection | 154 | 5.85e-27 | -0.501 | 3.80e-25 |
Processive synthesis on the lagging strand | 15 | 9.07e-04 | -0.495 | 7.11e-03 |
Activation of ATR in response to replication stress | 37 | 1.91e-07 | -0.495 | 4.72e-06 |
Lagging Strand Synthesis | 20 | 1.47e-04 | -0.490 | 1.67e-03 |
Telomere C-strand (Lagging Strand) Synthesis | 34 | 7.85e-07 | -0.489 | 1.81e-05 |
RHO GTPases Activate ROCKs | 18 | 3.59e-04 | 0.486 | 3.18e-03 |
Phosphorylation of CD3 and TCR zeta chains | 27 | 1.96e-05 | -0.475 | 2.96e-04 |
Resolution of AP sites via the multiple-nucleotide patch replacement pathway | 24 | 6.05e-05 | -0.473 | 8.09e-04 |
Removal of the Flap Intermediate | 14 | 2.48e-03 | -0.467 | 1.57e-02 |
PCNA-Dependent Long Patch Base Excision Repair | 21 | 2.29e-04 | -0.464 | 2.29e-03 |
BBSome-mediated cargo-targeting to cilium | 22 | 1.90e-04 | -0.460 | 2.02e-03 |
Generation of second messenger molecules | 38 | 1.37e-06 | -0.453 | 2.92e-05 |
Advanced glycosylation endproduct receptor signaling | 12 | 6.76e-03 | 0.451 | 3.51e-02 |
Gap junction trafficking | 13 | 4.93e-03 | 0.450 | 2.71e-02 |
Purine ribonucleoside monophosphate biosynthesis | 10 | 1.39e-02 | -0.449 | 5.99e-02 |
Early Phase of HIV Life Cycle | 14 | 3.92e-03 | -0.445 | 2.25e-02 |
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | 11 | 1.07e-02 | -0.445 | 4.95e-02 |
Establishment of Sister Chromatid Cohesion | 11 | 1.10e-02 | -0.443 | 5.06e-02 |
Synthesis of Leukotrienes (LT) and Eoxins (EX) | 15 | 3.06e-03 | 0.442 | 1.84e-02 |
Postmitotic nuclear pore complex (NPC) reformation | 27 | 7.16e-05 | -0.441 | 9.10e-04 |
Interactions of Vpr with host cellular proteins | 37 | 3.55e-06 | -0.440 | 6.81e-05 |
Diseases associated with the TLR signaling cascade | 23 | 2.81e-04 | 0.437 | 2.63e-03 |
Diseases of Immune System | 23 | 2.81e-04 | 0.437 | 2.63e-03 |
CD22 mediated BCR regulation | 59 | 6.94e-09 | -0.436 | 2.31e-07 |
SLBP independent Processing of Histone Pre-mRNAs | 10 | 1.70e-02 | -0.436 | 7.04e-02 |
Translesion synthesis by REV1 | 16 | 2.58e-03 | -0.435 | 1.61e-02 |
Interactions of Rev with host cellular proteins | 37 | 4.77e-06 | -0.435 | 8.66e-05 |
Dissolution of Fibrin Clot | 12 | 9.70e-03 | 0.431 | 4.64e-02 |
Extension of Telomeres | 51 | 1.09e-07 | -0.430 | 2.87e-06 |
Vpr-mediated nuclear import of PICs | 34 | 1.50e-05 | -0.429 | 2.32e-04 |
Rev-mediated nuclear export of HIV RNA | 35 | 1.17e-05 | -0.428 | 1.93e-04 |
Uptake and function of anthrax toxins | 10 | 1.92e-02 | 0.428 | 7.56e-02 |
Detoxification of Reactive Oxygen Species | 32 | 3.05e-05 | 0.426 | 4.33e-04 |
G1/S-Specific Transcription | 29 | 7.21e-05 | -0.426 | 9.10e-04 |
Signal transduction by L1 | 20 | 1.01e-03 | 0.424 | 7.72e-03 |
RHO GTPases Activate NADPH Oxidases | 21 | 8.13e-04 | 0.422 | 6.60e-03 |
Metabolism of non-coding RNA | 53 | 1.11e-07 | -0.421 | 2.87e-06 |
snRNP Assembly | 53 | 1.11e-07 | -0.421 | 2.87e-06 |
Transcription of E2F targets under negative control by DREAM complex | 19 | 1.51e-03 | -0.420 | 1.02e-02 |
WNT5A-dependent internalization of FZD4 | 13 | 8.74e-03 | 0.420 | 4.34e-02 |
RHO GTPases Activate WASPs and WAVEs | 35 | 2.11e-05 | 0.415 | 3.16e-04 |
Polymerase switching on the C-strand of the telomere | 26 | 2.49e-04 | -0.415 | 2.45e-03 |
Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | 11 | 1.72e-02 | 0.415 | 7.07e-02 |
Nuclear import of Rev protein | 34 | 2.89e-05 | -0.414 | 4.14e-04 |
Platelet sensitization by LDL | 16 | 4.20e-03 | 0.413 | 2.36e-02 |
NEP/NS2 Interacts with the Cellular Export Machinery | 32 | 6.13e-05 | -0.409 | 8.11e-04 |
Hyaluronan metabolism | 15 | 6.74e-03 | 0.404 | 3.51e-02 |
Translesion synthesis by POLI | 17 | 4.41e-03 | -0.399 | 2.48e-02 |
Translation | 295 | 4.36e-32 | -0.398 | 9.91e-30 |
Processive synthesis on the C-strand of the telomere | 19 | 2.78e-03 | -0.396 | 1.70e-02 |
Pre-NOTCH Processing in Golgi | 18 | 3.81e-03 | 0.394 | 2.20e-02 |
G0 and Early G1 | 27 | 4.38e-04 | -0.391 | 3.78e-03 |
PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases | 13 | 1.50e-02 | 0.390 | 6.35e-02 |
Transport of Ribonucleoproteins into the Host Nucleus | 32 | 1.46e-04 | -0.388 | 1.67e-03 |
Classical antibody-mediated complement activation | 69 | 2.98e-08 | -0.386 | 9.02e-07 |
Scavenging of heme from plasma | 71 | 2.01e-08 | -0.385 | 6.23e-07 |
Leading Strand Synthesis | 14 | 1.26e-02 | -0.385 | 5.58e-02 |
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
IRAK4 deficiency (TLR2/4) | 10 | 6.62e-06 | 8.23e-01 | 1.14e-04 |
MyD88 deficiency (TLR2/4) | 10 | 6.62e-06 | 8.23e-01 | 1.14e-04 |
Peptide chain elongation | 88 | 2.46e-30 | -7.05e-01 | 3.72e-28 |
Eukaryotic Translation Elongation | 93 | 7.89e-32 | -7.03e-01 | 1.34e-29 |
Selenocysteine synthesis | 92 | 9.58e-30 | -6.82e-01 | 1.10e-27 |
Viral mRNA Translation | 88 | 1.67e-28 | -6.82e-01 | 1.62e-26 |
Formation of a pool of free 40S subunits | 100 | 5.67e-32 | -6.80e-01 | 1.10e-29 |
Eukaryotic Translation Termination | 92 | 2.59e-29 | -6.77e-01 | 2.72e-27 |
Translocation of ZAP-70 to Immunological synapse | 24 | 1.86e-08 | -6.63e-01 | 5.90e-07 |
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 94 | 3.69e-28 | -6.56e-01 | 3.35e-26 |
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | 12 | 1.31e-04 | 6.37e-01 | 1.52e-03 |
alpha-linolenic acid (ALA) metabolism | 12 | 1.31e-04 | 6.37e-01 | 1.52e-03 |
Response of EIF2AK4 (GCN2) to amino acid deficiency | 100 | 9.21e-28 | -6.31e-01 | 6.61e-26 |
L13a-mediated translational silencing of Ceruloplasmin expression | 110 | 9.65e-30 | -6.24e-01 | 1.10e-27 |
Regulation of TLR by endogenous ligand | 11 | 3.45e-04 | 6.23e-01 | 3.13e-03 |
GTP hydrolysis and joining of the 60S ribosomal subunit | 111 | 8.89e-30 | -6.22e-01 | 1.10e-27 |
Unwinding of DNA | 12 | 2.11e-04 | -6.18e-01 | 2.15e-03 |
Formation of the ternary complex, and subsequently, the 43S complex | 51 | 2.80e-14 | -6.15e-01 | 1.31e-12 |
Major pathway of rRNA processing in the nucleolus and cytosol | 180 | 3.41e-43 | -5.94e-01 | 1.16e-40 |
rRNA processing in the nucleus and cytosol | 190 | 6.06e-45 | -5.90e-01 | 8.26e-42 |
Cap-dependent Translation Initiation | 118 | 5.14e-28 | -5.84e-01 | 3.89e-26 |
Eukaryotic Translation Initiation | 118 | 5.14e-28 | -5.84e-01 | 3.89e-26 |
Activation of the pre-replicative complex | 32 | 1.20e-08 | -5.82e-01 | 3.89e-07 |
WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | 11 | 1.04e-03 | 5.71e-01 | 7.86e-03 |
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 114 | 1.01e-25 | -5.68e-01 | 5.96e-24 |
Nonsense-Mediated Decay (NMD) | 114 | 1.01e-25 | -5.68e-01 | 5.96e-24 |
SRP-dependent cotranslational protein targeting to membrane | 111 | 1.26e-24 | -5.62e-01 | 6.59e-23 |
rRNA modification in the nucleus and cytosol | 59 | 1.02e-13 | -5.60e-01 | 4.48e-12 |
Selenoamino acid metabolism | 114 | 1.10e-24 | -5.55e-01 | 6.01e-23 |
rRNA processing | 217 | 4.38e-44 | -5.47e-01 | 2.99e-41 |
Influenza Viral RNA Transcription and Replication | 135 | 4.19e-28 | -5.47e-01 | 3.57e-26 |
NOTCH4 Activation and Transmission of Signal to the Nucleus | 10 | 2.84e-03 | 5.45e-01 | 1.73e-02 |
Translation initiation complex formation | 58 | 6.84e-13 | -5.45e-01 | 2.91e-11 |
Ribosomal scanning and start codon recognition | 58 | 1.10e-12 | -5.40e-01 | 4.39e-11 |
DNA strand elongation | 32 | 1.35e-07 | -5.38e-01 | 3.40e-06 |
Hyaluronan uptake and degradation | 12 | 1.32e-03 | 5.35e-01 | 9.29e-03 |
Heme degradation | 10 | 3.64e-03 | 5.31e-01 | 2.12e-02 |
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | 59 | 2.07e-12 | -5.29e-01 | 8.07e-11 |
PD-1 signaling | 28 | 1.37e-06 | -5.27e-01 | 2.92e-05 |
VLDLR internalisation and degradation | 12 | 1.78e-03 | 5.21e-01 | 1.16e-02 |
Telomere C-strand synthesis initiation | 13 | 1.36e-03 | -5.13e-01 | 9.36e-03 |
Nucleobase biosynthesis | 13 | 1.45e-03 | -5.10e-01 | 9.89e-03 |
MET activates RAP1 and RAC1 | 10 | 5.25e-03 | 5.10e-01 | 2.86e-02 |
Influenza Infection | 154 | 5.85e-27 | -5.01e-01 | 3.80e-25 |
Processive synthesis on the lagging strand | 15 | 9.07e-04 | -4.95e-01 | 7.11e-03 |
Activation of ATR in response to replication stress | 37 | 1.91e-07 | -4.95e-01 | 4.72e-06 |
Lagging Strand Synthesis | 20 | 1.47e-04 | -4.90e-01 | 1.67e-03 |
Telomere C-strand (Lagging Strand) Synthesis | 34 | 7.85e-07 | -4.89e-01 | 1.81e-05 |
RHO GTPases Activate ROCKs | 18 | 3.59e-04 | 4.86e-01 | 3.18e-03 |
Phosphorylation of CD3 and TCR zeta chains | 27 | 1.96e-05 | -4.75e-01 | 2.96e-04 |
Resolution of AP sites via the multiple-nucleotide patch replacement pathway | 24 | 6.05e-05 | -4.73e-01 | 8.09e-04 |
Removal of the Flap Intermediate | 14 | 2.48e-03 | -4.67e-01 | 1.57e-02 |
PCNA-Dependent Long Patch Base Excision Repair | 21 | 2.29e-04 | -4.64e-01 | 2.29e-03 |
BBSome-mediated cargo-targeting to cilium | 22 | 1.90e-04 | -4.60e-01 | 2.02e-03 |
Generation of second messenger molecules | 38 | 1.37e-06 | -4.53e-01 | 2.92e-05 |
Advanced glycosylation endproduct receptor signaling | 12 | 6.76e-03 | 4.51e-01 | 3.51e-02 |
Gap junction trafficking | 13 | 4.93e-03 | 4.50e-01 | 2.71e-02 |
Purine ribonucleoside monophosphate biosynthesis | 10 | 1.39e-02 | -4.49e-01 | 5.99e-02 |
Early Phase of HIV Life Cycle | 14 | 3.92e-03 | -4.45e-01 | 2.25e-02 |
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | 11 | 1.07e-02 | -4.45e-01 | 4.95e-02 |
Establishment of Sister Chromatid Cohesion | 11 | 1.10e-02 | -4.43e-01 | 5.06e-02 |
Synthesis of Leukotrienes (LT) and Eoxins (EX) | 15 | 3.06e-03 | 4.42e-01 | 1.84e-02 |
Postmitotic nuclear pore complex (NPC) reformation | 27 | 7.16e-05 | -4.41e-01 | 9.10e-04 |
Interactions of Vpr with host cellular proteins | 37 | 3.55e-06 | -4.40e-01 | 6.81e-05 |
Diseases associated with the TLR signaling cascade | 23 | 2.81e-04 | 4.37e-01 | 2.63e-03 |
Diseases of Immune System | 23 | 2.81e-04 | 4.37e-01 | 2.63e-03 |
CD22 mediated BCR regulation | 59 | 6.94e-09 | -4.36e-01 | 2.31e-07 |
SLBP independent Processing of Histone Pre-mRNAs | 10 | 1.70e-02 | -4.36e-01 | 7.04e-02 |
Translesion synthesis by REV1 | 16 | 2.58e-03 | -4.35e-01 | 1.61e-02 |
Interactions of Rev with host cellular proteins | 37 | 4.77e-06 | -4.35e-01 | 8.66e-05 |
Dissolution of Fibrin Clot | 12 | 9.70e-03 | 4.31e-01 | 4.64e-02 |
Extension of Telomeres | 51 | 1.09e-07 | -4.30e-01 | 2.87e-06 |
Vpr-mediated nuclear import of PICs | 34 | 1.50e-05 | -4.29e-01 | 2.32e-04 |
Rev-mediated nuclear export of HIV RNA | 35 | 1.17e-05 | -4.28e-01 | 1.93e-04 |
Uptake and function of anthrax toxins | 10 | 1.92e-02 | 4.28e-01 | 7.56e-02 |
Detoxification of Reactive Oxygen Species | 32 | 3.05e-05 | 4.26e-01 | 4.33e-04 |
G1/S-Specific Transcription | 29 | 7.21e-05 | -4.26e-01 | 9.10e-04 |
Signal transduction by L1 | 20 | 1.01e-03 | 4.24e-01 | 7.72e-03 |
RHO GTPases Activate NADPH Oxidases | 21 | 8.13e-04 | 4.22e-01 | 6.60e-03 |
Metabolism of non-coding RNA | 53 | 1.11e-07 | -4.21e-01 | 2.87e-06 |
snRNP Assembly | 53 | 1.11e-07 | -4.21e-01 | 2.87e-06 |
Transcription of E2F targets under negative control by DREAM complex | 19 | 1.51e-03 | -4.20e-01 | 1.02e-02 |
WNT5A-dependent internalization of FZD4 | 13 | 8.74e-03 | 4.20e-01 | 4.34e-02 |
RHO GTPases Activate WASPs and WAVEs | 35 | 2.11e-05 | 4.15e-01 | 3.16e-04 |
Polymerase switching on the C-strand of the telomere | 26 | 2.49e-04 | -4.15e-01 | 2.45e-03 |
Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | 11 | 1.72e-02 | 4.15e-01 | 7.07e-02 |
Nuclear import of Rev protein | 34 | 2.89e-05 | -4.14e-01 | 4.14e-04 |
Platelet sensitization by LDL | 16 | 4.20e-03 | 4.13e-01 | 2.36e-02 |
NEP/NS2 Interacts with the Cellular Export Machinery | 32 | 6.13e-05 | -4.09e-01 | 8.11e-04 |
Hyaluronan metabolism | 15 | 6.74e-03 | 4.04e-01 | 3.51e-02 |
Translesion synthesis by POLI | 17 | 4.41e-03 | -3.99e-01 | 2.48e-02 |
Translation | 295 | 4.36e-32 | -3.98e-01 | 9.91e-30 |
Processive synthesis on the C-strand of the telomere | 19 | 2.78e-03 | -3.96e-01 | 1.70e-02 |
Pre-NOTCH Processing in Golgi | 18 | 3.81e-03 | 3.94e-01 | 2.20e-02 |
G0 and Early G1 | 27 | 4.38e-04 | -3.91e-01 | 3.78e-03 |
PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases | 13 | 1.50e-02 | 3.90e-01 | 6.35e-02 |
Transport of Ribonucleoproteins into the Host Nucleus | 32 | 1.46e-04 | -3.88e-01 | 1.67e-03 |
Classical antibody-mediated complement activation | 69 | 2.98e-08 | -3.86e-01 | 9.02e-07 |
Scavenging of heme from plasma | 71 | 2.01e-08 | -3.85e-01 | 6.23e-07 |
Leading Strand Synthesis | 14 | 1.26e-02 | -3.85e-01 | 5.58e-02 |
Polymerase switching | 14 | 1.26e-02 | -3.85e-01 | 5.58e-02 |
Folding of actin by CCT/TriC | 10 | 3.57e-02 | -3.83e-01 | 1.22e-01 |
EPHB-mediated forward signaling | 32 | 1.83e-04 | 3.82e-01 | 1.97e-03 |
Export of Viral Ribonucleoproteins from Nucleus | 33 | 1.53e-04 | -3.81e-01 | 1.71e-03 |
Erythropoietin activates RAS | 13 | 1.76e-02 | 3.80e-01 | 7.10e-02 |
NS1 Mediated Effects on Host Pathways | 40 | 3.22e-05 | -3.80e-01 | 4.48e-04 |
Insulin receptor recycling | 21 | 2.60e-03 | 3.80e-01 | 1.61e-02 |
Recognition of DNA damage by PCNA-containing replication complex | 30 | 3.61e-04 | -3.76e-01 | 3.18e-03 |
Translesion synthesis by POLK | 17 | 7.28e-03 | -3.76e-01 | 3.75e-02 |
Neutrophil degranulation | 457 | 3.04e-43 | 3.76e-01 | 1.16e-40 |
Gap junction trafficking and regulation | 15 | 1.19e-02 | 3.75e-01 | 5.38e-02 |
Mitochondrial tRNA aminoacylation | 21 | 3.09e-03 | -3.73e-01 | 1.84e-02 |
Retrograde neurotrophin signalling | 12 | 2.53e-02 | 3.73e-01 | 9.40e-02 |
Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | 14 | 1.62e-02 | -3.71e-01 | 6.81e-02 |
Diseases of DNA repair | 10 | 4.27e-02 | -3.70e-01 | 1.39e-01 |
HDR through MMEJ (alt-NHEJ) | 10 | 4.30e-02 | -3.70e-01 | 1.39e-01 |
Mucopolysaccharidoses | 11 | 3.41e-02 | 3.69e-01 | 1.17e-01 |
Mismatch Repair | 15 | 1.39e-02 | -3.67e-01 | 5.99e-02 |
Creation of C4 and C2 activators | 71 | 9.77e-08 | -3.66e-01 | 2.66e-06 |
mRNA decay by 3’ to 5’ exoribonuclease | 16 | 1.16e-02 | -3.65e-01 | 5.26e-02 |
Collagen degradation | 29 | 6.92e-04 | 3.64e-01 | 5.72e-03 |
ROS and RNS production in phagocytes | 31 | 4.58e-04 | 3.64e-01 | 3.92e-03 |
Transferrin endocytosis and recycling | 26 | 1.35e-03 | 3.63e-01 | 9.36e-03 |
Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | 16 | 1.19e-02 | -3.63e-01 | 5.38e-02 |
RHO GTPases activate IQGAPs | 11 | 3.73e-02 | 3.63e-01 | 1.25e-01 |
Transport of the SLBP Dependant Mature mRNA | 36 | 1.67e-04 | -3.63e-01 | 1.83e-03 |
Removal of the Flap Intermediate from the C-strand | 17 | 9.82e-03 | -3.62e-01 | 4.67e-02 |
FCGR activation | 76 | 5.44e-08 | -3.61e-01 | 1.54e-06 |
Regulation of FZD by ubiquitination | 15 | 1.62e-02 | -3.59e-01 | 6.81e-02 |
tRNA processing in the nucleus | 59 | 1.89e-06 | -3.59e-01 | 3.90e-05 |
Transport of the SLBP independent Mature mRNA | 35 | 2.50e-04 | -3.58e-01 | 2.45e-03 |
Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | 14 | 2.12e-02 | -3.56e-01 | 8.19e-02 |
Regulation of expression of SLITs and ROBOs | 159 | 3.68e-14 | -3.48e-01 | 1.67e-12 |
Regulated proteolysis of p75NTR | 11 | 4.82e-02 | 3.44e-01 | 1.50e-01 |
Nuclear Pore Complex (NPC) Disassembly | 36 | 3.64e-04 | -3.43e-01 | 3.18e-03 |
Dectin-2 family | 19 | 9.69e-03 | 3.43e-01 | 4.64e-02 |
Translesion Synthesis by POLH | 18 | 1.20e-02 | -3.42e-01 | 5.38e-02 |
Role of LAT2/NTAL/LAB on calcium mobilization | 74 | 4.04e-07 | -3.41e-01 | 9.84e-06 |
Chemokine receptors bind chemokines | 37 | 3.40e-04 | -3.40e-01 | 3.11e-03 |
Sema4D in semaphorin signaling | 22 | 5.95e-03 | 3.39e-01 | 3.17e-02 |
E2F mediated regulation of DNA replication | 22 | 6.37e-03 | -3.36e-01 | 3.35e-02 |
COPI-independent Golgi-to-ER retrograde traffic | 33 | 8.51e-04 | 3.35e-01 | 6.83e-03 |
Pentose phosphate pathway | 13 | 3.65e-02 | 3.35e-01 | 1.23e-01 |
LDL clearance | 18 | 1.41e-02 | 3.34e-01 | 6.02e-02 |
GPVI-mediated activation cascade | 31 | 1.28e-03 | 3.34e-01 | 9.13e-03 |
tRNA modification in the nucleus and cytosol | 43 | 1.52e-04 | -3.34e-01 | 1.71e-03 |
Gap-filling DNA repair synthesis and ligation in GG-NER | 25 | 3.92e-03 | -3.33e-01 | 2.25e-02 |
FCERI mediated Ca+2 mobilization | 89 | 5.89e-08 | -3.32e-01 | 1.64e-06 |
Resolution of Abasic Sites (AP sites) | 37 | 4.98e-04 | -3.31e-01 | 4.21e-03 |
SUMOylation of SUMOylation proteins | 35 | 8.23e-04 | -3.27e-01 | 6.64e-03 |
tRNA Aminoacylation | 42 | 2.63e-04 | -3.25e-01 | 2.53e-03 |
Lysosome Vesicle Biogenesis | 32 | 1.50e-03 | 3.24e-01 | 1.02e-02 |
Regulation of IFNG signaling | 14 | 3.59e-02 | 3.24e-01 | 1.22e-01 |
Signaling by Erythropoietin | 24 | 6.10e-03 | 3.23e-01 | 3.24e-02 |
Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | 32 | 1.56e-03 | -3.23e-01 | 1.04e-02 |
Regulation of Glucokinase by Glucokinase Regulatory Protein | 32 | 1.56e-03 | -3.23e-01 | 1.04e-02 |
Sema4D induced cell migration and growth-cone collapse | 19 | 1.51e-02 | 3.22e-01 | 6.40e-02 |
Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | 11 | 6.60e-02 | 3.20e-01 | 1.86e-01 |
Metabolism of amine-derived hormones | 10 | 8.09e-02 | -3.19e-01 | 2.17e-01 |
Long-term potentiation | 14 | 3.91e-02 | -3.18e-01 | 1.29e-01 |
Glutamate and glutamine metabolism | 12 | 5.61e-02 | -3.18e-01 | 1.67e-01 |
Post-translational protein phosphorylation | 70 | 4.10e-06 | 3.18e-01 | 7.55e-05 |
Transcriptional Regulation by E2F6 | 34 | 1.36e-03 | -3.17e-01 | 9.36e-03 |
RNA Polymerase I Transcription Initiation | 44 | 2.78e-04 | -3.17e-01 | 2.63e-03 |
Chondroitin sulfate biosynthesis | 12 | 5.78e-02 | 3.16e-01 | 1.71e-01 |
Growth hormone receptor signaling | 20 | 1.44e-02 | 3.16e-01 | 6.14e-02 |
Golgi Cisternae Pericentriolar Stack Reorganization | 14 | 4.43e-02 | 3.10e-01 | 1.42e-01 |
Initial triggering of complement | 78 | 2.23e-06 | -3.10e-01 | 4.48e-05 |
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | 84 | 9.73e-07 | -3.09e-01 | 2.21e-05 |
RHO GTPases activate CIT | 18 | 2.35e-02 | 3.08e-01 | 8.86e-02 |
SUMOylation of RNA binding proteins | 47 | 2.56e-04 | -3.08e-01 | 2.49e-03 |
Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | 17 | 2.85e-02 | -3.07e-01 | 1.03e-01 |
Telomere Extension By Telomerase | 23 | 1.10e-02 | -3.06e-01 | 5.05e-02 |
Negative regulation of MET activity | 18 | 2.51e-02 | 3.05e-01 | 9.36e-02 |
tRNA processing | 134 | 1.13e-09 | -3.05e-01 | 4.06e-08 |
Termination of translesion DNA synthesis | 32 | 2.87e-03 | -3.05e-01 | 1.74e-02 |
Scavenging by Class A Receptors | 11 | 8.08e-02 | 3.04e-01 | 2.17e-01 |
TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | 20 | 1.90e-02 | -3.03e-01 | 7.52e-02 |
Role of phospholipids in phagocytosis | 88 | 1.17e-06 | -3.00e-01 | 2.61e-05 |
PINK1-PRKN Mediated Mitophagy | 21 | 1.79e-02 | -2.98e-01 | 7.19e-02 |
Prolonged ERK activation events | 13 | 6.27e-02 | 2.98e-01 | 1.79e-01 |
Recycling pathway of L1 | 26 | 8.55e-03 | 2.98e-01 | 4.27e-02 |
Intraflagellar transport | 39 | 1.35e-03 | -2.97e-01 | 9.36e-03 |
Regulation of IFNA signaling | 12 | 7.55e-02 | 2.96e-01 | 2.06e-01 |
trans-Golgi Network Vesicle Budding | 69 | 2.39e-05 | 2.94e-01 | 3.53e-04 |
Plasma lipoprotein assembly | 10 | 1.08e-01 | 2.93e-01 | 2.70e-01 |
CLEC7A (Dectin-1) induces NFAT activation | 11 | 9.23e-02 | -2.93e-01 | 2.41e-01 |
AKT phosphorylates targets in the cytosol | 14 | 5.85e-02 | 2.92e-01 | 1.73e-01 |
Metabolism of RNA | 685 | 1.57e-38 | -2.90e-01 | 4.27e-36 |
RNA Polymerase III Chain Elongation | 18 | 3.37e-02 | -2.89e-01 | 1.17e-01 |
Gluconeogenesis | 28 | 8.23e-03 | 2.88e-01 | 4.16e-02 |
Signal regulatory protein family interactions | 12 | 8.43e-02 | 2.88e-01 | 2.24e-01 |
Transport of Mature mRNAs Derived from Intronless Transcripts | 43 | 1.11e-03 | -2.87e-01 | 8.30e-03 |
MAP2K and MAPK activation | 34 | 3.74e-03 | 2.87e-01 | 2.17e-02 |
Endosomal Sorting Complex Required For Transport (ESCRT) | 29 | 7.90e-03 | 2.85e-01 | 4.02e-02 |
Notch-HLH transcription pathway | 28 | 9.05e-03 | 2.85e-01 | 4.45e-02 |
EPH-Ephrin signaling | 79 | 1.22e-05 | 2.85e-01 | 1.96e-04 |
ERKs are inactivated | 13 | 7.64e-02 | 2.84e-01 | 2.08e-01 |
SUMOylation of immune response proteins | 11 | 1.03e-01 | 2.84e-01 | 2.63e-01 |
Biotin transport and metabolism | 11 | 1.03e-01 | -2.84e-01 | 2.63e-01 |
Chromosome Maintenance | 105 | 5.23e-07 | -2.83e-01 | 1.25e-05 |
Activation of Matrix Metalloproteinases | 23 | 1.90e-02 | 2.82e-01 | 7.52e-02 |
Beta-oxidation of very long chain fatty acids | 10 | 1.22e-01 | 2.82e-01 | 2.96e-01 |
Transport of Mature mRNA Derived from an Intronless Transcript | 42 | 1.59e-03 | -2.82e-01 | 1.05e-02 |
The NLRP3 inflammasome | 15 | 6.05e-02 | 2.80e-01 | 1.74e-01 |
SUMOylation of DNA replication proteins | 46 | 1.05e-03 | -2.79e-01 | 7.91e-03 |
Budding and maturation of HIV virion | 26 | 1.40e-02 | 2.78e-01 | 6.02e-02 |
G-protein beta:gamma signalling | 29 | 9.51e-03 | 2.78e-01 | 4.60e-02 |
Cargo concentration in the ER | 30 | 8.37e-03 | 2.78e-01 | 4.21e-02 |
SUMOylation of chromatin organization proteins | 57 | 2.89e-04 | -2.78e-01 | 2.68e-03 |
Regulation of TP53 Activity through Acetylation | 29 | 1.00e-02 | -2.76e-01 | 4.72e-02 |
RHO GTPases activate KTN1 | 11 | 1.13e-01 | 2.76e-01 | 2.80e-01 |
RNA Polymerase III Transcription Initiation From Type 1 Promoter | 28 | 1.15e-02 | -2.76e-01 | 5.25e-02 |
Mitochondrial translation elongation | 91 | 6.17e-06 | -2.74e-01 | 1.09e-04 |
Cytosolic tRNA aminoacylation | 24 | 2.01e-02 | -2.74e-01 | 7.81e-02 |
Cohesin Loading onto Chromatin | 10 | 1.33e-01 | -2.74e-01 | 3.17e-01 |
Trafficking of GluR2-containing AMPA receptors | 12 | 1.01e-01 | 2.74e-01 | 2.57e-01 |
Homologous DNA Pairing and Strand Exchange | 42 | 2.17e-03 | -2.73e-01 | 1.38e-02 |
Defects in vitamin and cofactor metabolism | 21 | 3.04e-02 | -2.73e-01 | 1.07e-01 |
COPI-mediated anterograde transport | 78 | 3.17e-05 | 2.72e-01 | 4.45e-04 |
TNFs bind their physiological receptors | 25 | 1.88e-02 | -2.71e-01 | 7.50e-02 |
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | 81 | 2.53e-05 | 2.71e-01 | 3.71e-04 |
Transport of Mature mRNA derived from an Intron-Containing Transcript | 72 | 7.14e-05 | -2.71e-01 | 9.10e-04 |
Plasma lipoprotein remodeling | 18 | 4.68e-02 | 2.71e-01 | 1.47e-01 |
Dual Incision in GG-NER | 41 | 2.71e-03 | -2.71e-01 | 1.67e-02 |
FCGR3A-mediated IL10 synthesis | 99 | 3.84e-06 | -2.69e-01 | 7.27e-05 |
VxPx cargo-targeting to cilium | 19 | 4.27e-02 | 2.69e-01 | 1.39e-01 |
Binding and Uptake of Ligands by Scavenger Receptors | 92 | 8.56e-06 | -2.68e-01 | 1.44e-04 |
Signaling by Leptin | 10 | 1.42e-01 | 2.68e-01 | 3.30e-01 |
Plasma lipoprotein assembly, remodeling, and clearance | 53 | 7.36e-04 | 2.68e-01 | 6.04e-03 |
Deadenylation-dependent mRNA decay | 53 | 7.55e-04 | -2.67e-01 | 6.16e-03 |
Signaling by high-kinase activity BRAF mutants | 31 | 1.01e-02 | 2.67e-01 | 4.74e-02 |
Signaling by ROBO receptors | 199 | 8.42e-11 | -2.67e-01 | 3.19e-09 |
Presynaptic phase of homologous DNA pairing and strand exchange | 39 | 4.07e-03 | -2.66e-01 | 2.31e-02 |
Mitochondrial translation termination | 91 | 1.17e-05 | -2.66e-01 | 1.93e-04 |
Defects in cobalamin (B12) metabolism | 13 | 9.77e-02 | -2.65e-01 | 2.50e-01 |
CD28 dependent PI3K/Akt signaling | 22 | 3.23e-02 | -2.64e-01 | 1.13e-01 |
Degradation of the extracellular matrix | 78 | 5.98e-05 | 2.63e-01 | 8.07e-04 |
Mitochondrial translation initiation | 91 | 1.48e-05 | -2.63e-01 | 2.31e-04 |
Regulation of signaling by CBL | 18 | 5.47e-02 | 2.62e-01 | 1.65e-01 |
Integrin signaling | 22 | 3.38e-02 | 2.61e-01 | 1.17e-01 |
Metabolism of steroid hormones | 20 | 4.53e-02 | 2.59e-01 | 1.44e-01 |
Regulation of HSF1-mediated heat shock response | 79 | 7.09e-05 | -2.59e-01 | 9.10e-04 |
DNA Damage Bypass | 47 | 2.22e-03 | -2.58e-01 | 1.41e-02 |
Carnitine metabolism | 10 | 1.58e-01 | 2.58e-01 | 3.46e-01 |
Glycogen breakdown (glycogenolysis) | 13 | 1.08e-01 | 2.57e-01 | 2.70e-01 |
Tight junction interactions | 18 | 5.88e-02 | -2.57e-01 | 1.73e-01 |
IRAK1 recruits IKK complex | 10 | 1.59e-01 | 2.57e-01 | 3.46e-01 |
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | 10 | 1.59e-01 | 2.57e-01 | 3.46e-01 |
RHO GTPases activate PAKs | 20 | 4.66e-02 | 2.57e-01 | 1.47e-01 |
Fanconi Anemia Pathway | 36 | 7.64e-03 | -2.57e-01 | 3.90e-02 |
SUMOylation of DNA damage response and repair proteins | 77 | 9.89e-05 | -2.57e-01 | 1.18e-03 |
Mitochondrial translation | 97 | 1.26e-05 | -2.57e-01 | 1.99e-04 |
RHO GTPases activate PKNs | 48 | 2.14e-03 | 2.56e-01 | 1.37e-02 |
FCERI mediated MAPK activation | 90 | 2.82e-05 | -2.55e-01 | 4.09e-04 |
RNA Polymerase III Transcription Initiation From Type 2 Promoter | 27 | 2.21e-02 | -2.54e-01 | 8.51e-02 |
activated TAK1 mediates p38 MAPK activation | 19 | 5.54e-02 | 2.54e-01 | 1.65e-01 |
Viral Messenger RNA Synthesis | 44 | 3.57e-03 | -2.54e-01 | 2.09e-02 |
Caspase activation via extrinsic apoptotic signalling pathway | 25 | 2.81e-02 | 2.54e-01 | 1.02e-01 |
Telomere Maintenance | 80 | 9.00e-05 | -2.53e-01 | 1.09e-03 |
CDC6 association with the ORC:origin complex | 11 | 1.46e-01 | -2.53e-01 | 3.32e-01 |
Antigen processing-Cross presentation | 97 | 1.74e-05 | 2.52e-01 | 2.66e-04 |
Nuclear Envelope Breakdown | 53 | 1.69e-03 | -2.49e-01 | 1.11e-02 |
mRNA decay by 5’ to 3’ exoribonuclease | 15 | 9.46e-02 | -2.49e-01 | 2.46e-01 |
ISG15 antiviral mechanism | 72 | 2.79e-04 | -2.48e-01 | 2.63e-03 |
Golgi Associated Vesicle Biogenesis | 55 | 1.61e-03 | 2.46e-01 | 1.06e-02 |
Adenylate cyclase inhibitory pathway | 11 | 1.59e-01 | 2.45e-01 | 3.46e-01 |
Plasma lipoprotein clearance | 29 | 2.23e-02 | 2.45e-01 | 8.51e-02 |
NOTCH2 intracellular domain regulates transcription | 11 | 1.61e-01 | 2.44e-01 | 3.49e-01 |
RNA Polymerase I Transcription Termination | 27 | 2.88e-02 | -2.43e-01 | 1.04e-01 |
Pyrimidine salvage | 10 | 1.84e-01 | 2.43e-01 | 3.78e-01 |
ER to Golgi Anterograde Transport | 129 | 2.04e-06 | 2.42e-01 | 4.16e-05 |
RAS processing | 19 | 6.84e-02 | -2.41e-01 | 1.90e-01 |
Costimulation by the CD28 family | 74 | 3.57e-04 | -2.40e-01 | 3.18e-03 |
Cellular response to heat stress | 93 | 6.51e-05 | -2.40e-01 | 8.53e-04 |
SUMOylation of ubiquitinylation proteins | 39 | 9.70e-03 | -2.39e-01 | 4.64e-02 |
Myogenesis | 21 | 5.81e-02 | 2.39e-01 | 1.72e-01 |
Nephrin family interactions | 17 | 8.83e-02 | -2.39e-01 | 2.34e-01 |
PI-3K cascade:FGFR2 | 12 | 1.54e-01 | -2.37e-01 | 3.43e-01 |
Transport of Mature Transcript to Cytoplasm | 81 | 2.22e-04 | -2.37e-01 | 2.24e-03 |
rRNA processing in the mitochondrion | 27 | 3.33e-02 | -2.37e-01 | 1.16e-01 |
COPII-mediated vesicle transport | 65 | 9.90e-04 | 2.36e-01 | 7.58e-03 |
Signaling by RAF1 mutants | 34 | 1.74e-02 | 2.36e-01 | 7.07e-02 |
Endogenous sterols | 17 | 9.45e-02 | 2.34e-01 | 2.46e-01 |
Energy dependent regulation of mTOR by LKB1-AMPK | 27 | 3.53e-02 | 2.34e-01 | 1.20e-01 |
TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | 17 | 9.57e-02 | -2.33e-01 | 2.47e-01 |
Mitochondrial protein import | 64 | 1.29e-03 | -2.33e-01 | 9.17e-03 |
Effects of PIP2 hydrolysis | 24 | 4.98e-02 | -2.31e-01 | 1.55e-01 |
Interleukin-15 signaling | 14 | 1.34e-01 | 2.31e-01 | 3.17e-01 |
Glycosphingolipid metabolism | 36 | 1.66e-02 | 2.31e-01 | 6.88e-02 |
Cytochrome c-mediated apoptotic response | 13 | 1.50e-01 | 2.30e-01 | 3.36e-01 |
Inactivation of APC/C via direct inhibition of the APC/C complex | 21 | 6.76e-02 | -2.30e-01 | 1.90e-01 |
Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | 21 | 6.76e-02 | -2.30e-01 | 1.90e-01 |
Acetylcholine Neurotransmitter Release Cycle | 11 | 1.86e-01 | -2.30e-01 | 3.80e-01 |
Antiviral mechanism by IFN-stimulated genes | 80 | 3.74e-04 | -2.30e-01 | 3.25e-03 |
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | 12 | 1.68e-01 | 2.30e-01 | 3.59e-01 |
APC-Cdc20 mediated degradation of Nek2A | 26 | 4.32e-02 | -2.29e-01 | 1.39e-01 |
Metabolism of porphyrins | 22 | 6.35e-02 | 2.29e-01 | 1.80e-01 |
Regulation of TP53 Expression and Degradation | 36 | 1.81e-02 | -2.28e-01 | 7.26e-02 |
Frs2-mediated activation | 11 | 1.92e-01 | 2.27e-01 | 3.86e-01 |
RNA Polymerase III Transcription Termination | 23 | 5.94e-02 | -2.27e-01 | 1.73e-01 |
A tetrasaccharide linker sequence is required for GAG synthesis | 17 | 1.06e-01 | -2.27e-01 | 2.67e-01 |
Formation of the cornified envelope | 21 | 7.29e-02 | 2.26e-01 | 2.00e-01 |
HDR through Single Strand Annealing (SSA) | 37 | 1.74e-02 | -2.26e-01 | 7.07e-02 |
Interleukin-3, Interleukin-5 and GM-CSF signaling | 40 | 1.35e-02 | 2.26e-01 | 5.87e-02 |
Synthesis of PC | 24 | 5.64e-02 | 2.25e-01 | 1.67e-01 |
Clathrin-mediated endocytosis | 127 | 1.21e-05 | 2.25e-01 | 1.96e-04 |
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | 38 | 1.65e-02 | -2.25e-01 | 6.88e-02 |
HDMs demethylate histones | 22 | 6.88e-02 | 2.24e-01 | 1.90e-01 |
Regulation of Complement cascade | 95 | 1.82e-04 | -2.22e-01 | 1.97e-03 |
Inhibition of replication initiation of damaged DNA by RB1/E2F1 | 13 | 1.66e-01 | -2.22e-01 | 3.55e-01 |
Butyrophilin (BTN) family interactions | 10 | 2.25e-01 | -2.22e-01 | 4.27e-01 |
ADP signalling through P2Y purinoceptor 1 | 21 | 7.90e-02 | 2.21e-01 | 2.13e-01 |
GABA receptor activation | 35 | 2.36e-02 | 2.21e-01 | 8.87e-02 |
Late endosomal microautophagy | 30 | 3.65e-02 | 2.21e-01 | 1.23e-01 |
Activated NOTCH1 Transmits Signal to the Nucleus | 27 | 4.74e-02 | 2.20e-01 | 1.48e-01 |
Cross-presentation of soluble exogenous antigens (endosomes) | 47 | 9.26e-03 | 2.19e-01 | 4.53e-02 |
Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | 17 | 1.19e-01 | -2.19e-01 | 2.90e-01 |
Signaling by FGFR3 in disease | 13 | 1.73e-01 | -2.18e-01 | 3.65e-01 |
Signaling by FGFR3 point mutants in cancer | 13 | 1.73e-01 | -2.18e-01 | 3.65e-01 |
Processing of Capped Intron-Containing Pre-mRNA | 238 | 6.69e-09 | -2.18e-01 | 2.28e-07 |
Assembly of active LPL and LIPC lipase complexes | 10 | 2.33e-01 | 2.18e-01 | 4.39e-01 |
Cobalamin (Cbl, vitamin B12) transport and metabolism | 16 | 1.32e-01 | -2.18e-01 | 3.15e-01 |
Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon | 17 | 1.21e-01 | 2.17e-01 | 2.95e-01 |
Semaphorin interactions | 57 | 4.86e-03 | 2.16e-01 | 2.68e-02 |
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer’s disease models | 21 | 8.84e-02 | 2.15e-01 | 2.34e-01 |
Neurodegenerative Diseases | 21 | 8.84e-02 | 2.15e-01 | 2.34e-01 |
InlB-mediated entry of Listeria monocytogenes into host cell | 12 | 1.98e-01 | 2.14e-01 | 3.95e-01 |
Base Excision Repair | 58 | 4.84e-03 | -2.14e-01 | 2.68e-02 |
Complement cascade | 99 | 2.37e-04 | -2.14e-01 | 2.36e-03 |
Sealing of the nuclear envelope (NE) by ESCRT-III | 25 | 6.47e-02 | 2.13e-01 | 1.83e-01 |
Glutathione conjugation | 26 | 6.02e-02 | 2.13e-01 | 1.74e-01 |
Signaling by Activin | 10 | 2.44e-01 | -2.13e-01 | 4.51e-01 |
Resolution of Sister Chromatid Cohesion | 104 | 1.80e-04 | -2.13e-01 | 1.97e-03 |
FOXO-mediated transcription of cell cycle genes | 15 | 1.55e-01 | -2.12e-01 | 3.44e-01 |
Cargo recognition for clathrin-mediated endocytosis | 90 | 5.06e-04 | 2.12e-01 | 4.26e-03 |
PPARA activates gene expression | 104 | 1.94e-04 | 2.11e-01 | 2.04e-03 |
Regulation of TP53 Degradation | 35 | 3.04e-02 | -2.11e-01 | 1.07e-01 |
Spry regulation of FGF signaling | 16 | 1.44e-01 | 2.11e-01 | 3.31e-01 |
KSRP (KHSRP) binds and destabilizes mRNA | 17 | 1.32e-01 | -2.11e-01 | 3.15e-01 |
RAB GEFs exchange GTP for GDP on RABs | 88 | 6.40e-04 | 2.11e-01 | 5.35e-03 |
TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | 14 | 1.73e-01 | -2.10e-01 | 3.65e-01 |
RA biosynthesis pathway | 13 | 1.90e-01 | -2.10e-01 | 3.84e-01 |
Diseases of carbohydrate metabolism | 29 | 5.18e-02 | 2.09e-01 | 1.58e-01 |
Deadenylation of mRNA | 22 | 9.08e-02 | -2.08e-01 | 2.38e-01 |
S Phase | 160 | 5.65e-06 | -2.08e-01 | 1.01e-04 |
mRNA Splicing - Major Pathway | 179 | 1.67e-06 | -2.08e-01 | 3.49e-05 |
Inflammasomes | 20 | 1.08e-01 | 2.07e-01 | 2.70e-01 |
EPH-ephrin mediated repulsion of cells | 40 | 2.32e-02 | 2.07e-01 | 8.77e-02 |
Activation of GABAB receptors | 30 | 5.03e-02 | 2.06e-01 | 1.55e-01 |
GABA B receptor activation | 30 | 5.03e-02 | 2.06e-01 | 1.55e-01 |
ER-Phagosome pathway | 82 | 1.26e-03 | 2.06e-01 | 9.01e-03 |
Deposition of new CENPA-containing nucleosomes at the centromere | 40 | 2.57e-02 | -2.04e-01 | 9.48e-02 |
Nucleosome assembly | 40 | 2.57e-02 | -2.04e-01 | 9.48e-02 |
Defective B3GALT6 causes EDSP2 and SEMDJL1 | 11 | 2.42e-01 | -2.04e-01 | 4.51e-01 |
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | 33 | 4.31e-02 | 2.03e-01 | 1.39e-01 |
Erythrocytes take up carbon dioxide and release oxygen | 12 | 2.24e-01 | 2.03e-01 | 4.26e-01 |
O2/CO2 exchange in erythrocytes | 12 | 2.24e-01 | 2.03e-01 | 4.26e-01 |
Cellular response to hypoxia | 71 | 3.15e-03 | 2.03e-01 | 1.87e-02 |
HDR through Homologous Recombination (HRR) | 66 | 4.48e-03 | -2.02e-01 | 2.50e-02 |
Mitophagy | 28 | 6.47e-02 | -2.02e-01 | 1.83e-01 |
Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | 91 | 8.84e-04 | -2.02e-01 | 6.96e-03 |
Amplification of signal from the kinetochores | 91 | 8.84e-04 | -2.02e-01 | 6.96e-03 |
Processing and activation of SUMO | 10 | 2.72e-01 | -2.01e-01 | 4.82e-01 |
Regulation of lipid metabolism by PPARalpha | 106 | 3.61e-04 | 2.00e-01 | 3.18e-03 |
Mitotic Prometaphase | 184 | 2.79e-06 | -2.00e-01 | 5.44e-05 |
TBC/RABGAPs | 45 | 2.01e-02 | 2.00e-01 | 7.81e-02 |
Response of Mtb to phagocytosis | 22 | 1.04e-01 | 2.00e-01 | 2.64e-01 |
mRNA Splicing | 187 | 2.51e-06 | -2.00e-01 | 4.96e-05 |
Polo-like kinase mediated events | 16 | 1.70e-01 | -1.98e-01 | 3.61e-01 |
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | 182 | 4.09e-06 | -1.98e-01 | 7.55e-05 |
EML4 and NUDC in mitotic spindle formation | 95 | 8.64e-04 | -1.98e-01 | 6.88e-03 |
Innate Immune System | 966 | 2.58e-25 | 1.97e-01 | 1.47e-23 |
G beta:gamma signalling through PI3Kgamma | 22 | 1.10e-01 | 1.97e-01 | 2.73e-01 |
RNA Polymerase III Transcription Initiation | 36 | 4.14e-02 | -1.96e-01 | 1.36e-01 |
Metabolism of amino acids and derivatives | 324 | 1.23e-09 | -1.96e-01 | 4.29e-08 |
MyD88:MAL(TIRAP) cascade initiated on plasma membrane | 92 | 1.17e-03 | 1.96e-01 | 8.47e-03 |
Toll Like Receptor 2 (TLR2) Cascade | 92 | 1.17e-03 | 1.96e-01 | 8.47e-03 |
Toll Like Receptor TLR1:TLR2 Cascade | 92 | 1.17e-03 | 1.96e-01 | 8.47e-03 |
Toll Like Receptor TLR6:TLR2 Cascade | 92 | 1.17e-03 | 1.96e-01 | 8.47e-03 |
GP1b-IX-V activation signalling | 10 | 2.85e-01 | -1.95e-01 | 4.95e-01 |
NCAM1 interactions | 23 | 1.06e-01 | -1.95e-01 | 2.67e-01 |
DCC mediated attractive signaling | 13 | 2.24e-01 | -1.95e-01 | 4.26e-01 |
SUMOylation of DNA methylation proteins | 16 | 1.78e-01 | -1.95e-01 | 3.72e-01 |
PIWI-interacting RNA (piRNA) biogenesis | 23 | 1.07e-01 | -1.94e-01 | 2.69e-01 |
Paradoxical activation of RAF signaling by kinase inactive BRAF | 38 | 3.84e-02 | 1.94e-01 | 1.27e-01 |
Signaling by RAS mutants | 38 | 3.84e-02 | 1.94e-01 | 1.27e-01 |
Signaling by moderate kinase activity BRAF mutants | 38 | 3.84e-02 | 1.94e-01 | 1.27e-01 |
Signaling downstream of RAS mutants | 38 | 3.84e-02 | 1.94e-01 | 1.27e-01 |
Assembly and cell surface presentation of NMDA receptors | 18 | 1.57e-01 | -1.93e-01 | 3.46e-01 |
RNA Polymerase I Promoter Opening | 19 | 1.46e-01 | 1.92e-01 | 3.32e-01 |
Diseases associated with glycosylation precursor biosynthesis | 18 | 1.58e-01 | 1.92e-01 | 3.46e-01 |
G1/S Transition | 130 | 1.54e-04 | -1.92e-01 | 1.71e-03 |
Signalling to ERKs | 32 | 6.08e-02 | 1.91e-01 | 1.74e-01 |
Regulation of TP53 Activity through Association with Co-factors | 11 | 2.72e-01 | -1.91e-01 | 4.82e-01 |
Mitochondrial calcium ion transport | 22 | 1.21e-01 | -1.91e-01 | 2.94e-01 |
Interleukin-1 signaling | 97 | 1.15e-03 | 1.91e-01 | 8.47e-03 |
TNFR1-induced proapoptotic signaling | 12 | 2.52e-01 | -1.91e-01 | 4.58e-01 |
PI-3K cascade:FGFR4 | 10 | 2.97e-01 | -1.91e-01 | 5.08e-01 |
FOXO-mediated transcription of cell death genes | 16 | 1.87e-01 | 1.91e-01 | 3.80e-01 |
RNA Polymerase III Transcription Initiation From Type 3 Promoter | 28 | 8.16e-02 | -1.90e-01 | 2.19e-01 |
Mitotic Spindle Checkpoint | 108 | 6.58e-04 | -1.90e-01 | 5.47e-03 |
Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | 14 | 2.19e-01 | 1.90e-01 | 4.21e-01 |
Gap-filling DNA repair synthesis and ligation in TC-NER | 64 | 8.75e-03 | -1.89e-01 | 4.34e-02 |
NOTCH4 Intracellular Domain Regulates Transcription | 17 | 1.77e-01 | 1.89e-01 | 3.71e-01 |
Smooth Muscle Contraction | 31 | 6.84e-02 | 1.89e-01 | 1.90e-01 |
Dual incision in TC-NER | 65 | 8.43e-03 | -1.89e-01 | 4.22e-02 |
HSF1 activation | 26 | 9.59e-02 | -1.89e-01 | 2.47e-01 |
Tryptophan catabolism | 12 | 2.58e-01 | 1.88e-01 | 4.66e-01 |
Membrane binding and targetting of GAG proteins | 13 | 2.40e-01 | 1.88e-01 | 4.47e-01 |
Synthesis And Processing Of GAG, GAGPOL Polyproteins | 13 | 2.40e-01 | 1.88e-01 | 4.47e-01 |
Acyl chain remodelling of PC | 19 | 1.56e-01 | 1.88e-01 | 3.45e-01 |
Olfactory Signaling Pathway | 58 | 1.33e-02 | 1.88e-01 | 5.80e-02 |
Toll Like Receptor 4 (TLR4) Cascade | 121 | 3.58e-04 | 1.88e-01 | 3.18e-03 |
Formation of apoptosome | 11 | 2.81e-01 | 1.88e-01 | 4.92e-01 |
Regulation of the apoptosome activity | 11 | 2.81e-01 | 1.88e-01 | 4.92e-01 |
Signaling by NOTCH4 | 78 | 4.14e-03 | 1.88e-01 | 2.34e-02 |
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | 31 | 7.05e-02 | -1.88e-01 | 1.95e-01 |
Assembly Of The HIV Virion | 15 | 2.09e-01 | 1.87e-01 | 4.09e-01 |
RORA activates gene expression | 18 | 1.69e-01 | 1.87e-01 | 3.60e-01 |
Regulation of TP53 Activity | 151 | 7.29e-05 | -1.87e-01 | 9.11e-04 |
TRAF3-dependent IRF activation pathway | 13 | 2.44e-01 | 1.87e-01 | 4.51e-01 |
TRAF6 mediated IRF7 activation | 15 | 2.13e-01 | 1.86e-01 | 4.16e-01 |
Interconversion of nucleotide di- and triphosphates | 27 | 9.57e-02 | -1.85e-01 | 2.47e-01 |
TP53 Regulates Transcription of Cell Cycle Genes | 48 | 2.64e-02 | -1.85e-01 | 9.67e-02 |
Pre-NOTCH Expression and Processing | 65 | 9.90e-03 | 1.85e-01 | 4.68e-02 |
HuR (ELAVL1) binds and stabilizes mRNA | 10 | 3.11e-01 | 1.85e-01 | 5.22e-01 |
HCMV Early Events | 74 | 5.95e-03 | -1.85e-01 | 3.17e-02 |
Retinoid metabolism and transport | 24 | 1.17e-01 | 1.85e-01 | 2.87e-01 |
Transport to the Golgi and subsequent modification | 155 | 7.38e-05 | 1.84e-01 | 9.15e-04 |
Phase 4 - resting membrane potential | 10 | 3.13e-01 | 1.84e-01 | 5.22e-01 |
MET promotes cell motility | 26 | 1.04e-01 | 1.84e-01 | 2.64e-01 |
mRNA Splicing - Minor Pathway | 52 | 2.16e-02 | -1.84e-01 | 8.34e-02 |
RNA Polymerase II Transcription Termination | 65 | 1.03e-02 | -1.84e-01 | 4.83e-02 |
Activation of G protein gated Potassium channels | 19 | 1.66e-01 | 1.84e-01 | 3.55e-01 |
G protein gated Potassium channels | 19 | 1.66e-01 | 1.84e-01 | 3.55e-01 |
Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | 19 | 1.66e-01 | 1.84e-01 | 3.55e-01 |
Processing of Capped Intronless Pre-mRNA | 28 | 9.25e-02 | -1.84e-01 | 2.41e-01 |
Rab regulation of trafficking | 121 | 4.86e-04 | 1.84e-01 | 4.14e-03 |
Gene Silencing by RNA | 87 | 3.09e-03 | -1.84e-01 | 1.84e-02 |
L1CAM interactions | 85 | 3.48e-03 | 1.83e-01 | 2.04e-02 |
Mitotic Telophase/Cytokinesis | 13 | 2.53e-01 | -1.83e-01 | 4.59e-01 |
Trafficking and processing of endosomal TLR | 13 | 2.55e-01 | 1.82e-01 | 4.61e-01 |
Signal amplification | 28 | 9.51e-02 | 1.82e-01 | 2.46e-01 |
Intra-Golgi traffic | 43 | 3.87e-02 | 1.82e-01 | 1.28e-01 |
APC/C:Cdc20 mediated degradation of Cyclin B | 24 | 1.23e-01 | -1.82e-01 | 2.97e-01 |
Cell recruitment (pro-inflammatory response) | 22 | 1.41e-01 | 1.81e-01 | 3.29e-01 |
Purinergic signaling in leishmaniasis infection | 22 | 1.41e-01 | 1.81e-01 | 3.29e-01 |
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | 64 | 1.21e-02 | 1.81e-01 | 5.43e-02 |
SUMOylation | 165 | 5.95e-05 | -1.81e-01 | 8.07e-04 |
MTOR signalling | 39 | 5.03e-02 | 1.81e-01 | 1.55e-01 |
FCERI mediated NF-kB activation | 137 | 2.59e-04 | -1.81e-01 | 2.50e-03 |
Potassium Channels | 63 | 1.31e-02 | 1.81e-01 | 5.73e-02 |
Processing of SMDT1 | 15 | 2.26e-01 | -1.81e-01 | 4.28e-01 |
Amino acids regulate mTORC1 | 50 | 2.74e-02 | 1.80e-01 | 9.97e-02 |
EPHA-mediated growth cone collapse | 13 | 2.60e-01 | 1.80e-01 | 4.68e-01 |
Adherens junctions interactions | 18 | 1.86e-01 | 1.80e-01 | 3.80e-01 |
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | 27 | 1.06e-01 | -1.80e-01 | 2.67e-01 |
Toll-like Receptor Cascades | 143 | 2.05e-04 | 1.80e-01 | 2.11e-03 |
Cytosolic sulfonation of small molecules | 18 | 1.87e-01 | 1.80e-01 | 3.80e-01 |
Presynaptic function of Kainate receptors | 18 | 1.87e-01 | 1.80e-01 | 3.80e-01 |
Formation of ATP by chemiosmotic coupling | 18 | 1.88e-01 | 1.79e-01 | 3.83e-01 |
IRF3-mediated induction of type I IFN | 12 | 2.83e-01 | -1.79e-01 | 4.95e-01 |
Transcription-Coupled Nucleotide Excision Repair (TC-NER) | 78 | 6.34e-03 | -1.79e-01 | 3.35e-02 |
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | 16 | 2.16e-01 | 1.79e-01 | 4.19e-01 |
Apoptotic factor-mediated response | 18 | 1.89e-01 | 1.79e-01 | 3.84e-01 |
PERK regulates gene expression | 30 | 9.04e-02 | -1.79e-01 | 2.38e-01 |
Common Pathway of Fibrin Clot Formation | 14 | 2.48e-01 | 1.78e-01 | 4.55e-01 |
Hedgehog ligand biogenesis | 58 | 1.89e-02 | 1.78e-01 | 7.52e-02 |
ABC transporters in lipid homeostasis | 14 | 2.49e-01 | -1.78e-01 | 4.55e-01 |
Signaling by MET | 61 | 1.64e-02 | 1.78e-01 | 6.87e-02 |
Nucleotide salvage | 21 | 1.59e-01 | 1.77e-01 | 3.47e-01 |
Membrane Trafficking | 558 | 8.92e-13 | 1.77e-01 | 3.68e-11 |
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | 22 | 1.52e-01 | 1.77e-01 | 3.39e-01 |
Gene expression (Transcription) | 1323 | 4.44e-27 | -1.76e-01 | 3.02e-25 |
Positive epigenetic regulation of rRNA expression | 59 | 1.95e-02 | -1.76e-01 | 7.63e-02 |
RUNX3 regulates NOTCH signaling | 14 | 2.55e-01 | 1.76e-01 | 4.61e-01 |
Synthesis of DNA | 118 | 9.81e-04 | -1.76e-01 | 7.56e-03 |
Interleukin-6 signaling | 10 | 3.36e-01 | 1.76e-01 | 5.49e-01 |
Thrombin signalling through proteinase activated receptors (PARs) | 27 | 1.16e-01 | 1.75e-01 | 2.85e-01 |
Caspase activation via Death Receptors in the presence of ligand | 16 | 2.27e-01 | 1.74e-01 | 4.29e-01 |
Apoptosis induced DNA fragmentation | 10 | 3.42e-01 | 1.74e-01 | 5.54e-01 |
Hh mutants that don’t undergo autocatalytic processing are degraded by ERAD | 53 | 2.91e-02 | 1.73e-01 | 1.04e-01 |
RNA Polymerase III Abortive And Retractive Initiation | 41 | 5.53e-02 | -1.73e-01 | 1.65e-01 |
RNA Polymerase III Transcription | 41 | 5.53e-02 | -1.73e-01 | 1.65e-01 |
IRAK2 mediated activation of TAK1 complex | 10 | 3.46e-01 | -1.72e-01 | 5.57e-01 |
ZBP1(DAI) mediated induction of type I IFNs | 20 | 1.82e-01 | 1.72e-01 | 3.78e-01 |
SHC-mediated cascade:FGFR2 | 12 | 3.03e-01 | -1.72e-01 | 5.16e-01 |
Interleukin-1 family signaling | 124 | 9.64e-04 | 1.72e-01 | 7.46e-03 |
Ras activation upon Ca2+ influx through NMDA receptor | 15 | 2.50e-01 | -1.72e-01 | 4.55e-01 |
SUMO E3 ligases SUMOylate target proteins | 159 | 1.91e-04 | -1.71e-01 | 2.02e-03 |
Signaling by SCF-KIT | 40 | 6.15e-02 | 1.71e-01 | 1.76e-01 |
Synthesis, secretion, and deacylation of Ghrelin | 12 | 3.06e-01 | -1.71e-01 | 5.19e-01 |
Transport of bile salts and organic acids, metal ions and amine compounds | 55 | 2.91e-02 | 1.70e-01 | 1.04e-01 |
Regulation of PTEN stability and activity | 66 | 1.72e-02 | 1.70e-01 | 7.07e-02 |
Golgi-to-ER retrograde transport | 111 | 2.10e-03 | 1.69e-01 | 1.35e-02 |
Infection with Mycobacterium tuberculosis | 26 | 1.36e-01 | 1.69e-01 | 3.21e-01 |
Regulation of ornithine decarboxylase (ODC) | 49 | 4.16e-02 | 1.68e-01 | 1.36e-01 |
Triglyceride catabolism | 16 | 2.45e-01 | 1.68e-01 | 4.52e-01 |
BMAL1:CLOCK,NPAS2 activates circadian gene expression | 25 | 1.47e-01 | 1.67e-01 | 3.32e-01 |
Cyclin A/B1/B2 associated events during G2/M transition | 25 | 1.48e-01 | -1.67e-01 | 3.32e-01 |
ATF4 activates genes in response to endoplasmic reticulum stress | 25 | 1.48e-01 | -1.67e-01 | 3.32e-01 |
Interleukin-27 signaling | 11 | 3.38e-01 | 1.67e-01 | 5.50e-01 |
Defective EXT1 causes exostoses 1, TRPS2 and CHDS | 10 | 3.61e-01 | -1.67e-01 | 5.73e-01 |
Defective EXT2 causes exostoses 2 | 10 | 3.61e-01 | -1.67e-01 | 5.73e-01 |
N-Glycan antennae elongation | 13 | 2.99e-01 | -1.67e-01 | 5.10e-01 |
Iron uptake and transport | 52 | 3.78e-02 | 1.67e-01 | 1.26e-01 |
Carboxyterminal post-translational modifications of tubulin | 26 | 1.44e-01 | 1.66e-01 | 3.31e-01 |
Eicosanoid ligand-binding receptors | 13 | 3.02e-01 | -1.65e-01 | 5.15e-01 |
Signaling by FGFR4 in disease | 11 | 3.42e-01 | -1.65e-01 | 5.54e-01 |
Generic Transcription Pathway | 1077 | 5.34e-20 | -1.65e-01 | 2.60e-18 |
Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | 20 | 2.02e-01 | -1.65e-01 | 4.00e-01 |
Pre-NOTCH Transcription and Translation | 49 | 4.66e-02 | 1.64e-01 | 1.47e-01 |
DNA Replication | 125 | 1.51e-03 | -1.64e-01 | 1.02e-02 |
RAF activation | 32 | 1.08e-01 | 1.64e-01 | 2.70e-01 |
Global Genome Nucleotide Excision Repair (GG-NER) | 84 | 9.36e-03 | -1.64e-01 | 4.56e-02 |
Interleukin-37 signaling | 19 | 2.17e-01 | 1.63e-01 | 4.20e-01 |
FRS-mediated FGFR2 signaling | 14 | 2.90e-01 | -1.63e-01 | 5.01e-01 |
Glycogen storage diseases | 13 | 3.08e-01 | 1.63e-01 | 5.21e-01 |
NOTCH3 Activation and Transmission of Signal to the Nucleus | 23 | 1.76e-01 | 1.63e-01 | 3.69e-01 |
RAB geranylgeranylation | 60 | 2.91e-02 | 1.63e-01 | 1.04e-01 |
Toll Like Receptor 7/8 (TLR7/8) Cascade | 89 | 7.99e-03 | 1.63e-01 | 4.05e-02 |
Caspase-mediated cleavage of cytoskeletal proteins | 12 | 3.29e-01 | 1.63e-01 | 5.42e-01 |
Class I peroxisomal membrane protein import | 20 | 2.09e-01 | -1.62e-01 | 4.09e-01 |
PCP/CE pathway | 86 | 9.42e-03 | 1.62e-01 | 4.57e-02 |
Signaling by cytosolic FGFR1 fusion mutants | 17 | 2.48e-01 | 1.62e-01 | 4.55e-01 |
Regulation of TP53 Activity through Phosphorylation | 88 | 8.97e-03 | -1.61e-01 | 4.43e-02 |
Defective CFTR causes cystic fibrosis | 59 | 3.24e-02 | 1.61e-01 | 1.13e-01 |
ERK/MAPK targets | 22 | 1.92e-01 | 1.61e-01 | 3.86e-01 |
Cilium Assembly | 180 | 1.99e-04 | -1.61e-01 | 2.06e-03 |
Unblocking of NMDA receptors, glutamate binding and activation | 12 | 3.35e-01 | -1.61e-01 | 5.49e-01 |
Collagen formation | 66 | 2.41e-02 | 1.61e-01 | 9.02e-02 |
Syndecan interactions | 19 | 2.27e-01 | -1.60e-01 | 4.28e-01 |
FGFR2 mutant receptor activation | 22 | 1.93e-01 | -1.60e-01 | 3.88e-01 |
GRB2 events in ERBB2 signaling | 11 | 3.58e-01 | -1.60e-01 | 5.70e-01 |
Processing of DNA double-strand break ends | 71 | 1.98e-02 | -1.60e-01 | 7.73e-02 |
Downregulation of TGF-beta receptor signaling | 26 | 1.58e-01 | -1.60e-01 | 3.46e-01 |
G beta:gamma signalling through CDC42 | 17 | 2.54e-01 | 1.60e-01 | 4.61e-01 |
Integration of energy metabolism | 86 | 1.07e-02 | 1.59e-01 | 4.96e-02 |
Defective B3GAT3 causes JDSSDHD | 11 | 3.62e-01 | -1.59e-01 | 5.73e-01 |
Lysosphingolipid and LPA receptors | 11 | 3.62e-01 | -1.59e-01 | 5.73e-01 |
MET activates RAS signaling | 10 | 3.85e-01 | 1.59e-01 | 5.92e-01 |
Hh mutants abrogate ligand secretion | 54 | 4.49e-02 | 1.58e-01 | 1.43e-01 |
Suppression of phagosomal maturation | 12 | 3.44e-01 | 1.58e-01 | 5.56e-01 |
Regulation of activated PAK-2p34 by proteasome mediated degradation | 48 | 5.90e-02 | 1.58e-01 | 1.73e-01 |
RNA Polymerase II Transcription | 1196 | 4.47e-20 | -1.57e-01 | 2.26e-18 |
VEGFA-VEGFR2 Pathway | 92 | 9.27e-03 | 1.57e-01 | 4.53e-02 |
Recruitment of NuMA to mitotic centrosomes | 79 | 1.59e-02 | -1.57e-01 | 6.73e-02 |
FGFR1 mutant receptor activation | 23 | 1.93e-01 | 1.57e-01 | 3.88e-01 |
mTORC1-mediated signalling | 24 | 1.84e-01 | 1.57e-01 | 3.78e-01 |
Regulation of PLK1 Activity at G2/M Transition | 86 | 1.21e-02 | -1.57e-01 | 5.41e-02 |
Translocation of SLC2A4 (GLUT4) to the plasma membrane | 48 | 6.08e-02 | 1.56e-01 | 1.74e-01 |
Prolactin receptor signaling | 11 | 3.69e-01 | -1.56e-01 | 5.81e-01 |
Signaling by NODAL | 13 | 3.30e-01 | -1.56e-01 | 5.42e-01 |
RIP-mediated NFkB activation via ZBP1 | 17 | 2.67e-01 | 1.56e-01 | 4.76e-01 |
Sphingolipid metabolism | 78 | 1.76e-02 | 1.56e-01 | 7.10e-02 |
Signaling by BRAF and RAF fusions | 57 | 4.25e-02 | 1.55e-01 | 1.39e-01 |
The phototransduction cascade | 25 | 1.79e-01 | -1.55e-01 | 3.73e-01 |
RUNX2 regulates bone development | 23 | 1.98e-01 | 1.55e-01 | 3.95e-01 |
Formation of Incision Complex in GG-NER | 43 | 7.88e-02 | -1.55e-01 | 2.13e-01 |
Assembly of collagen fibrils and other multimeric structures | 42 | 8.24e-02 | 1.55e-01 | 2.20e-01 |
TP53 Regulates Transcription of Death Receptors and Ligands | 11 | 3.74e-01 | -1.55e-01 | 5.87e-01 |
MyD88 dependent cascade initiated on endosome | 88 | 1.25e-02 | 1.54e-01 | 5.53e-02 |
DNA Repair | 289 | 6.78e-06 | -1.54e-01 | 1.16e-04 |
Platelet activation, signaling and aggregation | 221 | 8.16e-05 | 1.54e-01 | 1.00e-03 |
Lysine catabolism | 11 | 3.78e-01 | 1.54e-01 | 5.89e-01 |
p130Cas linkage to MAPK signaling for integrins | 11 | 3.78e-01 | 1.54e-01 | 5.89e-01 |
Gastrin-CREB signalling pathway via PKC and MAPK | 14 | 3.20e-01 | 1.53e-01 | 5.32e-01 |
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | 14 | 3.22e-01 | 1.53e-01 | 5.33e-01 |
Nucleotide Excision Repair | 110 | 5.66e-03 | -1.53e-01 | 3.07e-02 |
G2/M DNA damage checkpoint | 68 | 3.00e-02 | -1.52e-01 | 1.06e-01 |
Cell Cycle | 623 | 8.80e-11 | -1.52e-01 | 3.24e-09 |
Degradation of DVL | 54 | 5.48e-02 | 1.51e-01 | 1.65e-01 |
Vif-mediated degradation of APOBEC3G | 52 | 6.03e-02 | 1.51e-01 | 1.74e-01 |
Signaling by BMP | 21 | 2.34e-01 | -1.50e-01 | 4.39e-01 |
Inwardly rectifying K+ channels | 23 | 2.15e-01 | 1.49e-01 | 4.18e-01 |
Downstream signaling of activated FGFR2 | 19 | 2.60e-01 | -1.49e-01 | 4.67e-01 |
HATs acetylate histones | 93 | 1.29e-02 | -1.49e-01 | 5.67e-02 |
XBP1(S) activates chaperone genes | 47 | 7.76e-02 | 1.49e-01 | 2.10e-01 |
Mitotic G1 phase and G1/S transition | 148 | 1.80e-03 | -1.49e-01 | 1.17e-02 |
Signaling by FGFR2 in disease | 32 | 1.46e-01 | -1.48e-01 | 3.32e-01 |
Oncogenic MAPK signaling | 73 | 2.86e-02 | 1.48e-01 | 1.03e-01 |
Negative regulation of NMDA receptor-mediated neuronal transmission | 14 | 3.39e-01 | -1.48e-01 | 5.50e-01 |
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | 87 | 1.73e-02 | 1.48e-01 | 7.07e-02 |
Centrosome maturation | 80 | 2.29e-02 | -1.47e-01 | 8.71e-02 |
Recruitment of mitotic centrosome proteins and complexes | 80 | 2.29e-02 | -1.47e-01 | 8.71e-02 |
Signaling by NTRKs | 116 | 6.47e-03 | 1.46e-01 | 3.39e-02 |
DNA Double-Strand Break Repair | 135 | 3.38e-03 | -1.46e-01 | 1.99e-02 |
Signaling by the B Cell Receptor (BCR) | 162 | 1.38e-03 | -1.46e-01 | 9.43e-03 |
Anti-inflammatory response favouring Leishmania parasite infection | 169 | 1.13e-03 | -1.45e-01 | 8.38e-03 |
Leishmania parasite growth and survival | 169 | 1.13e-03 | -1.45e-01 | 8.38e-03 |
RNA Polymerase I Promoter Clearance | 63 | 4.65e-02 | -1.45e-01 | 1.47e-01 |
RNA Polymerase I Transcription | 63 | 4.65e-02 | -1.45e-01 | 1.47e-01 |
Transcriptional regulation of white adipocyte differentiation | 77 | 2.79e-02 | 1.45e-01 | 1.02e-01 |
mRNA 3’-end processing | 56 | 6.16e-02 | -1.44e-01 | 1.76e-01 |
Beta-catenin phosphorylation cascade | 17 | 3.03e-01 | 1.44e-01 | 5.16e-01 |
Bile acid and bile salt metabolism | 29 | 1.80e-01 | 1.44e-01 | 3.73e-01 |
Citric acid cycle (TCA cycle) | 22 | 2.43e-01 | 1.44e-01 | 4.51e-01 |
Epigenetic regulation of gene expression | 100 | 1.29e-02 | -1.44e-01 | 5.67e-02 |
Defective B4GALT7 causes EDS, progeroid type | 11 | 4.09e-01 | -1.44e-01 | 6.18e-01 |
Negative regulation of NOTCH4 signaling | 54 | 6.79e-02 | 1.44e-01 | 1.90e-01 |
Cell Cycle, Mitotic | 501 | 4.02e-08 | -1.43e-01 | 1.19e-06 |
G beta:gamma signalling through BTK | 15 | 3.37e-01 | 1.43e-01 | 5.49e-01 |
Sialic acid metabolism | 28 | 1.91e-01 | 1.43e-01 | 3.85e-01 |
Response to elevated platelet cytosolic Ca2+ | 110 | 9.74e-03 | 1.43e-01 | 4.64e-02 |
Regulation of cholesterol biosynthesis by SREBP (SREBF) | 55 | 6.78e-02 | 1.42e-01 | 1.90e-01 |
Phosphorylation of the APC/C | 20 | 2.70e-01 | -1.42e-01 | 4.81e-01 |
G beta:gamma signalling through PLC beta | 17 | 3.11e-01 | 1.42e-01 | 5.22e-01 |
Homology Directed Repair | 110 | 1.01e-02 | -1.42e-01 | 4.74e-02 |
Cell Cycle Checkpoints | 259 | 8.41e-05 | -1.42e-01 | 1.02e-03 |
NR1H2 and NR1H3-mediated signaling | 39 | 1.26e-01 | 1.42e-01 | 3.02e-01 |
Signaling by Insulin receptor | 59 | 6.04e-02 | 1.41e-01 | 1.74e-01 |
Negative regulation of FGFR1 signaling | 24 | 2.33e-01 | 1.41e-01 | 4.39e-01 |
Metabolism of fat-soluble vitamins | 28 | 1.99e-01 | 1.40e-01 | 3.95e-01 |
IKK complex recruitment mediated by RIP1 | 23 | 2.44e-01 | 1.40e-01 | 4.51e-01 |
Post-chaperonin tubulin folding pathway | 19 | 2.91e-01 | 1.40e-01 | 5.02e-01 |
Acyl chain remodelling of PI | 10 | 4.44e-01 | 1.40e-01 | 6.45e-01 |
Ion channel transport | 133 | 5.68e-03 | 1.39e-01 | 3.07e-02 |
Signaling by NOTCH1 | 66 | 5.11e-02 | 1.39e-01 | 1.57e-01 |
Regulation of Apoptosis | 51 | 8.63e-02 | 1.39e-01 | 2.29e-01 |
Degradation of GLI1 by the proteasome | 57 | 7.11e-02 | 1.38e-01 | 1.96e-01 |
Interleukin-10 signaling | 34 | 1.63e-01 | 1.38e-01 | 3.52e-01 |
Signaling by NOTCH | 182 | 1.32e-03 | 1.38e-01 | 9.29e-03 |
Inactivation, recovery and regulation of the phototransduction cascade | 24 | 2.43e-01 | -1.38e-01 | 4.51e-01 |
PKA activation in glucagon signalling | 14 | 3.72e-01 | 1.38e-01 | 5.85e-01 |
Rho GTPase cycle | 126 | 7.63e-03 | 1.38e-01 | 3.90e-02 |
Platelet Aggregation (Plug Formation) | 28 | 2.08e-01 | 1.38e-01 | 4.08e-01 |
Asparagine N-linked glycosylation | 269 | 1.06e-04 | 1.37e-01 | 1.26e-03 |
Pregnenolone biosynthesis | 10 | 4.53e-01 | 1.37e-01 | 6.56e-01 |
TP53 Regulates Transcription of Caspase Activators and Caspases | 11 | 4.32e-01 | -1.37e-01 | 6.33e-01 |
Platelet degranulation | 106 | 1.50e-02 | 1.37e-01 | 6.35e-02 |
RET signaling | 32 | 1.83e-01 | 1.36e-01 | 3.78e-01 |
ABC transporter disorders | 70 | 4.99e-02 | 1.36e-01 | 1.55e-01 |
IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | 15 | 3.67e-01 | 1.35e-01 | 5.78e-01 |
Kinesins | 39 | 1.47e-01 | -1.34e-01 | 3.32e-01 |
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | 51 | 9.71e-02 | 1.34e-01 | 2.49e-01 |
Oncogene Induced Senescence | 33 | 1.83e-01 | 1.34e-01 | 3.78e-01 |
AURKA Activation by TPX2 | 71 | 5.11e-02 | -1.34e-01 | 1.57e-01 |
Interleukin-2 family signaling | 38 | 1.54e-01 | 1.34e-01 | 3.43e-01 |
Regulation of TP53 Activity through Methylation | 19 | 3.14e-01 | -1.33e-01 | 5.23e-01 |
IRE1alpha activates chaperones | 49 | 1.07e-01 | 1.33e-01 | 2.68e-01 |
Striated Muscle Contraction | 23 | 2.70e-01 | 1.33e-01 | 4.81e-01 |
FGFR2 alternative splicing | 25 | 2.50e-01 | -1.33e-01 | 4.55e-01 |
Anchoring of the basal body to the plasma membrane | 96 | 2.46e-02 | -1.33e-01 | 9.18e-02 |
NCAM signaling for neurite out-growth | 43 | 1.32e-01 | -1.33e-01 | 3.15e-01 |
Cell surface interactions at the vascular wall | 174 | 2.60e-03 | -1.32e-01 | 1.61e-02 |
Signaling by VEGF | 100 | 2.22e-02 | 1.32e-01 | 8.51e-02 |
Loss of Nlp from mitotic centrosomes | 68 | 5.94e-02 | -1.32e-01 | 1.73e-01 |
Loss of proteins required for interphase microtubule organization from the centrosome | 68 | 5.94e-02 | -1.32e-01 | 1.73e-01 |
TRAF6 mediated NF-kB activation | 23 | 2.73e-01 | 1.32e-01 | 4.82e-01 |
Interleukin-35 Signalling | 12 | 4.29e-01 | -1.32e-01 | 6.31e-01 |
Signaling by NTRK1 (TRKA) | 101 | 2.23e-02 | 1.32e-01 | 8.51e-02 |
Signaling by Hippo | 18 | 3.36e-01 | 1.31e-01 | 5.49e-01 |
Transcriptional regulation by small RNAs | 63 | 7.24e-02 | -1.31e-01 | 1.99e-01 |
Protein methylation | 15 | 3.81e-01 | -1.31e-01 | 5.90e-01 |
GAB1 signalosome | 15 | 3.81e-01 | 1.31e-01 | 5.90e-01 |
Toll Like Receptor 9 (TLR9) Cascade | 92 | 3.09e-02 | 1.30e-01 | 1.08e-01 |
WNT ligand biogenesis and trafficking | 21 | 3.07e-01 | 1.29e-01 | 5.20e-01 |
MyD88-independent TLR4 cascade | 96 | 2.93e-02 | 1.29e-01 | 1.04e-01 |
TRIF(TICAM1)-mediated TLR4 signaling | 96 | 2.93e-02 | 1.29e-01 | 1.04e-01 |
FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | 52 | 1.10e-01 | 1.28e-01 | 2.73e-01 |
Translation of Replicase and Assembly of the Replication Transcription Complex | 12 | 4.42e-01 | 1.28e-01 | 6.45e-01 |
Non-integrin membrane-ECM interactions | 37 | 1.78e-01 | -1.28e-01 | 3.72e-01 |
Deactivation of the beta-catenin transactivating complex | 36 | 1.84e-01 | -1.28e-01 | 3.78e-01 |
Synthesis of PE | 12 | 4.43e-01 | -1.28e-01 | 6.45e-01 |
Platelet homeostasis | 68 | 6.86e-02 | 1.28e-01 | 1.90e-01 |
B-WICH complex positively regulates rRNA expression | 44 | 1.43e-01 | -1.28e-01 | 3.31e-01 |
Ubiquitin Mediated Degradation of Phosphorylated Cdc25A | 50 | 1.23e-01 | 1.26e-01 | 2.96e-01 |
p53-Independent DNA Damage Response | 50 | 1.23e-01 | 1.26e-01 | 2.96e-01 |
p53-Independent G1/S DNA damage checkpoint | 50 | 1.23e-01 | 1.26e-01 | 2.96e-01 |
Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | 26 | 2.66e-01 | -1.26e-01 | 4.75e-01 |
Signaling by FGFR1 | 38 | 1.79e-01 | 1.26e-01 | 3.73e-01 |
Glutamate Neurotransmitter Release Cycle | 20 | 3.30e-01 | -1.26e-01 | 5.42e-01 |
Triglyceride metabolism | 25 | 2.77e-01 | 1.26e-01 | 4.88e-01 |
Stimuli-sensing channels | 73 | 6.41e-02 | 1.25e-01 | 1.82e-01 |
Intra-Golgi and retrograde Golgi-to-ER traffic | 179 | 3.95e-03 | 1.25e-01 | 2.25e-02 |
Formation of TC-NER Pre-Incision Complex | 53 | 1.17e-01 | -1.25e-01 | 2.86e-01 |
Activation of gene expression by SREBF (SREBP) | 42 | 1.62e-01 | 1.25e-01 | 3.51e-01 |
Glyoxylate metabolism and glycine degradation | 24 | 2.92e-01 | -1.24e-01 | 5.02e-01 |
Vitamin B5 (pantothenate) metabolism | 17 | 3.77e-01 | 1.24e-01 | 5.89e-01 |
DNA Replication Pre-Initiation | 82 | 5.27e-02 | -1.24e-01 | 1.60e-01 |
AUF1 (hnRNP D0) binds and destabilizes mRNA | 53 | 1.20e-01 | 1.23e-01 | 2.93e-01 |
Signaling by ERBB2 TMD/JMD mutants | 17 | 3.79e-01 | -1.23e-01 | 5.89e-01 |
Rap1 signalling | 13 | 4.41e-01 | 1.23e-01 | 6.45e-01 |
tRNA processing in the mitochondrion | 30 | 2.43e-01 | -1.23e-01 | 4.51e-01 |
MyD88 cascade initiated on plasma membrane | 82 | 5.43e-02 | 1.23e-01 | 1.64e-01 |
Toll Like Receptor 10 (TLR10) Cascade | 82 | 5.43e-02 | 1.23e-01 | 1.64e-01 |
Toll Like Receptor 5 (TLR5) Cascade | 82 | 5.43e-02 | 1.23e-01 | 1.64e-01 |
Basigin interactions | 23 | 3.12e-01 | -1.22e-01 | 5.22e-01 |
Repression of WNT target genes | 14 | 4.30e-01 | -1.22e-01 | 6.32e-01 |
Apoptotic execution phase | 45 | 1.58e-01 | 1.22e-01 | 3.46e-01 |
Signaling by ERBB2 KD Mutants | 20 | 3.48e-01 | -1.21e-01 | 5.58e-01 |
RMTs methylate histone arginines | 37 | 2.03e-01 | -1.21e-01 | 4.01e-01 |
Synthesis of PIPs at the Golgi membrane | 16 | 4.03e-01 | 1.21e-01 | 6.13e-01 |
Metabolism of steroids | 119 | 2.30e-02 | 1.21e-01 | 8.72e-02 |
GRB2:SOS provides linkage to MAPK signaling for Integrins | 12 | 4.70e-01 | 1.20e-01 | 6.71e-01 |
MHC class II antigen presentation | 101 | 3.72e-02 | 1.20e-01 | 1.25e-01 |
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 104 | 3.47e-02 | -1.20e-01 | 1.19e-01 |
Programmed Cell Death | 178 | 5.82e-03 | 1.20e-01 | 3.14e-02 |
Glycogen metabolism | 23 | 3.20e-01 | 1.20e-01 | 5.32e-01 |
Glycosaminoglycan metabolism | 94 | 4.51e-02 | 1.20e-01 | 1.44e-01 |
Interleukin receptor SHC signaling | 23 | 3.22e-01 | 1.19e-01 | 5.33e-01 |
Ubiquitin-dependent degradation of Cyclin D | 50 | 1.46e-01 | 1.19e-01 | 3.32e-01 |
Aflatoxin activation and detoxification | 14 | 4.41e-01 | 1.19e-01 | 6.45e-01 |
Signaling by NOTCH2 | 30 | 2.60e-01 | 1.19e-01 | 4.67e-01 |
Voltage gated Potassium channels | 25 | 3.04e-01 | 1.19e-01 | 5.17e-01 |
N-glycan antennae elongation in the medial/trans-Golgi | 21 | 3.48e-01 | -1.18e-01 | 5.58e-01 |
EGFR downregulation | 27 | 2.88e-01 | 1.18e-01 | 4.99e-01 |
Signaling by Receptor Tyrosine Kinases | 414 | 3.90e-05 | 1.18e-01 | 5.36e-04 |
Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | 12 | 4.80e-01 | -1.18e-01 | 6.78e-01 |
Fc epsilon receptor (FCERI) signaling | 190 | 5.23e-03 | -1.17e-01 | 2.86e-02 |
Regulation of insulin secretion | 60 | 1.16e-01 | 1.17e-01 | 2.85e-01 |
DNA Damage Recognition in GG-NER | 38 | 2.10e-01 | -1.17e-01 | 4.11e-01 |
Glucagon signaling in metabolic regulation | 27 | 2.92e-01 | 1.17e-01 | 5.02e-01 |
Nicotinate metabolism | 25 | 3.12e-01 | 1.17e-01 | 5.22e-01 |
Degradation of GLI2 by the proteasome | 56 | 1.31e-01 | 1.17e-01 | 3.13e-01 |
Muscle contraction | 135 | 1.93e-02 | 1.17e-01 | 7.59e-02 |
Condensation of Prometaphase Chromosomes | 11 | 5.04e-01 | -1.16e-01 | 6.95e-01 |
Nucleobase catabolism | 28 | 2.87e-01 | 1.16e-01 | 4.98e-01 |
Formation of tubulin folding intermediates by CCT/TriC | 22 | 3.46e-01 | -1.16e-01 | 5.58e-01 |
The canonical retinoid cycle in rods (twilight vision) | 10 | 5.26e-01 | 1.16e-01 | 7.16e-01 |
Metabolism of lipids | 626 | 7.53e-07 | 1.16e-01 | 1.77e-05 |
Transport of vitamins, nucleosides, and related molecules | 33 | 2.50e-01 | 1.16e-01 | 4.55e-01 |
Synthesis of IP3 and IP4 in the cytosol | 22 | 3.48e-01 | 1.15e-01 | 5.58e-01 |
Hedgehog ‘on’ state | 75 | 8.41e-02 | 1.15e-01 | 2.24e-01 |
Formation of Senescence-Associated Heterochromatin Foci (SAHF) | 13 | 4.72e-01 | 1.15e-01 | 6.73e-01 |
PLC beta mediated events | 43 | 1.92e-01 | 1.15e-01 | 3.86e-01 |
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | 53 | 1.47e-01 | 1.15e-01 | 3.32e-01 |
Constitutive Signaling by NOTCH1 PEST Domain Mutants | 53 | 1.47e-01 | 1.15e-01 | 3.32e-01 |
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | 53 | 1.47e-01 | 1.15e-01 | 3.32e-01 |
Signaling by NOTCH1 PEST Domain Mutants in Cancer | 53 | 1.47e-01 | 1.15e-01 | 3.32e-01 |
Signaling by NOTCH1 in Cancer | 53 | 1.47e-01 | 1.15e-01 | 3.32e-01 |
Downstream TCR signaling | 100 | 4.69e-02 | -1.15e-01 | 1.47e-01 |
Surfactant metabolism | 21 | 3.63e-01 | 1.15e-01 | 5.74e-01 |
Regulation of beta-cell development | 19 | 3.88e-01 | 1.14e-01 | 5.94e-01 |
ADP signalling through P2Y purinoceptor 12 | 18 | 4.01e-01 | 1.14e-01 | 6.10e-01 |
HIV Life Cycle | 144 | 1.85e-02 | -1.14e-01 | 7.41e-02 |
p38MAPK events | 13 | 4.79e-01 | 1.13e-01 | 6.77e-01 |
RHO GTPases Activate Formins | 117 | 3.43e-02 | -1.13e-01 | 1.18e-01 |
RUNX1 regulates transcription of genes involved in differentiation of HSCs | 82 | 7.62e-02 | 1.13e-01 | 2.08e-01 |
SHC1 events in EGFR signaling | 12 | 4.98e-01 | 1.13e-01 | 6.91e-01 |
Metabolism of cofactors | 19 | 3.94e-01 | 1.13e-01 | 6.03e-01 |
Metabolic disorders of biological oxidation enzymes | 25 | 3.29e-01 | 1.13e-01 | 5.42e-01 |
SUMOylation of intracellular receptors | 25 | 3.29e-01 | 1.13e-01 | 5.42e-01 |
Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | 11 | 5.19e-01 | -1.12e-01 | 7.11e-01 |
Signaling by NOTCH3 | 42 | 2.08e-01 | 1.12e-01 | 4.08e-01 |
Calnexin/calreticulin cycle | 26 | 3.22e-01 | 1.12e-01 | 5.33e-01 |
NIK–>noncanonical NF-kB signaling | 57 | 1.44e-01 | 1.12e-01 | 3.31e-01 |
FRS-mediated FGFR4 signaling | 12 | 5.02e-01 | -1.12e-01 | 6.93e-01 |
SHC-mediated cascade:FGFR4 | 10 | 5.40e-01 | -1.12e-01 | 7.28e-01 |
Vesicle-mediated transport | 648 | 1.24e-06 | 1.12e-01 | 2.72e-05 |
Downstream signaling of activated FGFR4 | 17 | 4.27e-01 | -1.11e-01 | 6.29e-01 |
Miscellaneous transport and binding events | 20 | 3.89e-01 | -1.11e-01 | 5.95e-01 |
O-linked glycosylation of mucins | 47 | 1.87e-01 | 1.11e-01 | 3.80e-01 |
G-protein mediated events | 44 | 2.02e-01 | 1.11e-01 | 4.00e-01 |
Autodegradation of the E3 ubiquitin ligase COP1 | 49 | 1.79e-01 | 1.11e-01 | 3.73e-01 |
Regulation of RUNX3 expression and activity | 55 | 1.54e-01 | 1.11e-01 | 3.43e-01 |
Signaling by ERBB2 ECD mutants | 15 | 4.58e-01 | -1.11e-01 | 6.61e-01 |
Negative regulators of DDX58/IFIH1 signaling | 34 | 2.65e-01 | -1.11e-01 | 4.74e-01 |
Organelle biogenesis and maintenance | 268 | 1.90e-03 | -1.10e-01 | 1.23e-02 |
Dopamine Neurotransmitter Release Cycle | 20 | 3.95e-01 | -1.10e-01 | 6.03e-01 |
EGR2 and SOX10-mediated initiation of Schwann cell myelination | 22 | 3.76e-01 | 1.09e-01 | 5.88e-01 |
Glycerophospholipid biosynthesis | 107 | 5.15e-02 | 1.09e-01 | 1.57e-01 |
Neuronal System | 258 | 2.60e-03 | 1.09e-01 | 1.61e-02 |
O-glycosylation of TSR domain-containing proteins | 26 | 3.37e-01 | -1.09e-01 | 5.49e-01 |
Metabolism of Angiotensinogen to Angiotensins | 11 | 5.36e-01 | 1.08e-01 | 7.25e-01 |
Apoptosis | 166 | 1.67e-02 | 1.08e-01 | 6.91e-02 |
TP53 Regulates Transcription of DNA Repair Genes | 61 | 1.46e-01 | -1.08e-01 | 3.32e-01 |
Signaling by Interleukins | 385 | 3.05e-04 | 1.07e-01 | 2.81e-03 |
TICAM1,TRAF6-dependent induction of TAK1 complex | 11 | 5.38e-01 | -1.07e-01 | 7.27e-01 |
Stabilization of p53 | 54 | 1.74e-01 | 1.07e-01 | 3.66e-01 |
G2/M Checkpoints | 139 | 2.98e-02 | -1.07e-01 | 1.05e-01 |
Regulation of KIT signaling | 15 | 4.75e-01 | 1.06e-01 | 6.75e-01 |
Regulation of innate immune responses to cytosolic DNA | 14 | 4.91e-01 | -1.06e-01 | 6.86e-01 |
Endosomal/Vacuolar pathway | 12 | 5.25e-01 | -1.06e-01 | 7.16e-01 |
Meiosis | 68 | 1.31e-01 | -1.06e-01 | 3.14e-01 |
Opioid Signalling | 75 | 1.14e-01 | 1.06e-01 | 2.81e-01 |
Activation of BH3-only proteins | 29 | 3.25e-01 | -1.06e-01 | 5.37e-01 |
Thromboxane signalling through TP receptor | 20 | 4.14e-01 | 1.06e-01 | 6.19e-01 |
Platelet calcium homeostasis | 21 | 4.03e-01 | 1.05e-01 | 6.13e-01 |
TAK1 activates NFkB by phosphorylation and activation of IKKs complex | 27 | 3.44e-01 | 1.05e-01 | 5.55e-01 |
CTLA4 inhibitory signaling | 21 | 4.04e-01 | -1.05e-01 | 6.14e-01 |
Regulation of RAS by GAPs | 66 | 1.42e-01 | 1.05e-01 | 3.30e-01 |
Norepinephrine Neurotransmitter Release Cycle | 14 | 4.98e-01 | -1.05e-01 | 6.91e-01 |
Dectin-1 mediated noncanonical NF-kB signaling | 58 | 1.69e-01 | 1.04e-01 | 3.60e-01 |
Amyloid fiber formation | 51 | 1.97e-01 | 1.04e-01 | 3.94e-01 |
Vpu mediated degradation of CD4 | 50 | 2.02e-01 | 1.04e-01 | 4.00e-01 |
ER Quality Control Compartment (ERQC) | 21 | 4.08e-01 | 1.04e-01 | 6.18e-01 |
Host Interactions of HIV factors | 129 | 4.15e-02 | -1.04e-01 | 1.36e-01 |
Metabolism of nitric oxide: NOS3 activation and regulation | 12 | 5.34e-01 | -1.04e-01 | 7.24e-01 |
DNA methylation | 20 | 4.23e-01 | 1.03e-01 | 6.26e-01 |
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | 32 | 3.11e-01 | 1.03e-01 | 5.22e-01 |
Degradation of cysteine and homocysteine | 12 | 5.36e-01 | 1.03e-01 | 7.25e-01 |
Attenuation phase | 23 | 3.95e-01 | -1.02e-01 | 6.03e-01 |
Asymmetric localization of PCP proteins | 60 | 1.71e-01 | 1.02e-01 | 3.62e-01 |
PI3K events in ERBB2 signaling | 11 | 5.58e-01 | -1.02e-01 | 7.44e-01 |
SUMOylation of transcription factors | 16 | 4.80e-01 | 1.02e-01 | 6.78e-01 |
Apoptotic cleavage of cellular proteins | 34 | 3.04e-01 | 1.02e-01 | 5.17e-01 |
Transcriptional regulation by RUNX2 | 101 | 7.72e-02 | 1.02e-01 | 2.10e-01 |
G-protein activation | 23 | 4.00e-01 | 1.01e-01 | 6.10e-01 |
Interaction between L1 and Ankyrins | 22 | 4.11e-01 | -1.01e-01 | 6.19e-01 |
Phospholipid metabolism | 186 | 1.74e-02 | 1.01e-01 | 7.07e-02 |
Collagen biosynthesis and modifying enzymes | 48 | 2.26e-01 | 1.01e-01 | 4.28e-01 |
Signaling by ERBB2 in Cancer | 21 | 4.23e-01 | -1.01e-01 | 6.26e-01 |
Nucleotide-like (purinergic) receptors | 12 | 5.47e-01 | -1.01e-01 | 7.34e-01 |
Phase II - Conjugation of compounds | 67 | 1.56e-01 | 1.00e-01 | 3.45e-01 |
Neurotransmitter receptors and postsynaptic signal transmission | 123 | 5.51e-02 | 1.00e-01 | 1.65e-01 |
Degradation of AXIN | 53 | 2.08e-01 | 1.00e-01 | 4.08e-01 |
Molecules associated with elastic fibres | 22 | 4.19e-01 | -9.96e-02 | 6.23e-01 |
NOD1/2 Signaling Pathway | 32 | 3.30e-01 | 9.95e-02 | 5.42e-01 |
Cytochrome P450 - arranged by substrate type | 34 | 3.16e-01 | 9.94e-02 | 5.25e-01 |
Metabolism of polyamines | 57 | 1.94e-01 | 9.94e-02 | 3.89e-01 |
Synaptic adhesion-like molecules | 14 | 5.20e-01 | 9.93e-02 | 7.12e-01 |
HSF1-dependent transactivation | 29 | 3.56e-01 | -9.91e-02 | 5.67e-01 |
Interleukin-17 signaling | 68 | 1.58e-01 | 9.90e-02 | 3.46e-01 |
Separation of Sister Chromatids | 167 | 2.74e-02 | -9.90e-02 | 9.97e-02 |
GLI3 is processed to GLI3R by the proteasome | 57 | 1.97e-01 | 9.88e-02 | 3.94e-01 |
SLC transporter disorders | 77 | 1.34e-01 | -9.88e-02 | 3.17e-01 |
SARS-CoV-1 Infection | 47 | 2.42e-01 | 9.86e-02 | 4.51e-01 |
Other semaphorin interactions | 16 | 4.95e-01 | 9.85e-02 | 6.90e-01 |
Transmission across Chemical Synapses | 172 | 2.61e-02 | 9.83e-02 | 9.60e-02 |
Extracellular matrix organization | 219 | 1.22e-02 | 9.82e-02 | 5.45e-02 |
Nuclear Events (kinase and transcription factor activation) | 53 | 2.16e-01 | 9.82e-02 | 4.19e-01 |
Arachidonic acid metabolism | 43 | 2.66e-01 | 9.81e-02 | 4.75e-01 |
NOTCH3 Intracellular Domain Regulates Transcription | 20 | 4.48e-01 | 9.79e-02 | 6.51e-01 |
COPI-dependent Golgi-to-ER retrograde traffic | 78 | 1.35e-01 | 9.78e-02 | 3.19e-01 |
Activation of NF-kappaB in B cells | 65 | 1.73e-01 | 9.77e-02 | 3.65e-01 |
Beta-catenin independent WNT signaling | 136 | 5.01e-02 | 9.73e-02 | 1.55e-01 |
Cargo trafficking to the periciliary membrane | 47 | 2.49e-01 | -9.72e-02 | 4.55e-01 |
C-type lectin receptors (CLRs) | 128 | 5.88e-02 | 9.67e-02 | 1.73e-01 |
GABA synthesis, release, reuptake and degradation | 13 | 5.46e-01 | -9.67e-02 | 7.34e-01 |
Nuclear Envelope (NE) Reassembly | 69 | 1.66e-01 | -9.65e-02 | 3.55e-01 |
CD28 dependent Vav1 pathway | 12 | 5.65e-01 | 9.59e-02 | 7.51e-01 |
TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | 13 | 5.50e-01 | -9.58e-02 | 7.37e-01 |
Interleukin-20 family signaling | 17 | 4.95e-01 | 9.55e-02 | 6.90e-01 |
Listeria monocytogenes entry into host cells | 17 | 4.96e-01 | 9.53e-02 | 6.90e-01 |
Constitutive Signaling by AKT1 E17K in Cancer | 25 | 4.11e-01 | 9.51e-02 | 6.19e-01 |
Signaling by KIT in disease | 20 | 4.62e-01 | -9.50e-02 | 6.63e-01 |
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | 20 | 4.62e-01 | -9.50e-02 | 6.63e-01 |
Synthesis of IP2, IP, and Ins in the cytosol | 13 | 5.54e-01 | 9.47e-02 | 7.42e-01 |
Autophagy | 124 | 6.88e-02 | 9.46e-02 | 1.90e-01 |
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | 43 | 2.84e-01 | -9.43e-02 | 4.95e-01 |
Downregulation of ERBB2 signaling | 24 | 4.24e-01 | -9.43e-02 | 6.27e-01 |
Metabolism of carbohydrates | 244 | 1.13e-02 | 9.42e-02 | 5.15e-02 |
Ca-dependent events | 29 | 3.82e-01 | 9.38e-02 | 5.90e-01 |
DAP12 interactions | 39 | 3.13e-01 | 9.35e-02 | 5.22e-01 |
Negative epigenetic regulation of rRNA expression | 62 | 2.05e-01 | -9.32e-02 | 4.03e-01 |
Complex I biogenesis | 55 | 2.36e-01 | 9.24e-02 | 4.42e-01 |
TP53 Regulates Metabolic Genes | 84 | 1.44e-01 | 9.23e-02 | 3.31e-01 |
Transport of small molecules | 557 | 1.99e-04 | 9.22e-02 | 2.06e-03 |
p75 NTR receptor-mediated signalling | 89 | 1.34e-01 | 9.18e-02 | 3.17e-01 |
MAP kinase activation | 63 | 2.08e-01 | 9.17e-02 | 4.08e-01 |
Keratan sulfate/keratin metabolism | 27 | 4.12e-01 | 9.13e-02 | 6.19e-01 |
Transcriptional regulation of granulopoiesis | 46 | 2.84e-01 | 9.13e-02 | 4.95e-01 |
Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | 12 | 5.86e-01 | 9.09e-02 | 7.65e-01 |
Diseases of hemostasis | 12 | 5.86e-01 | 9.09e-02 | 7.65e-01 |
Uptake and actions of bacterial toxins | 27 | 4.14e-01 | 9.07e-02 | 6.19e-01 |
Chaperone Mediated Autophagy | 20 | 4.83e-01 | -9.06e-02 | 6.80e-01 |
Constitutive Signaling by Aberrant PI3K in Cancer | 54 | 2.50e-01 | -9.06e-02 | 4.55e-01 |
HSP90 chaperone cycle for steroid hormone receptors (SHR) | 36 | 3.47e-01 | 9.05e-02 | 5.58e-01 |
HDACs deacetylate histones | 47 | 2.83e-01 | 9.05e-02 | 4.95e-01 |
Sphingolipid de novo biosynthesis | 42 | 3.10e-01 | 9.04e-02 | 5.22e-01 |
Metal ion SLC transporters | 21 | 4.74e-01 | 9.03e-02 | 6.73e-01 |
IRS-related events triggered by IGF1R | 35 | 3.56e-01 | -9.02e-02 | 5.67e-01 |
G2/M Transition | 179 | 3.77e-02 | -9.01e-02 | 1.26e-01 |
Toll Like Receptor 3 (TLR3) Cascade | 92 | 1.37e-01 | 8.98e-02 | 3.21e-01 |
Synthesis of PIPs at the plasma membrane | 52 | 2.64e-01 | 8.96e-02 | 4.73e-01 |
Phase 0 - rapid depolarisation | 22 | 4.68e-01 | -8.94e-02 | 6.69e-01 |
G alpha (12/13) signalling events | 69 | 1.99e-01 | 8.93e-02 | 3.96e-01 |
Class C/3 (Metabotropic glutamate/pheromone receptors) | 12 | 5.92e-01 | 8.93e-02 | 7.73e-01 |
Transcriptional regulation by RUNX3 | 90 | 1.44e-01 | 8.91e-02 | 3.31e-01 |
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | 16 | 5.39e-01 | -8.86e-02 | 7.28e-01 |
Phase 2 - plateau phase | 12 | 5.95e-01 | 8.86e-02 | 7.75e-01 |
IRS-mediated signalling | 34 | 3.72e-01 | -8.84e-02 | 5.85e-01 |
Collagen chain trimerization | 27 | 4.29e-01 | -8.80e-02 | 6.31e-01 |
Fatty acid metabolism | 152 | 6.13e-02 | 8.79e-02 | 1.76e-01 |
RUNX2 regulates osteoblast differentiation | 18 | 5.19e-01 | 8.78e-02 | 7.11e-01 |
TCR signaling | 121 | 9.61e-02 | -8.76e-02 | 2.47e-01 |
Termination of O-glycan biosynthesis | 16 | 5.44e-01 | 8.75e-02 | 7.33e-01 |
Signaling by FGFR2 IIIa TM | 18 | 5.22e-01 | -8.71e-02 | 7.13e-01 |
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | 37 | 3.60e-01 | -8.70e-02 | 5.72e-01 |
Mitotic G2-G2/M phases | 181 | 4.44e-02 | -8.66e-02 | 1.42e-01 |
CASP8 activity is inhibited | 11 | 6.19e-01 | -8.66e-02 | 7.91e-01 |
Dimerization of procaspase-8 | 11 | 6.19e-01 | -8.66e-02 | 7.91e-01 |
Regulation by c-FLIP | 11 | 6.19e-01 | -8.66e-02 | 7.91e-01 |
Defective B3GALTL causes Peters-plus syndrome (PpS) | 25 | 4.54e-01 | -8.65e-02 | 6.56e-01 |
Signaling by FGFR1 in disease | 30 | 4.12e-01 | 8.65e-02 | 6.19e-01 |
Mitotic Metaphase and Anaphase | 224 | 2.57e-02 | -8.65e-02 | 9.48e-02 |
Aquaporin-mediated transport | 37 | 3.63e-01 | 8.64e-02 | 5.74e-01 |
Estrogen-dependent nuclear events downstream of ESR-membrane signaling | 22 | 4.85e-01 | -8.60e-02 | 6.81e-01 |
Methylation | 12 | 6.06e-01 | -8.59e-02 | 7.85e-01 |
Diseases of programmed cell death | 28 | 4.32e-01 | 8.58e-02 | 6.33e-01 |
Interleukin-6 family signaling | 18 | 5.28e-01 | 8.58e-02 | 7.18e-01 |
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | 22 | 4.87e-01 | 8.56e-02 | 6.82e-01 |
DNA Double Strand Break Response | 47 | 3.12e-01 | -8.52e-02 | 5.22e-01 |
M Phase | 359 | 5.87e-03 | -8.46e-02 | 3.15e-02 |
Transcriptional Regulation by TP53 | 351 | 6.51e-03 | -8.45e-02 | 3.40e-02 |
Nonhomologous End-Joining (NHEJ) | 42 | 3.44e-01 | -8.44e-02 | 5.55e-01 |
Nuclear Receptor transcription pathway | 36 | 3.81e-01 | -8.43e-02 | 5.90e-01 |
Incretin synthesis, secretion, and inactivation | 10 | 6.45e-01 | -8.42e-02 | 8.09e-01 |
Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | 10 | 6.45e-01 | -8.42e-02 | 8.09e-01 |
PI3K Cascade | 30 | 4.25e-01 | -8.42e-02 | 6.27e-01 |
Resolution of D-loop Structures through Holliday Junction Intermediates | 32 | 4.11e-01 | -8.40e-02 | 6.19e-01 |
DARPP-32 events | 22 | 4.98e-01 | 8.34e-02 | 6.91e-01 |
RNA Polymerase I Promoter Escape | 44 | 3.39e-01 | -8.33e-02 | 5.50e-01 |
Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | 36 | 3.87e-01 | 8.33e-02 | 5.94e-01 |
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | 72 | 2.22e-01 | 8.33e-02 | 4.23e-01 |
Metabolism of nucleotides | 86 | 1.82e-01 | -8.33e-02 | 3.78e-01 |
Tie2 Signaling | 16 | 5.64e-01 | 8.32e-02 | 7.51e-01 |
Fertilization | 12 | 6.18e-01 | 8.31e-02 | 7.91e-01 |
Mitotic Anaphase | 223 | 3.35e-02 | -8.26e-02 | 1.16e-01 |
The role of GTSE1 in G2/M progression after G2 checkpoint | 58 | 2.77e-01 | 8.25e-02 | 4.88e-01 |
Autodegradation of Cdh1 by Cdh1:APC/C | 64 | 2.55e-01 | 8.22e-02 | 4.61e-01 |
Prefoldin mediated transfer of substrate to CCT/TriC | 26 | 4.68e-01 | -8.22e-02 | 6.69e-01 |
TNFR1-induced NFkappaB signaling pathway | 25 | 4.77e-01 | -8.22e-02 | 6.76e-01 |
G alpha (s) signalling events | 141 | 9.21e-02 | 8.22e-02 | 2.41e-01 |
Signaling by Rho GTPases | 367 | 7.03e-03 | 8.19e-02 | 3.63e-02 |
Post-translational modification: synthesis of GPI-anchored proteins | 57 | 2.85e-01 | 8.19e-02 | 4.95e-01 |
Peroxisomal lipid metabolism | 27 | 4.62e-01 | 8.18e-02 | 6.63e-01 |
Infectious disease | 775 | 1.11e-04 | -8.16e-02 | 1.30e-03 |
Downregulation of ERBB2:ERBB3 signaling | 12 | 6.24e-01 | -8.16e-02 | 7.92e-01 |
Late Phase of HIV Life Cycle | 131 | 1.10e-01 | -8.09e-02 | 2.73e-01 |
Diseases of signal transduction by growth factor receptors and second messengers | 339 | 1.05e-02 | 8.09e-02 | 4.87e-02 |
Downstream signaling of activated FGFR3 | 16 | 5.75e-01 | -8.09e-02 | 7.57e-01 |
Glucagon-type ligand receptors | 20 | 5.32e-01 | -8.07e-02 | 7.22e-01 |
Signaling by FGFR2 | 60 | 2.81e-01 | -8.06e-02 | 4.92e-01 |
PI Metabolism | 80 | 2.14e-01 | 8.04e-02 | 4.16e-01 |
Synthesis of PIPs at the late endosome membrane | 11 | 6.45e-01 | 8.03e-02 | 8.09e-01 |
Josephin domain DUBs | 10 | 6.60e-01 | 8.03e-02 | 8.21e-01 |
TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | 18 | 5.56e-01 | -8.02e-02 | 7.43e-01 |
Peroxisomal protein import | 57 | 2.96e-01 | 8.01e-02 | 5.07e-01 |
Netrin-1 signaling | 40 | 3.82e-01 | -7.99e-02 | 5.90e-01 |
Activation of SMO | 13 | 6.19e-01 | 7.97e-02 | 7.91e-01 |
NOTCH2 Activation and Transmission of Signal to the Nucleus | 20 | 5.41e-01 | 7.89e-02 | 7.29e-01 |
Cellular responses to stress | 499 | 2.61e-03 | -7.87e-02 | 1.61e-02 |
Activation of BAD and translocation to mitochondria | 15 | 5.98e-01 | 7.87e-02 | 7.77e-01 |
G alpha (z) signalling events | 36 | 4.16e-01 | 7.84e-02 | 6.20e-01 |
SARS-CoV-2 Infection | 63 | 2.82e-01 | 7.83e-02 | 4.94e-01 |
MAPK6/MAPK4 signaling | 82 | 2.21e-01 | 7.82e-02 | 4.23e-01 |
Interferon Signaling | 177 | 7.37e-02 | -7.79e-02 | 2.02e-01 |
Mitotic Prophase | 98 | 1.83e-01 | -7.78e-02 | 3.78e-01 |
Inositol phosphate metabolism | 42 | 3.84e-01 | 7.76e-02 | 5.91e-01 |
Reproduction | 80 | 2.31e-01 | -7.75e-02 | 4.35e-01 |
Aberrant regulation of mitotic cell cycle due to RB1 defects | 36 | 4.21e-01 | -7.74e-02 | 6.25e-01 |
Diseases of mitotic cell cycle | 36 | 4.21e-01 | -7.74e-02 | 6.25e-01 |
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | 46 | 3.64e-01 | -7.74e-02 | 5.74e-01 |
VEGFR2 mediated vascular permeability | 27 | 4.88e-01 | 7.72e-02 | 6.82e-01 |
PTEN Regulation | 138 | 1.18e-01 | 7.71e-02 | 2.88e-01 |
TRAF6-mediated induction of TAK1 complex within TLR4 complex | 16 | 5.94e-01 | 7.71e-02 | 7.73e-01 |
UCH proteinases | 86 | 2.17e-01 | 7.70e-02 | 4.19e-01 |
Cardiac conduction | 86 | 2.21e-01 | 7.63e-02 | 4.23e-01 |
Immune System | 1892 | 4.20e-08 | 7.62e-02 | 1.22e-06 |
CD209 (DC-SIGN) signaling | 20 | 5.56e-01 | 7.60e-02 | 7.43e-01 |
Nef mediated downregulation of MHC class I complex cell surface expression | 10 | 6.79e-01 | -7.55e-02 | 8.33e-01 |
Biosynthesis of specialized proresolving mediators (SPMs) | 16 | 6.04e-01 | 7.50e-02 | 7.83e-01 |
RHO GTPase Effectors | 250 | 4.32e-02 | 7.43e-02 | 1.39e-01 |
Competing endogenous RNAs (ceRNAs) regulate PTEN translation | 11 | 6.71e-01 | 7.40e-02 | 8.31e-01 |
Elevation of cytosolic Ca2+ levels | 12 | 6.59e-01 | 7.35e-02 | 8.21e-01 |
Cellular responses to external stimuli | 505 | 4.74e-03 | -7.34e-02 | 2.64e-02 |
APC/C:Cdc20 mediated degradation of Securin | 66 | 3.03e-01 | 7.33e-02 | 5.16e-01 |
Regulation of TNFR1 signaling | 34 | 4.60e-01 | -7.31e-02 | 6.63e-01 |
Sema3A PAK dependent Axon repulsion | 16 | 6.13e-01 | 7.30e-02 | 7.89e-01 |
Cellular hexose transport | 15 | 6.25e-01 | -7.29e-02 | 7.92e-01 |
Serotonin Neurotransmitter Release Cycle | 15 | 6.29e-01 | -7.21e-02 | 7.96e-01 |
PKMTs methylate histone lysines | 44 | 4.12e-01 | -7.15e-02 | 6.19e-01 |
RUNX3 regulates p14-ARF | 10 | 6.96e-01 | 7.14e-02 | 8.47e-01 |
Glutamate binding, activation of AMPA receptors and synaptic plasticity | 20 | 5.80e-01 | 7.14e-02 | 7.61e-01 |
Trafficking of AMPA receptors | 20 | 5.80e-01 | 7.14e-02 | 7.61e-01 |
Branched-chain amino acid catabolism | 21 | 5.72e-01 | -7.13e-02 | 7.54e-01 |
Switching of origins to a post-replicative state | 89 | 2.46e-01 | -7.12e-02 | 4.52e-01 |
SCF-beta-TrCP mediated degradation of Emi1 | 53 | 3.77e-01 | 7.01e-02 | 5.89e-01 |
N-glycan trimming in the ER and Calnexin/Calreticulin cycle | 35 | 4.73e-01 | 7.01e-02 | 6.73e-01 |
IGF1R signaling cascade | 36 | 4.70e-01 | -6.96e-02 | 6.71e-01 |
ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | 32 | 4.96e-01 | -6.95e-02 | 6.90e-01 |
Disassembly of the destruction complex and recruitment of AXIN to the membrane | 29 | 5.18e-01 | 6.93e-02 | 7.11e-01 |
Signaling by Non-Receptor Tyrosine Kinases | 48 | 4.07e-01 | 6.93e-02 | 6.16e-01 |
Signaling by PTK6 | 48 | 4.07e-01 | 6.93e-02 | 6.16e-01 |
Degradation of beta-catenin by the destruction complex | 83 | 2.77e-01 | 6.90e-02 | 4.88e-01 |
Vasopressin regulates renal water homeostasis via Aquaporins | 34 | 4.88e-01 | 6.87e-02 | 6.82e-01 |
Protein localization | 157 | 1.38e-01 | -6.86e-02 | 3.24e-01 |
Downregulation of SMAD2/3:SMAD4 transcriptional activity | 23 | 5.70e-01 | -6.85e-02 | 7.54e-01 |
SLC-mediated transmembrane transport | 180 | 1.16e-01 | 6.79e-02 | 2.86e-01 |
CD28 co-stimulation | 33 | 5.00e-01 | -6.79e-02 | 6.92e-01 |
Activation of the AP-1 family of transcription factors | 10 | 7.10e-01 | 6.78e-02 | 8.58e-01 |
FRS-mediated FGFR3 signaling | 11 | 6.97e-01 | -6.78e-02 | 8.48e-01 |
Macroautophagy | 110 | 2.20e-01 | 6.77e-02 | 4.21e-01 |
Processing of Intronless Pre-mRNAs | 19 | 6.09e-01 | -6.77e-02 | 7.87e-01 |
Aberrant regulation of mitotic exit in cancer due to RB1 defects | 20 | 6.01e-01 | -6.76e-02 | 7.80e-01 |
Retrograde transport at the Trans-Golgi-Network | 49 | 4.14e-01 | 6.75e-02 | 6.19e-01 |
MAPK targets/ Nuclear events mediated by MAP kinases | 31 | 5.16e-01 | 6.74e-02 | 7.09e-01 |
Interleukin-12 signaling | 44 | 4.43e-01 | 6.69e-02 | 6.45e-01 |
CRMPs in Sema3A signaling | 14 | 6.68e-01 | 6.63e-02 | 8.29e-01 |
SHC-mediated cascade:FGFR1 | 12 | 6.93e-01 | 6.59e-02 | 8.44e-01 |
MASTL Facilitates Mitotic Progression | 10 | 7.19e-01 | -6.57e-02 | 8.64e-01 |
Keratinization | 32 | 5.21e-01 | 6.55e-02 | 7.12e-01 |
FCGR3A-mediated phagocytosis | 121 | 2.19e-01 | -6.48e-02 | 4.20e-01 |
Leishmania phagocytosis | 121 | 2.19e-01 | -6.48e-02 | 4.20e-01 |
Parasite infection | 121 | 2.19e-01 | -6.48e-02 | 4.20e-01 |
Interleukin-12 family signaling | 53 | 4.15e-01 | 6.47e-02 | 6.20e-01 |
CLEC7A (Dectin-1) signaling | 96 | 2.74e-01 | 6.46e-02 | 4.84e-01 |
GRB2 events in EGFR signaling | 11 | 7.12e-01 | 6.44e-02 | 8.58e-01 |
Negative regulation of FGFR3 signaling | 20 | 6.18e-01 | 6.43e-02 | 7.91e-01 |
Meiotic synapsis | 45 | 4.58e-01 | -6.39e-02 | 6.61e-01 |
Resolution of D-Loop Structures | 33 | 5.27e-01 | -6.37e-02 | 7.17e-01 |
p53-Dependent G1 DNA Damage Response | 63 | 3.84e-01 | 6.35e-02 | 5.91e-01 |
p53-Dependent G1/S DNA damage checkpoint | 63 | 3.84e-01 | 6.35e-02 | 5.91e-01 |
ABC-family proteins mediated transport | 93 | 2.97e-01 | 6.26e-02 | 5.08e-01 |
Oxidative Stress Induced Senescence | 79 | 3.36e-01 | 6.26e-02 | 5.49e-01 |
Acyl chain remodelling of PG | 11 | 7.19e-01 | 6.26e-02 | 8.64e-01 |
NoRC negatively regulates rRNA expression | 59 | 4.13e-01 | -6.16e-02 | 6.19e-01 |
Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. | 124 | 2.38e-01 | 6.14e-02 | 4.45e-01 |
Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | 29 | 5.67e-01 | -6.14e-02 | 7.52e-01 |
NOTCH1 Intracellular Domain Regulates Transcription | 44 | 4.81e-01 | 6.13e-02 | 6.79e-01 |
Respiratory electron transport | 101 | 2.87e-01 | 6.13e-02 | 4.98e-01 |
Orc1 removal from chromatin | 69 | 3.81e-01 | -6.09e-02 | 5.90e-01 |
MECP2 regulates neuronal receptors and channels | 13 | 7.04e-01 | -6.08e-02 | 8.55e-01 |
Metalloprotease DUBs | 21 | 6.31e-01 | 6.06e-02 | 7.98e-01 |
Platelet Adhesion to exposed collagen | 13 | 7.09e-01 | -5.98e-02 | 8.57e-01 |
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | 36 | 5.38e-01 | -5.93e-02 | 7.27e-01 |
Blood group systems biosynthesis | 17 | 6.72e-01 | -5.92e-02 | 8.31e-01 |
Aggrephagy | 22 | 6.32e-01 | -5.89e-02 | 7.99e-01 |
Glucose metabolism | 84 | 3.52e-01 | 5.87e-02 | 5.63e-01 |
Gamma carboxylation, hypusine formation and arylsulfatase activation | 34 | 5.62e-01 | -5.75e-02 | 7.48e-01 |
Signaling by EGFR | 46 | 5.00e-01 | 5.75e-02 | 6.92e-01 |
FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | 24 | 6.29e-01 | -5.70e-02 | 7.96e-01 |
Signaling by PDGFRA extracellular domain mutants | 12 | 7.33e-01 | 5.69e-02 | 8.76e-01 |
Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | 12 | 7.33e-01 | 5.69e-02 | 8.76e-01 |
Synthesis of glycosylphosphatidylinositol (GPI) | 17 | 6.85e-01 | -5.68e-02 | 8.37e-01 |
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | 10 | 7.58e-01 | -5.63e-02 | 8.86e-01 |
TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | 18 | 6.81e-01 | -5.60e-02 | 8.34e-01 |
Metabolism of folate and pterines | 16 | 6.99e-01 | 5.59e-02 | 8.49e-01 |
The role of Nef in HIV-1 replication and disease pathogenesis | 28 | 6.13e-01 | 5.53e-02 | 7.89e-01 |
Chromatin modifying enzymes | 217 | 1.63e-01 | -5.50e-02 | 3.51e-01 |
Chromatin organization | 217 | 1.63e-01 | -5.50e-02 | 3.51e-01 |
Fatty acyl-CoA biosynthesis | 34 | 5.80e-01 | 5.48e-02 | 7.61e-01 |
Biological oxidations | 135 | 2.72e-01 | 5.47e-02 | 4.82e-01 |
Signaling by WNT | 253 | 1.35e-01 | 5.45e-02 | 3.19e-01 |
Synthesis of bile acids and bile salts | 24 | 6.44e-01 | 5.45e-02 | 8.09e-01 |
Zinc transporters | 14 | 7.24e-01 | 5.44e-02 | 8.69e-01 |
Cell death signalling via NRAGE, NRIF and NADE | 70 | 4.32e-01 | 5.43e-02 | 6.33e-01 |
Xenobiotics | 11 | 7.56e-01 | -5.42e-02 | 8.84e-01 |
MAP3K8 (TPL2)-dependent MAPK1/3 activation | 16 | 7.09e-01 | 5.40e-02 | 8.57e-01 |
Cytosolic iron-sulfur cluster assembly | 13 | 7.39e-01 | -5.34e-02 | 8.79e-01 |
Signaling by Hedgehog | 120 | 3.14e-01 | 5.33e-02 | 5.23e-01 |
PRC2 methylates histones and DNA | 29 | 6.21e-01 | -5.31e-02 | 7.92e-01 |
Signaling by TGFB family members | 91 | 3.83e-01 | -5.30e-02 | 5.91e-01 |
Regulation of PTEN mRNA translation | 13 | 7.42e-01 | 5.28e-02 | 8.79e-01 |
mRNA Capping | 29 | 6.22e-01 | -5.28e-02 | 7.92e-01 |
Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS) | 10 | 7.75e-01 | 5.23e-02 | 8.95e-01 |
MicroRNA (miRNA) biogenesis | 24 | 6.58e-01 | -5.22e-02 | 8.21e-01 |
Antigen Presentation: Folding, assembly and peptide loading of class I MHC | 25 | 6.52e-01 | 5.21e-02 | 8.17e-01 |
Death Receptor Signalling | 132 | 3.10e-01 | 5.11e-02 | 5.22e-01 |
Phase I - Functionalization of compounds | 63 | 4.84e-01 | 5.09e-02 | 6.81e-01 |
The citric acid (TCA) cycle and respiratory electron transport | 172 | 2.50e-01 | 5.09e-02 | 4.55e-01 |
Transcription of the HIV genome | 67 | 4.73e-01 | -5.08e-02 | 6.73e-01 |
Selective autophagy | 58 | 5.07e-01 | -5.04e-02 | 6.98e-01 |
CDT1 association with the CDC6:ORC:origin complex | 57 | 5.11e-01 | 5.04e-02 | 7.03e-01 |
SCF(Skp2)-mediated degradation of p27/p21 | 60 | 5.01e-01 | 5.02e-02 | 6.93e-01 |
Regulation of RUNX2 expression and activity | 66 | 4.84e-01 | 4.98e-02 | 6.81e-01 |
Protein folding | 90 | 4.16e-01 | 4.97e-02 | 6.20e-01 |
Ion transport by P-type ATPases | 42 | 5.78e-01 | 4.96e-02 | 7.60e-01 |
Signaling by TGF-beta Receptor Complex | 72 | 4.67e-01 | -4.95e-02 | 6.69e-01 |
SUMOylation of transcription cofactors | 44 | 5.71e-01 | -4.94e-02 | 7.54e-01 |
Regulation of mRNA stability by proteins that bind AU-rich elements | 87 | 4.27e-01 | 4.93e-02 | 6.29e-01 |
TGF-beta receptor signaling activates SMADs | 32 | 6.36e-01 | -4.84e-02 | 8.02e-01 |
Regulation of actin dynamics for phagocytic cup formation | 123 | 3.55e-01 | -4.83e-02 | 5.67e-01 |
CDK-mediated phosphorylation and removal of Cdc6 | 71 | 4.82e-01 | 4.83e-02 | 6.79e-01 |
Axon guidance | 455 | 7.79e-02 | -4.82e-02 | 2.11e-01 |
Signaling by Retinoic Acid | 31 | 6.42e-01 | -4.82e-02 | 8.09e-01 |
HIV Infection | 224 | 2.14e-01 | -4.82e-02 | 4.16e-01 |
Metabolism of proteins | 1714 | 9.36e-04 | -4.81e-02 | 7.29e-03 |
Misspliced GSK3beta mutants stabilize beta-catenin | 15 | 7.47e-01 | 4.81e-02 | 8.79e-01 |
S33 mutants of beta-catenin aren’t phosphorylated | 15 | 7.47e-01 | 4.81e-02 | 8.79e-01 |
S37 mutants of beta-catenin aren’t phosphorylated | 15 | 7.47e-01 | 4.81e-02 | 8.79e-01 |
S45 mutants of beta-catenin aren’t phosphorylated | 15 | 7.47e-01 | 4.81e-02 | 8.79e-01 |
T41 mutants of beta-catenin aren’t phosphorylated | 15 | 7.47e-01 | 4.81e-02 | 8.79e-01 |
phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex | 15 | 7.47e-01 | 4.81e-02 | 8.79e-01 |
Meiotic recombination | 38 | 6.09e-01 | -4.79e-02 | 7.87e-01 |
SHC1 events in ERBB2 signaling | 17 | 7.33e-01 | 4.78e-02 | 8.76e-01 |
Signaling by GPCR | 536 | 5.98e-02 | 4.75e-02 | 1.74e-01 |
Chaperonin-mediated protein folding | 84 | 4.54e-01 | 4.73e-02 | 6.56e-01 |
Glycogen synthesis | 13 | 7.70e-01 | 4.69e-02 | 8.93e-01 |
Neurexins and neuroligins | 37 | 6.22e-01 | -4.68e-02 | 7.92e-01 |
Estrogen-dependent gene expression | 99 | 4.21e-01 | -4.68e-02 | 6.25e-01 |
G1/S DNA Damage Checkpoints | 65 | 5.16e-01 | 4.66e-02 | 7.09e-01 |
Pyruvate metabolism and Citric Acid (TCA) cycle | 52 | 5.61e-01 | 4.66e-02 | 7.48e-01 |
NRAGE signals death through JNK | 53 | 5.58e-01 | 4.65e-02 | 7.45e-01 |
ATF6 (ATF6-alpha) activates chaperones | 12 | 7.82e-01 | 4.61e-02 | 9.01e-01 |
Other interleukin signaling | 18 | 7.35e-01 | 4.61e-02 | 8.76e-01 |
Signaling by NTRK3 (TRKC) | 16 | 7.50e-01 | -4.60e-02 | 8.81e-01 |
Integrin cell surface interactions | 52 | 5.67e-01 | 4.59e-02 | 7.51e-01 |
NF-kB is activated and signals survival | 12 | 7.84e-01 | -4.57e-02 | 9.01e-01 |
Nervous system development | 474 | 8.86e-02 | -4.57e-02 | 2.34e-01 |
Class I MHC mediated antigen processing & presentation | 349 | 1.43e-01 | 4.56e-02 | 3.31e-01 |
Alpha-protein kinase 1 signaling pathway | 11 | 7.95e-01 | -4.54e-02 | 9.04e-01 |
Insulin processing | 21 | 7.20e-01 | 4.52e-02 | 8.64e-01 |
CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | 23 | 7.09e-01 | -4.50e-02 | 8.57e-01 |
Heparan sulfate/heparin (HS-GAG) metabolism | 37 | 6.40e-01 | 4.44e-02 | 8.07e-01 |
Receptor-type tyrosine-protein phosphatases | 12 | 7.91e-01 | 4.43e-02 | 9.04e-01 |
MET activates PTK2 signaling | 15 | 7.68e-01 | -4.40e-02 | 8.93e-01 |
HCMV Infection | 96 | 4.59e-01 | -4.37e-02 | 6.61e-01 |
Glutathione synthesis and recycling | 10 | 8.11e-01 | 4.36e-02 | 9.07e-01 |
Amino acid transport across the plasma membrane | 23 | 7.19e-01 | 4.33e-02 | 8.64e-01 |
ADORA2B mediated anti-inflammatory cytokines production | 73 | 5.26e-01 | -4.29e-02 | 7.16e-01 |
Synthesis of substrates in N-glycan biosythesis | 58 | 5.72e-01 | 4.29e-02 | 7.54e-01 |
Laminin interactions | 21 | 7.34e-01 | 4.29e-02 | 8.76e-01 |
Hemostasis | 547 | 8.96e-02 | 4.24e-02 | 2.36e-01 |
Association of TriC/CCT with target proteins during biosynthesis | 37 | 6.57e-01 | -4.22e-02 | 8.21e-01 |
Signaling by FGFR3 | 31 | 6.85e-01 | 4.21e-02 | 8.37e-01 |
Signal Transduction | 1882 | 3.05e-03 | 4.13e-02 | 1.84e-02 |
FRS-mediated FGFR1 signaling | 14 | 7.93e-01 | 4.04e-02 | 9.04e-01 |
Depolymerisation of the Nuclear Lamina | 15 | 7.87e-01 | -4.03e-02 | 9.03e-01 |
PIP3 activates AKT signaling | 239 | 2.92e-01 | 3.95e-02 | 5.03e-01 |
DNA Damage/Telomere Stress Induced Senescence | 44 | 6.52e-01 | -3.93e-02 | 8.17e-01 |
PKA activation | 15 | 7.92e-01 | 3.93e-02 | 9.04e-01 |
SIRT1 negatively regulates rRNA expression | 24 | 7.40e-01 | -3.91e-02 | 8.79e-01 |
Senescence-Associated Secretory Phenotype (SASP) | 66 | 5.86e-01 | 3.88e-02 | 7.65e-01 |
Nicotinamide salvaging | 14 | 8.02e-01 | 3.87e-02 | 9.07e-01 |
Intracellular signaling by second messengers | 271 | 2.73e-01 | 3.87e-02 | 4.82e-01 |
Cytosolic sensors of pathogen-associated DNA | 62 | 5.98e-01 | -3.87e-02 | 7.77e-01 |
cGMP effects | 12 | 8.17e-01 | 3.86e-02 | 9.10e-01 |
Formation of Fibrin Clot (Clotting Cascade) | 26 | 7.36e-01 | 3.82e-02 | 8.77e-01 |
PKA-mediated phosphorylation of CREB | 17 | 7.86e-01 | -3.81e-02 | 9.02e-01 |
Regulation of pyruvate dehydrogenase (PDH) complex | 15 | 8.00e-01 | -3.78e-02 | 9.07e-01 |
Heme biosynthesis | 14 | 8.08e-01 | 3.75e-02 | 9.07e-01 |
Cell-cell junction organization | 38 | 6.89e-01 | -3.75e-02 | 8.41e-01 |
Diseases of metabolism | 189 | 3.75e-01 | 3.75e-02 | 5.87e-01 |
Negative regulation of MAPK pathway | 42 | 6.75e-01 | 3.73e-02 | 8.31e-01 |
Activation of NMDA receptors and postsynaptic events | 58 | 6.23e-01 | -3.73e-02 | 7.92e-01 |
Cyclin D associated events in G1 | 47 | 6.60e-01 | -3.71e-02 | 8.21e-01 |
G1 Phase | 47 | 6.60e-01 | -3.71e-02 | 8.21e-01 |
Post NMDA receptor activation events | 48 | 6.60e-01 | -3.67e-02 | 8.21e-01 |
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | 17 | 7.96e-01 | -3.62e-02 | 9.04e-01 |
Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | 17 | 7.96e-01 | -3.62e-02 | 9.04e-01 |
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | 18 | 7.90e-01 | -3.62e-02 | 9.04e-01 |
Signaling by Ligand-Responsive EGFR Variants in Cancer | 18 | 7.90e-01 | -3.62e-02 | 9.04e-01 |
GPCR downstream signalling | 493 | 1.70e-01 | 3.61e-02 | 3.62e-01 |
Maturation of nucleoprotein | 10 | 8.44e-01 | 3.60e-02 | 9.28e-01 |
Cyclin A:Cdk2-associated events at S phase entry | 85 | 5.66e-01 | -3.60e-02 | 7.51e-01 |
HIV Transcription Initiation | 45 | 6.77e-01 | -3.59e-02 | 8.31e-01 |
RNA Polymerase II HIV Promoter Escape | 45 | 6.77e-01 | -3.59e-02 | 8.31e-01 |
RNA Polymerase II Promoter Escape | 45 | 6.77e-01 | -3.59e-02 | 8.31e-01 |
RNA Polymerase II Transcription Initiation | 45 | 6.77e-01 | -3.59e-02 | 8.31e-01 |
RNA Polymerase II Transcription Initiation And Promoter Clearance | 45 | 6.77e-01 | -3.59e-02 | 8.31e-01 |
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | 45 | 6.77e-01 | -3.59e-02 | 8.31e-01 |
CaM pathway | 27 | 7.47e-01 | 3.59e-02 | 8.79e-01 |
Calmodulin induced events | 27 | 7.47e-01 | 3.59e-02 | 8.79e-01 |
Extra-nuclear estrogen signaling | 67 | 6.13e-01 | -3.57e-02 | 7.89e-01 |
Metabolism of vitamins and cofactors | 155 | 4.43e-01 | 3.57e-02 | 6.45e-01 |
TNFR2 non-canonical NF-kB pathway | 95 | 5.49e-01 | -3.56e-02 | 7.37e-01 |
Transcriptional activation of mitochondrial biogenesis | 51 | 6.61e-01 | -3.55e-02 | 8.21e-01 |
Regulation of RUNX1 Expression and Activity | 18 | 8.02e-01 | -3.42e-02 | 9.07e-01 |
Diseases associated with N-glycosylation of proteins | 17 | 8.13e-01 | -3.31e-02 | 9.08e-01 |
JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | 18 | 8.08e-01 | 3.31e-02 | 9.07e-01 |
TICAM1-dependent activation of IRF3/IRF7 | 12 | 8.43e-01 | 3.30e-02 | 9.28e-01 |
Signaling by ERBB4 | 44 | 7.05e-01 | 3.30e-02 | 8.55e-01 |
Nuclear signaling by ERBB4 | 24 | 7.80e-01 | 3.29e-02 | 9.00e-01 |
ECM proteoglycans | 35 | 7.37e-01 | 3.28e-02 | 8.77e-01 |
Negative regulation of FGFR4 signaling | 21 | 7.95e-01 | 3.28e-02 | 9.04e-01 |
Translation of structural proteins | 28 | 7.64e-01 | 3.27e-02 | 8.91e-01 |
Adaptive Immune System | 756 | 1.27e-01 | -3.26e-02 | 3.04e-01 |
Regulation of APC/C activators between G1/S and early anaphase | 79 | 6.18e-01 | -3.25e-02 | 7.91e-01 |
Class A/1 (Rhodopsin-like receptors) | 162 | 4.77e-01 | -3.24e-02 | 6.76e-01 |
Signalling to RAS | 19 | 8.07e-01 | 3.23e-02 | 9.07e-01 |
Elastic fibre formation | 32 | 7.52e-01 | 3.23e-02 | 8.83e-01 |
DAP12 signaling | 28 | 7.69e-01 | -3.20e-02 | 8.93e-01 |
Disorders of Developmental Biology | 12 | 8.49e-01 | 3.18e-02 | 9.28e-01 |
Disorders of Nervous System Development | 12 | 8.49e-01 | 3.18e-02 | 9.28e-01 |
Loss of function of MECP2 in Rett syndrome | 12 | 8.49e-01 | 3.18e-02 | 9.28e-01 |
Pervasive developmental disorders | 12 | 8.49e-01 | 3.18e-02 | 9.28e-01 |
TCF dependent signaling in response to WNT | 165 | 4.87e-01 | 3.14e-02 | 6.82e-01 |
Ion homeostasis | 40 | 7.32e-01 | 3.13e-02 | 8.76e-01 |
Mitochondrial Fatty Acid Beta-Oxidation | 36 | 7.47e-01 | 3.11e-02 | 8.79e-01 |
Cleavage of the damaged pyrimidine | 29 | 7.72e-01 | -3.11e-02 | 8.93e-01 |
Depyrimidination | 29 | 7.72e-01 | -3.11e-02 | 8.93e-01 |
Recognition and association of DNA glycosylase with site containing an affected pyrimidine | 29 | 7.72e-01 | -3.11e-02 | 8.93e-01 |
Adrenaline,noradrenaline inhibits insulin secretion | 24 | 7.92e-01 | 3.11e-02 | 9.04e-01 |
Transcriptional Regulation by VENTX | 38 | 7.41e-01 | -3.10e-02 | 8.79e-01 |
APC/C-mediated degradation of cell cycle proteins | 86 | 6.24e-01 | -3.06e-02 | 7.92e-01 |
Regulation of mitotic cell cycle | 86 | 6.24e-01 | -3.06e-02 | 7.92e-01 |
Antimicrobial peptides | 33 | 7.62e-01 | 3.04e-02 | 8.90e-01 |
Metabolism | 1768 | 3.45e-02 | 3.03e-02 | 1.18e-01 |
RNA polymerase II transcribes snRNA genes | 72 | 6.57e-01 | 3.03e-02 | 8.21e-01 |
Activation of kainate receptors upon glutamate binding | 26 | 7.91e-01 | 3.00e-02 | 9.04e-01 |
Cholesterol biosynthesis | 24 | 8.01e-01 | 2.97e-02 | 9.07e-01 |
Neurotransmitter release cycle | 39 | 7.50e-01 | 2.95e-02 | 8.81e-01 |
Synthesis of very long-chain fatty acyl-CoAs | 21 | 8.16e-01 | 2.93e-02 | 9.10e-01 |
Activation of HOX genes during differentiation | 68 | 6.76e-01 | 2.93e-02 | 8.31e-01 |
Activation of anterior HOX genes in hindbrain development during early embryogenesis | 68 | 6.76e-01 | 2.93e-02 | 8.31e-01 |
Sulfur amino acid metabolism | 23 | 8.08e-01 | 2.93e-02 | 9.07e-01 |
Constitutive Signaling by EGFRvIII | 14 | 8.50e-01 | 2.92e-02 | 9.28e-01 |
Signaling by EGFRvIII in Cancer | 14 | 8.50e-01 | 2.92e-02 | 9.28e-01 |
Insulin receptor signalling cascade | 39 | 7.55e-01 | 2.89e-02 | 8.84e-01 |
Mitochondrial iron-sulfur cluster biogenesis | 13 | 8.57e-01 | -2.88e-02 | 9.34e-01 |
Initiation of Nuclear Envelope (NE) Reformation | 19 | 8.28e-01 | 2.88e-02 | 9.17e-01 |
Signaling by NTRK2 (TRKB) | 20 | 8.30e-01 | -2.77e-02 | 9.18e-01 |
Purine salvage | 12 | 8.68e-01 | 2.77e-02 | 9.36e-01 |
Abortive elongation of HIV-1 transcript in the absence of Tat | 23 | 8.19e-01 | 2.75e-02 | 9.10e-01 |
Factors involved in megakaryocyte development and platelet production | 116 | 6.09e-01 | 2.75e-02 | 7.87e-01 |
Cellular Senescence | 144 | 5.75e-01 | 2.71e-02 | 7.57e-01 |
Biosynthesis of DHA-derived SPMs | 14 | 8.61e-01 | -2.71e-02 | 9.35e-01 |
Regulation of FOXO transcriptional activity by acetylation | 10 | 8.84e-01 | 2.66e-02 | 9.45e-01 |
Cyclin E associated events during G1/S transition | 83 | 6.80e-01 | -2.62e-02 | 8.34e-01 |
RIPK1-mediated regulated necrosis | 29 | 8.08e-01 | 2.61e-02 | 9.07e-01 |
Regulated Necrosis | 29 | 8.08e-01 | 2.61e-02 | 9.07e-01 |
Regulation of necroptotic cell death | 29 | 8.08e-01 | 2.61e-02 | 9.07e-01 |
TNF signaling | 43 | 7.71e-01 | -2.56e-02 | 8.93e-01 |
ERBB2 Regulates Cell Motility | 10 | 8.89e-01 | -2.56e-02 | 9.48e-01 |
SARS-CoV Infections | 139 | 6.07e-01 | 2.53e-02 | 7.86e-01 |
ESR-mediated signaling | 162 | 5.83e-01 | -2.50e-02 | 7.64e-01 |
Transcriptional Regulation by MECP2 | 47 | 7.67e-01 | 2.49e-02 | 8.93e-01 |
Post-translational protein modification | 1189 | 1.55e-01 | 2.45e-02 | 3.44e-01 |
Cell-Cell communication | 87 | 6.93e-01 | -2.45e-02 | 8.44e-01 |
Class B/2 (Secretin family receptors) | 56 | 7.54e-01 | 2.42e-02 | 8.84e-01 |
PI3K/AKT Signaling in Cancer | 80 | 7.10e-01 | -2.40e-02 | 8.58e-01 |
Base-Excision Repair, AP Site Formation | 31 | 8.19e-01 | -2.38e-02 | 9.10e-01 |
Downstream signaling events of B Cell Receptor (BCR) | 79 | 7.15e-01 | 2.38e-02 | 8.61e-01 |
Signaling by WNT in cancer | 30 | 8.22e-01 | 2.37e-02 | 9.12e-01 |
Disease | 1350 | 1.48e-01 | -2.35e-02 | 3.32e-01 |
Prostacyclin signalling through prostacyclin receptor | 16 | 8.73e-01 | 2.31e-02 | 9.38e-01 |
Diseases associated with O-glycosylation of proteins | 48 | 7.84e-01 | -2.28e-02 | 9.01e-01 |
RNA Polymerase II Pre-transcription Events | 78 | 7.28e-01 | -2.28e-02 | 8.73e-01 |
Constitutive Signaling by NOTCH1 HD Domain Mutants | 14 | 8.84e-01 | -2.25e-02 | 9.45e-01 |
Signaling by NOTCH1 HD Domain Mutants in Cancer | 14 | 8.84e-01 | -2.25e-02 | 9.45e-01 |
Pyruvate metabolism | 28 | 8.39e-01 | 2.22e-02 | 9.26e-01 |
Regulation of MECP2 expression and activity | 28 | 8.39e-01 | 2.21e-02 | 9.26e-01 |
ATF6 (ATF6-alpha) activates chaperone genes | 10 | 9.06e-01 | 2.16e-02 | 9.57e-01 |
Formation of HIV-1 elongation complex containing HIV-1 Tat | 42 | 8.12e-01 | -2.12e-02 | 9.07e-01 |
HIV Transcription Elongation | 42 | 8.12e-01 | -2.12e-02 | 9.07e-01 |
Tat-mediated elongation of the HIV-1 transcript | 42 | 8.12e-01 | -2.12e-02 | 9.07e-01 |
Transcriptional regulation of pluripotent stem cells | 19 | 8.74e-01 | 2.10e-02 | 9.39e-01 |
Signaling by ERBB2 | 44 | 8.10e-01 | -2.09e-02 | 9.07e-01 |
Keratan sulfate biosynthesis | 22 | 8.69e-01 | -2.03e-02 | 9.36e-01 |
Fcgamma receptor (FCGR) dependent phagocytosis | 147 | 6.75e-01 | -2.00e-02 | 8.31e-01 |
Transport of inorganic cations/anions and amino acids/oligopeptides | 79 | 7.59e-01 | 2.00e-02 | 8.86e-01 |
PECAM1 interactions | 12 | 9.06e-01 | 1.97e-02 | 9.57e-01 |
Interleukin-7 signaling | 21 | 8.76e-01 | -1.96e-02 | 9.41e-01 |
Regulation of localization of FOXO transcription factors | 11 | 9.11e-01 | 1.95e-02 | 9.59e-01 |
Antigen processing: Ubiquitination & Proteasome degradation | 288 | 5.70e-01 | -1.95e-02 | 7.54e-01 |
Lewis blood group biosynthesis | 13 | 9.05e-01 | -1.91e-02 | 9.57e-01 |
HS-GAG biosynthesis | 20 | 8.83e-01 | 1.90e-02 | 9.45e-01 |
Pexophagy | 11 | 9.14e-01 | 1.89e-02 | 9.59e-01 |
Acyl chain remodelling of PS | 14 | 9.03e-01 | -1.89e-02 | 9.57e-01 |
RNA Pol II CTD phosphorylation and interaction with CE | 27 | 8.69e-01 | -1.83e-02 | 9.36e-01 |
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | 27 | 8.69e-01 | -1.83e-02 | 9.36e-01 |
RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | 53 | 8.19e-01 | 1.81e-02 | 9.10e-01 |
Hedgehog ‘off’ state | 92 | 7.64e-01 | 1.81e-02 | 8.91e-01 |
HIV elongation arrest and recovery | 32 | 8.61e-01 | 1.78e-02 | 9.35e-01 |
Pausing and recovery of HIV elongation | 32 | 8.61e-01 | 1.78e-02 | 9.35e-01 |
DAG and IP3 signaling | 33 | 8.60e-01 | 1.78e-02 | 9.35e-01 |
Ephrin signaling | 17 | 9.01e-01 | -1.75e-02 | 9.57e-01 |
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | 13 | 9.13e-01 | -1.74e-02 | 9.59e-01 |
NRIF signals cell death from the nucleus | 15 | 9.08e-01 | 1.72e-02 | 9.58e-01 |
HCMV Late Events | 69 | 8.09e-01 | -1.68e-02 | 9.07e-01 |
Cell junction organization | 59 | 8.23e-01 | -1.68e-02 | 9.13e-01 |
Downstream signal transduction | 27 | 8.81e-01 | 1.67e-02 | 9.44e-01 |
Developmental Biology | 727 | 4.53e-01 | -1.64e-02 | 6.56e-01 |
Cell-extracellular matrix interactions | 14 | 9.17e-01 | 1.60e-02 | 9.60e-01 |
IL-6-type cytokine receptor ligand interactions | 12 | 9.24e-01 | -1.59e-02 | 9.65e-01 |
Cdc20:Phospho-APC/C mediated degradation of Cyclin A | 71 | 8.17e-01 | 1.58e-02 | 9.10e-01 |
p75NTR recruits signalling complexes | 12 | 9.25e-01 | 1.57e-02 | 9.65e-01 |
Packaging Of Telomere Ends | 20 | 9.04e-01 | 1.56e-02 | 9.57e-01 |
STING mediated induction of host immune responses | 15 | 9.17e-01 | -1.55e-02 | 9.60e-01 |
Negative regulation of the PI3K/AKT network | 87 | 8.03e-01 | -1.55e-02 | 9.07e-01 |
Diseases of glycosylation | 108 | 7.82e-01 | 1.54e-02 | 9.01e-01 |
Deubiquitination | 241 | 6.83e-01 | 1.53e-02 | 8.36e-01 |
Receptor Mediated Mitophagy | 11 | 9.30e-01 | 1.52e-02 | 9.68e-01 |
Chondroitin sulfate/dermatan sulfate metabolism | 38 | 8.71e-01 | -1.52e-02 | 9.37e-01 |
SHC1 events in ERBB4 signaling | 10 | 9.34e-01 | -1.51e-02 | 9.68e-01 |
Formation of HIV elongation complex in the absence of HIV Tat | 44 | 8.64e-01 | -1.50e-02 | 9.35e-01 |
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | 72 | 8.27e-01 | 1.49e-02 | 9.17e-01 |
Signaling by FGFR | 69 | 8.33e-01 | -1.47e-02 | 9.20e-01 |
G alpha (q) signalling events | 131 | 7.76e-01 | 1.44e-02 | 8.96e-01 |
Signaling by EGFR in Cancer | 23 | 9.06e-01 | -1.41e-02 | 9.57e-01 |
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | 75 | 8.35e-01 | 1.39e-02 | 9.22e-01 |
FOXO-mediated transcription | 58 | 8.55e-01 | -1.38e-02 | 9.33e-01 |
Nitric oxide stimulates guanylate cyclase | 15 | 9.27e-01 | -1.37e-02 | 9.66e-01 |
Circadian Clock | 67 | 8.48e-01 | -1.35e-02 | 9.28e-01 |
Protein-protein interactions at synapses | 57 | 8.60e-01 | 1.35e-02 | 9.35e-01 |
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | 73 | 8.43e-01 | 1.34e-02 | 9.28e-01 |
Formation of the Early Elongation Complex | 33 | 8.94e-01 | 1.34e-02 | 9.51e-01 |
Formation of the HIV-1 Early Elongation Complex | 33 | 8.94e-01 | 1.34e-02 | 9.51e-01 |
NGF-stimulated transcription | 31 | 8.98e-01 | 1.33e-02 | 9.54e-01 |
Disorders of transmembrane transporters | 147 | 7.87e-01 | 1.29e-02 | 9.03e-01 |
Ub-specific processing proteases | 170 | 7.74e-01 | -1.28e-02 | 8.94e-01 |
Response of EIF2AK1 (HRI) to heme deficiency | 14 | 9.35e-01 | 1.26e-02 | 9.68e-01 |
Signaling by FGFR4 | 31 | 9.06e-01 | 1.22e-02 | 9.57e-01 |
Glycolysis | 67 | 8.65e-01 | 1.20e-02 | 9.35e-01 |
Protein ubiquitination | 72 | 8.64e-01 | -1.17e-02 | 9.35e-01 |
FLT3 Signaling | 244 | 7.53e-01 | 1.17e-02 | 8.83e-01 |
APC/C:Cdc20 mediated degradation of mitotic proteins | 74 | 8.63e-01 | 1.16e-02 | 9.35e-01 |
Interleukin-4 and Interleukin-13 signaling | 92 | 8.49e-01 | 1.15e-02 | 9.28e-01 |
Cristae formation | 31 | 9.14e-01 | 1.13e-02 | 9.59e-01 |
Pausing and recovery of Tat-mediated HIV elongation | 30 | 9.15e-01 | 1.12e-02 | 9.60e-01 |
Tat-mediated HIV elongation arrest and recovery | 30 | 9.15e-01 | 1.12e-02 | 9.60e-01 |
Peptide ligand-binding receptors | 92 | 8.54e-01 | 1.11e-02 | 9.32e-01 |
Negative regulation of FGFR2 signaling | 23 | 9.27e-01 | -1.11e-02 | 9.66e-01 |
Synthesis of active ubiquitin: roles of E1 and E2 enzymes | 30 | 9.19e-01 | -1.08e-02 | 9.60e-01 |
Visual phototransduction | 59 | 8.86e-01 | 1.07e-02 | 9.46e-01 |
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | 21 | 9.32e-01 | 1.07e-02 | 9.68e-01 |
Signaling by PDGFR in disease | 19 | 9.36e-01 | -1.07e-02 | 9.68e-01 |
Cytokine Signaling in Immune system | 735 | 6.25e-01 | 1.06e-02 | 7.92e-01 |
Purine catabolism | 16 | 9.42e-01 | 1.05e-02 | 9.71e-01 |
Formation of the beta-catenin:TCF transactivating complex | 46 | 9.05e-01 | -1.01e-02 | 9.57e-01 |
GPCR ligand binding | 229 | 7.96e-01 | -9.91e-03 | 9.04e-01 |
DDX58/IFIH1-mediated induction of interferon-alpha/beta | 63 | 8.93e-01 | 9.77e-03 | 9.51e-01 |
p75NTR signals via NF-kB | 15 | 9.49e-01 | -9.51e-03 | 9.75e-01 |
Activation of RAC1 | 11 | 9.57e-01 | 9.49e-03 | 9.80e-01 |
Signaling by Nuclear Receptors | 218 | 8.11e-01 | -9.41e-03 | 9.07e-01 |
Intrinsic Pathway of Fibrin Clot Formation | 16 | 9.49e-01 | -9.28e-03 | 9.75e-01 |
Diseases associated with glycosaminoglycan metabolism | 26 | 9.36e-01 | 9.15e-03 | 9.68e-01 |
Constitutive Signaling by Overexpressed ERBB2 | 11 | 9.60e-01 | -8.78e-03 | 9.81e-01 |
Acyl chain remodelling of PE | 20 | 9.47e-01 | 8.65e-03 | 9.74e-01 |
Peptide hormone metabolism | 51 | 9.18e-01 | -8.38e-03 | 9.60e-01 |
TRP channels | 17 | 9.52e-01 | 8.36e-03 | 9.77e-01 |
MAPK1/MAPK3 signaling | 235 | 8.45e-01 | 7.39e-03 | 9.28e-01 |
Potential therapeutics for SARS | 77 | 9.12e-01 | -7.32e-03 | 9.59e-01 |
Signaling by PDGF | 44 | 9.36e-01 | 6.99e-03 | 9.68e-01 |
Interferon gamma signaling | 83 | 9.13e-01 | 6.96e-03 | 9.59e-01 |
Downstream signaling of activated FGFR1 | 20 | 9.57e-01 | 6.93e-03 | 9.80e-01 |
mitochondrial fatty acid beta-oxidation of saturated fatty acids | 11 | 9.69e-01 | -6.84e-03 | 9.87e-01 |
Intrinsic Pathway for Apoptosis | 52 | 9.33e-01 | 6.77e-03 | 9.68e-01 |
Ovarian tumor domain proteases | 37 | 9.44e-01 | -6.72e-03 | 9.71e-01 |
Synthesis of PA | 32 | 9.51e-01 | -6.22e-03 | 9.77e-01 |
G alpha (i) signalling events | 243 | 8.70e-01 | 6.10e-03 | 9.37e-01 |
MAPK family signaling cascades | 269 | 8.64e-01 | 6.05e-03 | 9.35e-01 |
RAF/MAP kinase cascade | 230 | 8.78e-01 | 5.88e-03 | 9.41e-01 |
Regulation of PTEN gene transcription | 59 | 9.39e-01 | -5.74e-03 | 9.70e-01 |
TICAM1, RIP1-mediated IKK complex recruitment | 19 | 9.66e-01 | 5.69e-03 | 9.85e-01 |
Formation of RNA Pol II elongation complex | 57 | 9.41e-01 | 5.68e-03 | 9.70e-01 |
RNA Polymerase II Transcription Elongation | 57 | 9.41e-01 | 5.68e-03 | 9.70e-01 |
Interleukin-2 signaling | 11 | 9.75e-01 | -5.42e-03 | 9.87e-01 |
Mitochondrial biogenesis | 88 | 9.32e-01 | -5.28e-03 | 9.68e-01 |
RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | 36 | 9.60e-01 | -4.80e-03 | 9.81e-01 |
O-linked glycosylation | 83 | 9.40e-01 | -4.74e-03 | 9.70e-01 |
Ca2+ pathway | 57 | 9.56e-01 | -4.25e-03 | 9.79e-01 |
AMER1 mutants destabilize the destruction complex | 14 | 9.79e-01 | 4.02e-03 | 9.87e-01 |
APC truncation mutants have impaired AXIN binding | 14 | 9.79e-01 | 4.02e-03 | 9.87e-01 |
AXIN missense mutants destabilize the destruction complex | 14 | 9.79e-01 | 4.02e-03 | 9.87e-01 |
AXIN mutants destabilize the destruction complex, activating WNT signaling | 14 | 9.79e-01 | 4.02e-03 | 9.87e-01 |
Truncations of AMER1 destabilize the destruction complex | 14 | 9.79e-01 | 4.02e-03 | 9.87e-01 |
truncated APC mutants destabilize the destruction complex | 14 | 9.79e-01 | 4.02e-03 | 9.87e-01 |
Condensation of Prophase Chromosomes | 29 | 9.70e-01 | -3.98e-03 | 9.87e-01 |
Leishmania infection | 245 | 9.28e-01 | -3.34e-03 | 9.67e-01 |
HS-GAG degradation | 16 | 9.82e-01 | -3.20e-03 | 9.88e-01 |
Interferon alpha/beta signaling | 57 | 9.67e-01 | -3.15e-03 | 9.86e-01 |
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | 80 | 9.62e-01 | 3.07e-03 | 9.82e-01 |
Cleavage of the damaged purine | 24 | 9.80e-01 | -3.02e-03 | 9.87e-01 |
Depurination | 24 | 9.80e-01 | -3.02e-03 | 9.87e-01 |
Recognition and association of DNA glycosylase with site containing an affected purine | 24 | 9.80e-01 | -3.02e-03 | 9.87e-01 |
Inhibition of DNA recombination at telomere | 35 | 9.76e-01 | -2.88e-03 | 9.87e-01 |
Unfolded Protein Response (UPR) | 86 | 9.75e-01 | 1.92e-03 | 9.87e-01 |
Signaling by FGFR in disease | 50 | 9.83e-01 | 1.79e-03 | 9.88e-01 |
Neddylation | 218 | 9.69e-01 | 1.52e-03 | 9.87e-01 |
Metabolism of water-soluble vitamins and cofactors | 109 | 9.80e-01 | -1.42e-03 | 9.87e-01 |
RAF-independent MAPK1/3 activation | 21 | 9.92e-01 | 1.28e-03 | 9.96e-01 |
E3 ubiquitin ligases ubiquitinate target proteins | 52 | 9.89e-01 | -1.06e-03 | 9.94e-01 |
VEGFR2 mediated cell proliferation | 18 | 9.95e-01 | 8.48e-04 | 9.97e-01 |
TP53 Regulates Transcription of Cell Death Genes | 42 | 9.93e-01 | 7.83e-04 | 9.96e-01 |
Transcriptional regulation by RUNX1 | 184 | 9.87e-01 | -6.87e-04 | 9.92e-01 |
Assembly of the pre-replicative complex | 66 | 9.96e-01 | -3.75e-04 | 9.97e-01 |
PI-3K cascade:FGFR1 | 12 | 9.99e-01 | 2.62e-04 | 9.99e-01 |
Synthesis of PIPs at the early endosome membrane | 16 | 1.00e+00 | -5.78e-05 | 1.00e+00 |
IRAK4 deficiency (TLR2/4)
512 | |
---|---|
set | IRAK4 deficiency (TLR2/4) |
setSize | 10 |
pANOVA | 6.62e-06 |
s.dist | 0.823 |
p.adjustANOVA | 0.000114 |
Top enriched genes
GeneID | Gene Rank |
---|---|
MYD88 | 11614 |
BTK | 11379 |
CD36 | 11354 |
TLR2 | 10761 |
CD14 | 10542 |
LY96 | 10002 |
TLR4 | 9355 |
TLR1 | 8749 |
TLR6 | 7631 |
TIRAP | 6862 |
GeneID | Gene Rank |
---|---|
MYD88 | 11614 |
BTK | 11379 |
CD36 | 11354 |
TLR2 | 10761 |
CD14 | 10542 |
LY96 | 10002 |
TLR4 | 9355 |
TLR1 | 8749 |
TLR6 | 7631 |
TIRAP | 6862 |
MyD88 deficiency (TLR2/4)
685 | |
---|---|
set | MyD88 deficiency (TLR2/4) |
setSize | 10 |
pANOVA | 6.62e-06 |
s.dist | 0.823 |
p.adjustANOVA | 0.000114 |
Top enriched genes
GeneID | Gene Rank |
---|---|
MYD88 | 11614 |
BTK | 11379 |
CD36 | 11354 |
TLR2 | 10761 |
CD14 | 10542 |
LY96 | 10002 |
TLR4 | 9355 |
TLR1 | 8749 |
TLR6 | 7631 |
TIRAP | 6862 |
GeneID | Gene Rank |
---|---|
MYD88 | 11614 |
BTK | 11379 |
CD36 | 11354 |
TLR2 | 10761 |
CD14 | 10542 |
LY96 | 10002 |
TLR4 | 9355 |
TLR1 | 8749 |
TLR6 | 7631 |
TIRAP | 6862 |
Peptide chain elongation
807 | |
---|---|
set | Peptide chain elongation |
setSize | 88 |
pANOVA | 2.46e-30 |
s.dist | -0.705 |
p.adjustANOVA | 3.72e-28 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL3 | -9701 |
RPS2 | -9635 |
RPL14 | -9390 |
EEF1A1 | -9389 |
RPL23A | -9382 |
RPL5 | -9359 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
RPL4 | -9065 |
RPL22 | -8915 |
RPS3 | -8856 |
RPS25 | -8832 |
RPL21 | -8773 |
RPS27A | -8722 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
RPL6 | -8498 |
GeneID | Gene Rank |
---|---|
RPL3 | -9701 |
RPS2 | -9635 |
RPL14 | -9390 |
EEF1A1 | -9389 |
RPL23A | -9382 |
RPL5 | -9359 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
RPL4 | -9065 |
RPL22 | -8915 |
RPS3 | -8856 |
RPS25 | -8832 |
RPL21 | -8773 |
RPS27A | -8722 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
RPL6 | -8498 |
RPL34 | -8489 |
RPS20 | -8476 |
RPL17 | -8462 |
RPL27A | -8420 |
RPS12 | -8401 |
RPS14 | -8337 |
RPS23 | -8334 |
RPL10 | -8318 |
RPS27 | -8260 |
RPLP2 | -8255 |
RPL36A | -8130 |
RPS7 | -8047 |
RPL35A | -8046 |
RPL10A | -7989 |
RPL29 | -7954 |
RPL11 | -7928 |
RPL32 | -7914 |
RPS15A | -7912 |
RPL22L1 | -7828 |
RPL30 | -7783 |
RPL18 | -7781 |
RPL35 | -7710 |
RPL26 | -7648 |
RPS4X | -7636 |
RPS10 | -7629 |
RPL24 | -7626 |
RPS16 | -7617 |
RPL18A | -7609 |
RPL31 | -7521 |
RPL9 | -7451 |
RPL15 | -7380 |
RPS13 | -7375 |
RPL7A | -7296 |
RPS18 | -7288 |
RPS8 | -7161 |
RPS17 | -7134 |
EEF2 | -7073 |
RPL19 | -7006 |
RPL23 | -6933 |
RPS29 | -6791 |
RPS11 | -6742 |
RPS21 | -6706 |
RPL37 | -6660 |
RPL38 | -6589 |
RPS28 | -6429 |
RPL36 | -6343 |
RPL8 | -6274 |
RPL27 | -6068 |
RPL41 | -6065 |
RPL39 | -5790 |
RPS19 | -5616 |
RPL13 | -5550 |
RPS26 | -5524 |
RPS15 | -5342 |
RPS24 | -5310 |
RPL37A | -4774 |
RPSA | -4559 |
RPL36AL | -4148 |
RPLP1 | -3887 |
RPL28 | -1952 |
UBA52 | -1437 |
FAU | -1029 |
RPL39L | -69 |
RPS4Y1 | 1461 |
RPS9 | 2392 |
RPS27L | 2784 |
RPL3L | 5700 |
RPL26L1 | 6187 |
Eukaryotic Translation Elongation
350 | |
---|---|
set | Eukaryotic Translation Elongation |
setSize | 93 |
pANOVA | 7.89e-32 |
s.dist | -0.703 |
p.adjustANOVA | 1.34e-29 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL3 | -9701 |
RPS2 | -9635 |
RPL14 | -9390 |
EEF1A1 | -9389 |
RPL23A | -9382 |
RPL5 | -9359 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
EEF1B2 | -9090 |
RPL4 | -9065 |
EEF1G | -8961 |
RPL22 | -8915 |
RPS3 | -8856 |
RPS25 | -8832 |
RPL21 | -8773 |
RPS27A | -8722 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
GeneID | Gene Rank |
---|---|
RPL3 | -9701 |
RPS2 | -9635 |
RPL14 | -9390 |
EEF1A1 | -9389 |
RPL23A | -9382 |
RPL5 | -9359 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
EEF1B2 | -9090 |
RPL4 | -9065 |
EEF1G | -8961 |
RPL22 | -8915 |
RPS3 | -8856 |
RPS25 | -8832 |
RPL21 | -8773 |
RPS27A | -8722 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
RPL6 | -8498 |
RPL34 | -8489 |
RPS20 | -8476 |
RPL17 | -8462 |
RPL27A | -8420 |
RPS12 | -8401 |
RPS14 | -8337 |
RPS23 | -8334 |
RPL10 | -8318 |
RPS27 | -8260 |
RPLP2 | -8255 |
RPL36A | -8130 |
RPS7 | -8047 |
RPL35A | -8046 |
RPL10A | -7989 |
RPL29 | -7954 |
RPL11 | -7928 |
RPL32 | -7914 |
RPS15A | -7912 |
RPL22L1 | -7828 |
RPL30 | -7783 |
RPL18 | -7781 |
RPL35 | -7710 |
RPL26 | -7648 |
RPS4X | -7636 |
RPS10 | -7629 |
RPL24 | -7626 |
RPS16 | -7617 |
RPL18A | -7609 |
RPL31 | -7521 |
RPL9 | -7451 |
RPL15 | -7380 |
RPS13 | -7375 |
RPL7A | -7296 |
RPS18 | -7288 |
RPS8 | -7161 |
RPS17 | -7134 |
EEF2 | -7073 |
RPL19 | -7006 |
RPL23 | -6933 |
RPS29 | -6791 |
RPS11 | -6742 |
RPS21 | -6706 |
RPL37 | -6660 |
EEF1A1P5 | -6596 |
RPL38 | -6589 |
RPS28 | -6429 |
RPL36 | -6343 |
RPL8 | -6274 |
RPL27 | -6068 |
RPL41 | -6065 |
RPL39 | -5790 |
RPS19 | -5616 |
RPL13 | -5550 |
RPS26 | -5524 |
RPS15 | -5342 |
RPS24 | -5310 |
EEF1D | -4995 |
RPL37A | -4774 |
RPSA | -4559 |
RPL36AL | -4148 |
RPLP1 | -3887 |
RPL28 | -1952 |
EEF1A2 | -1947 |
UBA52 | -1437 |
FAU | -1029 |
RPL39L | -69 |
RPS4Y1 | 1461 |
RPS9 | 2392 |
RPS27L | 2784 |
RPL3L | 5700 |
RPL26L1 | 6187 |
Selenocysteine synthesis
1060 | |
---|---|
set | Selenocysteine synthesis |
setSize | 92 |
pANOVA | 9.58e-30 |
s.dist | -0.682 |
p.adjustANOVA | 1.1e-27 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL3 | -9701 |
RPS2 | -9635 |
RPL14 | -9390 |
RPL23A | -9382 |
RPL5 | -9359 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
RPL4 | -9065 |
RPL22 | -8915 |
RPS3 | -8856 |
RPS25 | -8832 |
RPL21 | -8773 |
RPS27A | -8722 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
RPL6 | -8498 |
RPL34 | -8489 |
GeneID | Gene Rank |
---|---|
RPL3 | -9701 |
RPS2 | -9635 |
RPL14 | -9390 |
RPL23A | -9382 |
RPL5 | -9359 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
RPL4 | -9065 |
RPL22 | -8915 |
RPS3 | -8856 |
RPS25 | -8832 |
RPL21 | -8773 |
RPS27A | -8722 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
RPL6 | -8498 |
RPL34 | -8489 |
RPS20 | -8476 |
RPL17 | -8462 |
RPL27A | -8420 |
RPS12 | -8401 |
RPS14 | -8337 |
RPS23 | -8334 |
RPL10 | -8318 |
RPS27 | -8260 |
RPLP2 | -8255 |
RPL36A | -8130 |
RPS7 | -8047 |
RPL35A | -8046 |
RPL10A | -7989 |
RPL29 | -7954 |
RPL11 | -7928 |
RPL32 | -7914 |
RPS15A | -7912 |
RPL22L1 | -7828 |
RPL30 | -7783 |
RPL18 | -7781 |
RPL35 | -7710 |
RPL26 | -7648 |
RPS4X | -7636 |
RPS10 | -7629 |
RPL24 | -7626 |
RPS16 | -7617 |
RPL18A | -7609 |
RPL31 | -7521 |
RPL9 | -7451 |
RPL15 | -7380 |
RPS13 | -7375 |
RPL7A | -7296 |
RPS18 | -7288 |
RPS8 | -7161 |
RPS17 | -7134 |
SEPSECS | -7064 |
RPL19 | -7006 |
RPL23 | -6933 |
RPS29 | -6791 |
RPS11 | -6742 |
RPS21 | -6706 |
RPL37 | -6660 |
RPL38 | -6589 |
RPS28 | -6429 |
SARS1 | -6425 |
RPL36 | -6343 |
RPL8 | -6274 |
SECISBP2 | -6069 |
RPL27 | -6068 |
RPL41 | -6065 |
RPL39 | -5790 |
RPS19 | -5616 |
RPL13 | -5550 |
RPS26 | -5524 |
RPS15 | -5342 |
RPS24 | -5310 |
EEFSEC | -5238 |
RPL37A | -4774 |
RPSA | -4559 |
RPL36AL | -4148 |
RPLP1 | -3887 |
PSTK | -3075 |
RPL28 | -1952 |
UBA52 | -1437 |
FAU | -1029 |
RPL39L | -69 |
RPS4Y1 | 1461 |
RPS9 | 2392 |
RPS27L | 2784 |
RPL3L | 5700 |
RPL26L1 | 6187 |
SEPHS2 | 7242 |
Viral mRNA Translation
1315 | |
---|---|
set | Viral mRNA Translation |
setSize | 88 |
pANOVA | 1.67e-28 |
s.dist | -0.682 |
p.adjustANOVA | 1.62e-26 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL3 | -9701 |
RPS2 | -9635 |
RPL14 | -9390 |
RPL23A | -9382 |
RPL5 | -9359 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
RPL4 | -9065 |
RPL22 | -8915 |
RPS3 | -8856 |
RPS25 | -8832 |
RPL21 | -8773 |
RPS27A | -8722 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
RPL6 | -8498 |
RPL34 | -8489 |
GeneID | Gene Rank |
---|---|
RPL3 | -9701 |
RPS2 | -9635 |
RPL14 | -9390 |
RPL23A | -9382 |
RPL5 | -9359 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
RPL4 | -9065 |
RPL22 | -8915 |
RPS3 | -8856 |
RPS25 | -8832 |
RPL21 | -8773 |
RPS27A | -8722 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
RPL6 | -8498 |
RPL34 | -8489 |
RPS20 | -8476 |
RPL17 | -8462 |
RPL27A | -8420 |
RPS12 | -8401 |
RPS14 | -8337 |
RPS23 | -8334 |
RPL10 | -8318 |
RPS27 | -8260 |
RPLP2 | -8255 |
RPL36A | -8130 |
RPS7 | -8047 |
RPL35A | -8046 |
RPL10A | -7989 |
RPL29 | -7954 |
RPL11 | -7928 |
RPL32 | -7914 |
RPS15A | -7912 |
RPL22L1 | -7828 |
RPL30 | -7783 |
RPL18 | -7781 |
RPL35 | -7710 |
RPL26 | -7648 |
RPS4X | -7636 |
RPS10 | -7629 |
RPL24 | -7626 |
RPS16 | -7617 |
RPL18A | -7609 |
RPL31 | -7521 |
RPL9 | -7451 |
RPL15 | -7380 |
RPS13 | -7375 |
RPL7A | -7296 |
RPS18 | -7288 |
RPS8 | -7161 |
RPS17 | -7134 |
RPL19 | -7006 |
RPL23 | -6933 |
RPS29 | -6791 |
RPS11 | -6742 |
RPS21 | -6706 |
RPL37 | -6660 |
RPL38 | -6589 |
RPS28 | -6429 |
RPL36 | -6343 |
RPL8 | -6274 |
RPL27 | -6068 |
RPL41 | -6065 |
RPL39 | -5790 |
RPS19 | -5616 |
RPL13 | -5550 |
RPS26 | -5524 |
RPS15 | -5342 |
RPS24 | -5310 |
RPL37A | -4774 |
RPSA | -4559 |
RPL36AL | -4148 |
RPLP1 | -3887 |
GRSF1 | -3125 |
RPL28 | -1952 |
UBA52 | -1437 |
FAU | -1029 |
RPL39L | -69 |
RPS4Y1 | 1461 |
RPS9 | 2392 |
RPS27L | 2784 |
RPL3L | 5700 |
RPL26L1 | 6187 |
DNAJC3 | 8291 |
Formation of a pool of free 40S subunits
392 | |
---|---|
set | Formation of a pool of free 40S subunits |
setSize | 100 |
pANOVA | 5.67e-32 |
s.dist | -0.68 |
p.adjustANOVA | 1.1e-29 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL3 | -9701 |
RPS2 | -9635 |
RPL14 | -9390 |
RPL23A | -9382 |
RPL5 | -9359 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
RPL4 | -9065 |
RPL22 | -8915 |
EIF3B | -8874 |
RPS3 | -8856 |
RPS25 | -8832 |
RPL21 | -8773 |
RPS27A | -8722 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
EIF3E | -8600 |
GeneID | Gene Rank |
---|---|
RPL3 | -9701 |
RPS2 | -9635 |
RPL14 | -9390 |
RPL23A | -9382 |
RPL5 | -9359 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
RPL4 | -9065 |
RPL22 | -8915 |
EIF3B | -8874 |
RPS3 | -8856 |
RPS25 | -8832 |
RPL21 | -8773 |
RPS27A | -8722 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
EIF3E | -8600 |
RPL6 | -8498 |
RPL34 | -8489 |
RPS20 | -8476 |
RPL17 | -8462 |
RPL27A | -8420 |
RPS12 | -8401 |
EIF1AX | -8394 |
RPS14 | -8337 |
RPS23 | -8334 |
RPL10 | -8318 |
RPS27 | -8260 |
RPLP2 | -8255 |
RPL36A | -8130 |
RPS7 | -8047 |
RPL35A | -8046 |
RPL10A | -7989 |
RPL29 | -7954 |
RPL11 | -7928 |
RPL32 | -7914 |
RPS15A | -7912 |
RPL22L1 | -7828 |
RPL30 | -7783 |
RPL18 | -7781 |
EIF3L | -7766 |
RPL35 | -7710 |
RPL26 | -7648 |
RPS4X | -7636 |
RPS10 | -7629 |
RPL24 | -7626 |
RPS16 | -7617 |
RPL18A | -7609 |
RPL31 | -7521 |
RPL9 | -7451 |
RPL15 | -7380 |
RPS13 | -7375 |
RPL7A | -7296 |
RPS18 | -7288 |
RPS8 | -7161 |
RPS17 | -7134 |
RPL19 | -7006 |
RPL23 | -6933 |
RPS29 | -6791 |
RPS11 | -6742 |
RPS21 | -6706 |
RPL37 | -6660 |
RPL38 | -6589 |
RPS28 | -6429 |
RPL36 | -6343 |
RPL8 | -6274 |
RPL27 | -6068 |
RPL41 | -6065 |
EIF3J | -6001 |
EIF3H | -5894 |
RPL39 | -5790 |
EIF3M | -5620 |
RPS19 | -5616 |
RPL13 | -5550 |
RPS26 | -5524 |
RPS15 | -5342 |
RPS24 | -5310 |
RPL37A | -4774 |
RPSA | -4559 |
EIF3D | -4337 |
RPL36AL | -4148 |
RPLP1 | -3887 |
EIF3C | -3750 |
EIF3F | -3748 |
EIF3I | -2671 |
RPL28 | -1952 |
EIF3G | -1676 |
EIF3A | -1537 |
UBA52 | -1437 |
FAU | -1029 |
EIF3K | -298 |
RPL39L | -69 |
RPS4Y1 | 1461 |
RPS9 | 2392 |
RPS27L | 2784 |
RPL3L | 5700 |
RPL26L1 | 6187 |
Eukaryotic Translation Termination
352 | |
---|---|
set | Eukaryotic Translation Termination |
setSize | 92 |
pANOVA | 2.59e-29 |
s.dist | -0.677 |
p.adjustANOVA | 2.72e-27 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL3 | -9701 |
RPS2 | -9635 |
RPL14 | -9390 |
RPL23A | -9382 |
RPL5 | -9359 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
RPL4 | -9065 |
RPL22 | -8915 |
N6AMT1 | -8889 |
RPS3 | -8856 |
RPS25 | -8832 |
RPL21 | -8773 |
RPS27A | -8722 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
RPL6 | -8498 |
GeneID | Gene Rank |
---|---|
RPL3 | -9701 |
RPS2 | -9635 |
RPL14 | -9390 |
RPL23A | -9382 |
RPL5 | -9359 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
RPL4 | -9065 |
RPL22 | -8915 |
N6AMT1 | -8889 |
RPS3 | -8856 |
RPS25 | -8832 |
RPL21 | -8773 |
RPS27A | -8722 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
RPL6 | -8498 |
RPL34 | -8489 |
RPS20 | -8476 |
RPL17 | -8462 |
RPL27A | -8420 |
RPS12 | -8401 |
RPS14 | -8337 |
GSPT2 | -8336 |
RPS23 | -8334 |
RPL10 | -8318 |
RPS27 | -8260 |
RPLP2 | -8255 |
RPL36A | -8130 |
RPS7 | -8047 |
RPL35A | -8046 |
RPL10A | -7989 |
RPL29 | -7954 |
RPL11 | -7928 |
RPL32 | -7914 |
RPS15A | -7912 |
RPL22L1 | -7828 |
RPL30 | -7783 |
RPL18 | -7781 |
RPL35 | -7710 |
RPL26 | -7648 |
RPS4X | -7636 |
RPS10 | -7629 |
RPL24 | -7626 |
RPS16 | -7617 |
RPL18A | -7609 |
RPL31 | -7521 |
RPL9 | -7451 |
RPL15 | -7380 |
RPS13 | -7375 |
RPL7A | -7296 |
RPS18 | -7288 |
RPS8 | -7161 |
RPS17 | -7134 |
RPL19 | -7006 |
RPL23 | -6933 |
RPS29 | -6791 |
RPS11 | -6742 |
RPS21 | -6706 |
RPL37 | -6660 |
RPL38 | -6589 |
GSPT1 | -6576 |
RPS28 | -6429 |
RPL36 | -6343 |
RPL8 | -6274 |
RPL27 | -6068 |
RPL41 | -6065 |
RPL39 | -5790 |
RPS19 | -5616 |
RPL13 | -5550 |
RPS26 | -5524 |
RPS15 | -5342 |
RPS24 | -5310 |
RPL37A | -4774 |
RPSA | -4559 |
RPL36AL | -4148 |
RPLP1 | -3887 |
RPL28 | -1952 |
UBA52 | -1437 |
FAU | -1029 |
TRMT112 | -370 |
RPL39L | -69 |
RPS4Y1 | 1461 |
RPS9 | 2392 |
RPS27L | 2784 |
ETF1 | 4300 |
APEH | 4454 |
RPL3L | 5700 |
RPL26L1 | 6187 |
Translocation of ZAP-70 to Immunological synapse
1278 | |
---|---|
set | Translocation of ZAP-70 to Immunological synapse |
setSize | 24 |
pANOVA | 1.86e-08 |
s.dist | -0.663 |
p.adjustANOVA | 5.9e-07 |
Top enriched genes
GeneID | Gene Rank |
---|---|
TRBV12-3 | -9724 |
CD247 | -9497 |
LCK | -9485 |
HLA-DQA2 | -9407 |
TRAV19 | -9396 |
CD3E | -9378 |
TRAC | -9330 |
CD3G | -9125 |
HLA-DQB2 | -9021 |
CD3D | -8747 |
TRBC1 | -8666 |
ZAP70 | -8662 |
TRAV29DV5 | -8326 |
TRAV8-4 | -7607 |
HLA-DPB1 | -7109 |
TRBV7-9 | -6741 |
HLA-DRA | -6613 |
HLA-DPA1 | -5854 |
CD4 | -4882 |
HLA-DQA1 | -1465 |
GeneID | Gene Rank |
---|---|
TRBV12-3 | -9724 |
CD247 | -9497 |
LCK | -9485 |
HLA-DQA2 | -9407 |
TRAV19 | -9396 |
CD3E | -9378 |
TRAC | -9330 |
CD3G | -9125 |
HLA-DQB2 | -9021 |
CD3D | -8747 |
TRBC1 | -8666 |
ZAP70 | -8662 |
TRAV29DV5 | -8326 |
TRAV8-4 | -7607 |
HLA-DPB1 | -7109 |
TRBV7-9 | -6741 |
HLA-DRA | -6613 |
HLA-DPA1 | -5854 |
CD4 | -4882 |
HLA-DQA1 | -1465 |
HLA-DRB5 | -1119 |
HLA-DRB1 | 1353 |
HLA-DQB1 | 3660 |
PTPN22 | 5604 |
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
743 | |
---|---|
set | Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) |
setSize | 94 |
pANOVA | 3.69e-28 |
s.dist | -0.656 |
p.adjustANOVA | 3.35e-26 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL3 | -9701 |
RPS2 | -9635 |
RPL14 | -9390 |
RPL23A | -9382 |
RPL5 | -9359 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
RPL4 | -9065 |
RPL22 | -8915 |
RPS3 | -8856 |
RPS25 | -8832 |
RPL21 | -8773 |
RPS27A | -8722 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
RPL6 | -8498 |
RPL34 | -8489 |
GeneID | Gene Rank |
---|---|
RPL3 | -9701 |
RPS2 | -9635 |
RPL14 | -9390 |
RPL23A | -9382 |
RPL5 | -9359 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
RPL4 | -9065 |
RPL22 | -8915 |
RPS3 | -8856 |
RPS25 | -8832 |
RPL21 | -8773 |
RPS27A | -8722 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
RPL6 | -8498 |
RPL34 | -8489 |
RPS20 | -8476 |
RPL17 | -8462 |
RPL27A | -8420 |
RPS12 | -8401 |
RPS14 | -8337 |
GSPT2 | -8336 |
RPS23 | -8334 |
RPL10 | -8318 |
RPS27 | -8260 |
RPLP2 | -8255 |
NCBP2 | -8212 |
RPL36A | -8130 |
RPS7 | -8047 |
RPL35A | -8046 |
RPL10A | -7989 |
RPL29 | -7954 |
RPL11 | -7928 |
RPL32 | -7914 |
RPS15A | -7912 |
RPL22L1 | -7828 |
RPL30 | -7783 |
RPL18 | -7781 |
RPL35 | -7710 |
RPL26 | -7648 |
RPS4X | -7636 |
RPS10 | -7629 |
RPL24 | -7626 |
RPS16 | -7617 |
RPL18A | -7609 |
RPL31 | -7521 |
RPL9 | -7451 |
RPL15 | -7380 |
RPS13 | -7375 |
RPL7A | -7296 |
RPS18 | -7288 |
RPS8 | -7161 |
RPS17 | -7134 |
RPL19 | -7006 |
RPL23 | -6933 |
RPS29 | -6791 |
RPS11 | -6742 |
RPS21 | -6706 |
RPL37 | -6660 |
RPL38 | -6589 |
GSPT1 | -6576 |
RPS28 | -6429 |
RPL36 | -6343 |
RPL8 | -6274 |
RPL27 | -6068 |
RPL41 | -6065 |
RPL39 | -5790 |
RPS19 | -5616 |
RPL13 | -5550 |
RPS26 | -5524 |
RPS15 | -5342 |
RPS24 | -5310 |
RPL37A | -4774 |
RPSA | -4559 |
RPL36AL | -4148 |
RPLP1 | -3887 |
PABPC1 | -3482 |
RPL28 | -1952 |
UBA52 | -1437 |
NCBP1 | -1125 |
FAU | -1029 |
RPL39L | -69 |
RPS4Y1 | 1461 |
RPS9 | 2392 |
RPS27L | 2784 |
ETF1 | 4300 |
RPL3L | 5700 |
RPL26L1 | 6187 |
UPF1 | 6979 |
EIF4G1 | 9922 |
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism
1330 | |
---|---|
set | alpha-linolenic (omega3) and linoleic (omega6) acid metabolism |
setSize | 12 |
pANOVA | 0.000131 |
s.dist | 0.637 |
p.adjustANOVA | 0.00152 |
Top enriched genes
GeneID | Gene Rank |
---|---|
ACAA1 | 11576 |
ACOT8 | 10812 |
ACSL1 | 10810 |
ELOVL1 | 10305 |
FADS1 | 10296 |
HSD17B4 | 9667 |
ELOVL3 | 9628 |
ACOX1 | 8434 |
ABCD1 | 6135 |
FADS2 | 5662 |
ELOVL5 | 2295 |
SCP2 | -1758 |
GeneID | Gene Rank |
---|---|
ACAA1 | 11576 |
ACOT8 | 10812 |
ACSL1 | 10810 |
ELOVL1 | 10305 |
FADS1 | 10296 |
HSD17B4 | 9667 |
ELOVL3 | 9628 |
ACOX1 | 8434 |
ABCD1 | 6135 |
FADS2 | 5662 |
ELOVL5 | 2295 |
SCP2 | -1758 |
alpha-linolenic acid (ALA) metabolism
1331 | |
---|---|
set | alpha-linolenic acid (ALA) metabolism |
setSize | 12 |
pANOVA | 0.000131 |
s.dist | 0.637 |
p.adjustANOVA | 0.00152 |
Top enriched genes
GeneID | Gene Rank |
---|---|
ACAA1 | 11576 |
ACOT8 | 10812 |
ACSL1 | 10810 |
ELOVL1 | 10305 |
FADS1 | 10296 |
HSD17B4 | 9667 |
ELOVL3 | 9628 |
ACOX1 | 8434 |
ABCD1 | 6135 |
FADS2 | 5662 |
ELOVL5 | 2295 |
SCP2 | -1758 |
GeneID | Gene Rank |
---|---|
ACAA1 | 11576 |
ACOT8 | 10812 |
ACSL1 | 10810 |
ELOVL1 | 10305 |
FADS1 | 10296 |
HSD17B4 | 9667 |
ELOVL3 | 9628 |
ACOX1 | 8434 |
ABCD1 | 6135 |
FADS2 | 5662 |
ELOVL5 | 2295 |
SCP2 | -1758 |
Response of EIF2AK4 (GCN2) to amino acid deficiency
1007 | |
---|---|
set | Response of EIF2AK4 (GCN2) to amino acid deficiency |
setSize | 100 |
pANOVA | 9.21e-28 |
s.dist | -0.631 |
p.adjustANOVA | 6.61e-26 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL3 | -9701 |
RPS2 | -9635 |
RPL14 | -9390 |
RPL23A | -9382 |
RPL5 | -9359 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
RPL4 | -9065 |
RPL22 | -8915 |
RPS3 | -8856 |
RPS25 | -8832 |
RPL21 | -8773 |
RPS27A | -8722 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
RPL6 | -8498 |
RPL34 | -8489 |
GeneID | Gene Rank |
---|---|
RPL3 | -9701 |
RPS2 | -9635 |
RPL14 | -9390 |
RPL23A | -9382 |
RPL5 | -9359 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
RPL4 | -9065 |
RPL22 | -8915 |
RPS3 | -8856 |
RPS25 | -8832 |
RPL21 | -8773 |
RPS27A | -8722 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
RPL6 | -8498 |
RPL34 | -8489 |
RPS20 | -8476 |
RPL17 | -8462 |
RPL27A | -8420 |
RPS12 | -8401 |
RPS14 | -8337 |
RPS23 | -8334 |
RPL10 | -8318 |
RPS27 | -8260 |
RPLP2 | -8255 |
RPL36A | -8130 |
RPS7 | -8047 |
RPL35A | -8046 |
RPL10A | -7989 |
RPL29 | -7954 |
RPL11 | -7928 |
RPL32 | -7914 |
RPS15A | -7912 |
RPL22L1 | -7828 |
RPL30 | -7783 |
RPL18 | -7781 |
RPL35 | -7710 |
RPL26 | -7648 |
RPS4X | -7636 |
RPS10 | -7629 |
RPL24 | -7626 |
RPS16 | -7617 |
RPL18A | -7609 |
RPL31 | -7521 |
RPL9 | -7451 |
RPL15 | -7380 |
RPS13 | -7375 |
RPL7A | -7296 |
RPS18 | -7288 |
RPS8 | -7161 |
RPS17 | -7134 |
RPL19 | -7006 |
RPL23 | -6933 |
RPS29 | -6791 |
IMPACT | -6768 |
RPS11 | -6742 |
RPS21 | -6706 |
RPL37 | -6660 |
RPL38 | -6589 |
GCN1 | -6541 |
RPS28 | -6429 |
RPL36 | -6343 |
RPL8 | -6274 |
ASNS | -6196 |
RPL27 | -6068 |
RPL41 | -6065 |
RPL39 | -5790 |
RPS19 | -5616 |
RPL13 | -5550 |
RPS26 | -5524 |
RPS15 | -5342 |
RPS24 | -5310 |
ATF2 | -4941 |
RPL37A | -4774 |
RPSA | -4559 |
RPL36AL | -4148 |
RPLP1 | -3887 |
EIF2S1 | -3350 |
ATF3 | -2894 |
RPL28 | -1952 |
EIF2AK4 | -1601 |
UBA52 | -1437 |
TRIB3 | -1365 |
FAU | -1029 |
ATF4 | -994 |
RPL39L | -69 |
EIF2S2 | 297 |
EIF2S3 | 1308 |
RPS4Y1 | 1461 |
CEBPG | 1958 |
RPS9 | 2392 |
RPS27L | 2784 |
DDIT3 | 3500 |
RPL3L | 5700 |
RPL26L1 | 6187 |
CEBPB | 11028 |
L13a-mediated translational silencing of Ceruloplasmin expression
588 | |
---|---|
set | L13a-mediated translational silencing of Ceruloplasmin expression |
setSize | 110 |
pANOVA | 9.65e-30 |
s.dist | -0.624 |
p.adjustANOVA | 1.1e-27 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL3 | -9701 |
RPS2 | -9635 |
RPL14 | -9390 |
RPL23A | -9382 |
RPL5 | -9359 |
EIF4A2 | -9355 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
RPL4 | -9065 |
RPL22 | -8915 |
EIF3B | -8874 |
RPS3 | -8856 |
RPS25 | -8832 |
RPL21 | -8773 |
RPS27A | -8722 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
GeneID | Gene Rank |
---|---|
RPL3 | -9701 |
RPS2 | -9635 |
RPL14 | -9390 |
RPL23A | -9382 |
RPL5 | -9359 |
EIF4A2 | -9355 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
RPL4 | -9065 |
RPL22 | -8915 |
EIF3B | -8874 |
RPS3 | -8856 |
RPS25 | -8832 |
RPL21 | -8773 |
RPS27A | -8722 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
EIF3E | -8600 |
RPL6 | -8498 |
RPL34 | -8489 |
RPS20 | -8476 |
RPL17 | -8462 |
RPL27A | -8420 |
RPS12 | -8401 |
EIF1AX | -8394 |
RPS14 | -8337 |
RPS23 | -8334 |
EIF4B | -8328 |
RPL10 | -8318 |
RPS27 | -8260 |
RPLP2 | -8255 |
RPL36A | -8130 |
RPS7 | -8047 |
RPL35A | -8046 |
RPL10A | -7989 |
RPL29 | -7954 |
RPL11 | -7928 |
RPL32 | -7914 |
RPS15A | -7912 |
RPL22L1 | -7828 |
RPL30 | -7783 |
RPL18 | -7781 |
EIF3L | -7766 |
RPL35 | -7710 |
RPL26 | -7648 |
RPS4X | -7636 |
RPS10 | -7629 |
RPL24 | -7626 |
RPS16 | -7617 |
RPL18A | -7609 |
RPL31 | -7521 |
RPL9 | -7451 |
RPL15 | -7380 |
RPS13 | -7375 |
RPL7A | -7296 |
RPS18 | -7288 |
RPS8 | -7161 |
RPS17 | -7134 |
RPL19 | -7006 |
RPL23 | -6933 |
RPS29 | -6791 |
RPS11 | -6742 |
RPS21 | -6706 |
RPL37 | -6660 |
RPL38 | -6589 |
RPS28 | -6429 |
RPL36 | -6343 |
RPL8 | -6274 |
RPL27 | -6068 |
RPL41 | -6065 |
EIF3J | -6001 |
EIF3H | -5894 |
RPL39 | -5790 |
EIF3M | -5620 |
RPS19 | -5616 |
RPL13 | -5550 |
RPS26 | -5524 |
RPS15 | -5342 |
RPS24 | -5310 |
RPL37A | -4774 |
RPSA | -4559 |
EIF3D | -4337 |
RPL36AL | -4148 |
RPLP1 | -3887 |
EIF3C | -3750 |
EIF3F | -3748 |
PABPC1 | -3482 |
EIF2S1 | -3350 |
EIF3I | -2671 |
RPL28 | -1952 |
EIF3G | -1676 |
EIF3A | -1537 |
UBA52 | -1437 |
FAU | -1029 |
EIF3K | -298 |
RPL39L | -69 |
EIF2S2 | 297 |
EIF2S3 | 1308 |
RPS4Y1 | 1461 |
EIF4E | 2104 |
RPS9 | 2392 |
RPS27L | 2784 |
RPL3L | 5700 |
EIF4A1 | 5928 |
RPL26L1 | 6187 |
EIF4H | 7435 |
EIF4G1 | 9922 |
Regulation of TLR by endogenous ligand
967 | |
---|---|
set | Regulation of TLR by endogenous ligand |
setSize | 11 |
pANOVA | 0.000345 |
s.dist | 0.623 |
p.adjustANOVA | 0.00313 |
Top enriched genes
GeneID | Gene Rank |
---|---|
S100A9 | 11432 |
CD36 | 11354 |
S100A8 | 11315 |
TLR2 | 10761 |
CD14 | 10542 |
LY96 | 10002 |
TLR4 | 9355 |
TLR1 | 8749 |
TLR6 | 7631 |
S100A1 | 892 |
HMGB1 | -7684 |
GeneID | Gene Rank |
---|---|
S100A9 | 11432 |
CD36 | 11354 |
S100A8 | 11315 |
TLR2 | 10761 |
CD14 | 10542 |
LY96 | 10002 |
TLR4 | 9355 |
TLR1 | 8749 |
TLR6 | 7631 |
S100A1 | 892 |
HMGB1 | -7684 |
GTP hydrolysis and joining of the 60S ribosomal subunit
434 | |
---|---|
set | GTP hydrolysis and joining of the 60S ribosomal subunit |
setSize | 111 |
pANOVA | 8.89e-30 |
s.dist | -0.622 |
p.adjustANOVA | 1.1e-27 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL3 | -9701 |
RPS2 | -9635 |
RPL14 | -9390 |
RPL23A | -9382 |
RPL5 | -9359 |
EIF4A2 | -9355 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
RPL4 | -9065 |
RPL22 | -8915 |
EIF3B | -8874 |
RPS3 | -8856 |
RPS25 | -8832 |
RPL21 | -8773 |
RPS27A | -8722 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
GeneID | Gene Rank |
---|---|
RPL3 | -9701 |
RPS2 | -9635 |
RPL14 | -9390 |
RPL23A | -9382 |
RPL5 | -9359 |
EIF4A2 | -9355 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
RPL4 | -9065 |
RPL22 | -8915 |
EIF3B | -8874 |
RPS3 | -8856 |
RPS25 | -8832 |
RPL21 | -8773 |
RPS27A | -8722 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
EIF3E | -8600 |
RPL6 | -8498 |
RPL34 | -8489 |
RPS20 | -8476 |
RPL17 | -8462 |
RPL27A | -8420 |
RPS12 | -8401 |
EIF1AX | -8394 |
RPS14 | -8337 |
RPS23 | -8334 |
EIF4B | -8328 |
RPL10 | -8318 |
RPS27 | -8260 |
RPLP2 | -8255 |
RPL36A | -8130 |
RPS7 | -8047 |
RPL35A | -8046 |
RPL10A | -7989 |
RPL29 | -7954 |
RPL11 | -7928 |
RPL32 | -7914 |
RPS15A | -7912 |
RPL22L1 | -7828 |
RPL30 | -7783 |
RPL18 | -7781 |
EIF3L | -7766 |
RPL35 | -7710 |
RPL26 | -7648 |
RPS4X | -7636 |
RPS10 | -7629 |
RPL24 | -7626 |
RPS16 | -7617 |
RPL18A | -7609 |
RPL31 | -7521 |
RPL9 | -7451 |
RPL15 | -7380 |
RPS13 | -7375 |
RPL7A | -7296 |
RPS18 | -7288 |
RPS8 | -7161 |
RPS17 | -7134 |
RPL19 | -7006 |
RPL23 | -6933 |
RPS29 | -6791 |
RPS11 | -6742 |
RPS21 | -6706 |
RPL37 | -6660 |
RPL38 | -6589 |
RPS28 | -6429 |
RPL36 | -6343 |
RPL8 | -6274 |
RPL27 | -6068 |
RPL41 | -6065 |
EIF3J | -6001 |
EIF5B | -5931 |
EIF3H | -5894 |
RPL39 | -5790 |
EIF3M | -5620 |
RPS19 | -5616 |
RPL13 | -5550 |
RPS26 | -5524 |
RPS15 | -5342 |
RPS24 | -5310 |
RPL37A | -4774 |
RPSA | -4559 |
EIF3D | -4337 |
RPL36AL | -4148 |
RPLP1 | -3887 |
EIF3C | -3750 |
EIF3F | -3748 |
EIF2S1 | -3350 |
EIF3I | -2671 |
RPL28 | -1952 |
EIF3G | -1676 |
EIF3A | -1537 |
UBA52 | -1437 |
FAU | -1029 |
EIF5 | -416 |
EIF3K | -298 |
RPL39L | -69 |
EIF2S2 | 297 |
EIF2S3 | 1308 |
RPS4Y1 | 1461 |
EIF4E | 2104 |
RPS9 | 2392 |
RPS27L | 2784 |
RPL3L | 5700 |
EIF4A1 | 5928 |
RPL26L1 | 6187 |
EIF4H | 7435 |
EIF4G1 | 9922 |
Unwinding of DNA
1304 | |
---|---|
set | Unwinding of DNA |
setSize | 12 |
pANOVA | 0.000211 |
s.dist | -0.618 |
p.adjustANOVA | 0.00215 |
Top enriched genes
GeneID | Gene Rank |
---|---|
MCM3 | -9769 |
MCM6 | -9297 |
GINS4 | -8200 |
MCM7 | -7720 |
MCM4 | -7627 |
MCM2 | -7557 |
MCM8 | -6138 |
CDC45 | -5643 |
GINS3 | -3998 |
GINS2 | -3279 |
GINS1 | -976 |
MCM5 | 1277 |
GeneID | Gene Rank |
---|---|
MCM3 | -9769 |
MCM6 | -9297 |
GINS4 | -8200 |
MCM7 | -7720 |
MCM4 | -7627 |
MCM2 | -7557 |
MCM8 | -6138 |
CDC45 | -5643 |
GINS3 | -3998 |
GINS2 | -3279 |
GINS1 | -976 |
MCM5 | 1277 |
Formation of the ternary complex, and subsequently, the 43S complex
398 | |
---|---|
set | Formation of the ternary complex, and subsequently, the 43S complex |
setSize | 51 |
pANOVA | 2.8e-14 |
s.dist | -0.615 |
p.adjustANOVA | 1.31e-12 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS2 | -9635 |
RPS3A | -9257 |
RPS6 | -9170 |
EIF3B | -8874 |
RPS3 | -8856 |
RPS25 | -8832 |
RPS27A | -8722 |
RPS5 | -8698 |
EIF3E | -8600 |
RPS20 | -8476 |
RPS12 | -8401 |
EIF1AX | -8394 |
RPS14 | -8337 |
RPS23 | -8334 |
RPS27 | -8260 |
RPS7 | -8047 |
RPS15A | -7912 |
EIF3L | -7766 |
RPS4X | -7636 |
RPS10 | -7629 |
GeneID | Gene Rank |
---|---|
RPS2 | -9635 |
RPS3A | -9257 |
RPS6 | -9170 |
EIF3B | -8874 |
RPS3 | -8856 |
RPS25 | -8832 |
RPS27A | -8722 |
RPS5 | -8698 |
EIF3E | -8600 |
RPS20 | -8476 |
RPS12 | -8401 |
EIF1AX | -8394 |
RPS14 | -8337 |
RPS23 | -8334 |
RPS27 | -8260 |
RPS7 | -8047 |
RPS15A | -7912 |
EIF3L | -7766 |
RPS4X | -7636 |
RPS10 | -7629 |
RPS16 | -7617 |
RPS13 | -7375 |
RPS18 | -7288 |
RPS8 | -7161 |
RPS17 | -7134 |
RPS29 | -6791 |
RPS11 | -6742 |
RPS21 | -6706 |
RPS28 | -6429 |
EIF3J | -6001 |
EIF3H | -5894 |
EIF3M | -5620 |
RPS19 | -5616 |
RPS26 | -5524 |
RPS15 | -5342 |
RPS24 | -5310 |
RPSA | -4559 |
EIF3D | -4337 |
EIF3C | -3750 |
EIF3F | -3748 |
EIF2S1 | -3350 |
EIF3I | -2671 |
EIF3G | -1676 |
EIF3A | -1537 |
FAU | -1029 |
EIF3K | -298 |
EIF2S2 | 297 |
EIF2S3 | 1308 |
RPS4Y1 | 1461 |
RPS9 | 2392 |
RPS27L | 2784 |
Major pathway of rRNA processing in the nucleolus and cytosol
625 | |
---|---|
set | Major pathway of rRNA processing in the nucleolus and cytosol |
setSize | 180 |
pANOVA | 3.41e-43 |
s.dist | -0.594 |
p.adjustANOVA | 1.16e-40 |
Top enriched genes
GeneID | Gene Rank |
---|---|
TSR1 | -9723 |
NOP14 | -9719 |
RPL3 | -9701 |
FBL | -9671 |
RPS2 | -9635 |
RPP40 | -9619 |
RPL14 | -9390 |
RPL23A | -9382 |
GNL3 | -9380 |
NOP58 | -9366 |
RPL5 | -9359 |
NOL11 | -9354 |
UTP4 | -9338 |
RPS3A | -9257 |
NOB1 | -9253 |
WDR75 | -9213 |
RPS6 | -9170 |
NCL | -9167 |
BMS1 | -9164 |
RPL7 | -9134 |
GeneID | Gene Rank |
---|---|
TSR1 | -9723 |
NOP14 | -9719 |
RPL3 | -9701 |
FBL | -9671 |
RPS2 | -9635 |
RPP40 | -9619 |
RPL14 | -9390 |
RPL23A | -9382 |
GNL3 | -9380 |
NOP58 | -9366 |
RPL5 | -9359 |
NOL11 | -9354 |
UTP4 | -9338 |
RPS3A | -9257 |
NOB1 | -9253 |
WDR75 | -9213 |
RPS6 | -9170 |
NCL | -9167 |
BMS1 | -9164 |
RPL7 | -9134 |
RPL4 | -9065 |
RPL22 | -8915 |
RPS3 | -8856 |
WDR43 | -8851 |
RPS25 | -8832 |
RPL21 | -8773 |
TEX10 | -8744 |
RPS27A | -8722 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
LAS1L | -8501 |
RPL6 | -8498 |
RPL34 | -8489 |
RPS20 | -8476 |
RPL17 | -8462 |
RPL27A | -8420 |
RIOK2 | -8405 |
RPS12 | -8401 |
NOP56 | -8346 |
RPS14 | -8337 |
RPS23 | -8334 |
RPL10 | -8318 |
UTP15 | -8280 |
EXOSC5 | -8271 |
RPS27 | -8260 |
RPLP2 | -8255 |
IMP4 | -8233 |
EXOSC2 | -8172 |
RPL36A | -8130 |
NIP7 | -8124 |
RRP9 | -8121 |
RPS7 | -8047 |
RPL35A | -8046 |
RPL10A | -7989 |
SNU13 | -7987 |
EXOSC6 | -7982 |
PDCD11 | -7980 |
WDR3 | -7973 |
DDX47 | -7962 |
RPL29 | -7954 |
RPL11 | -7928 |
RPL32 | -7914 |
RPS15A | -7912 |
EXOSC8 | -7905 |
RPL22L1 | -7828 |
RPL30 | -7783 |
RPL18 | -7781 |
RCL1 | -7761 |
RPL35 | -7710 |
RPL26 | -7648 |
RPS4X | -7636 |
RPS10 | -7629 |
RPL24 | -7626 |
RPP25 | -7624 |
RPS16 | -7617 |
RPL18A | -7609 |
CSNK1E | -7527 |
RPL31 | -7521 |
PNO1 | -7506 |
EXOSC9 | -7477 |
RPL9 | -7451 |
RPL15 | -7380 |
RPS13 | -7375 |
HEATR1 | -7360 |
PELP1 | -7329 |
RPL7A | -7296 |
RPS18 | -7288 |
PWP2 | -7199 |
NOL9 | -7193 |
RPP30 | -7173 |
RPS8 | -7161 |
RPS17 | -7134 |
RPL19 | -7006 |
IMP3 | -6997 |
WDR46 | -6977 |
NOL6 | -6945 |
RPL23 | -6933 |
UTP20 | -6898 |
EBNA1BP2 | -6864 |
RPS29 | -6791 |
RPS11 | -6742 |
EMG1 | -6735 |
RPS21 | -6706 |
RPL37 | -6660 |
MPHOSPH10 | -6590 |
RPL38 | -6589 |
EXOSC7 | -6585 |
RPP38 | -6534 |
KRR1 | -6432 |
RPS28 | -6429 |
RPL36 | -6343 |
RPL8 | -6274 |
RPL27 | -6068 |
RPL41 | -6065 |
BYSL | -5863 |
WDR36 | -5853 |
RBM28 | -5810 |
RPL39 | -5790 |
DHX37 | -5761 |
RPS19 | -5616 |
RPL13 | -5550 |
RPS26 | -5524 |
PES1 | -5491 |
UTP6 | -5444 |
RPS15 | -5342 |
RPS24 | -5310 |
BOP1 | -5141 |
EXOSC10 | -5112 |
RPL37A | -4774 |
MTREX | -4734 |
LTV1 | -4592 |
RRP7A | -4574 |
RPSA | -4559 |
WDR18 | -4348 |
DCAF13 | -4245 |
RPL36AL | -4148 |
DIS3 | -3916 |
RPLP1 | -3887 |
DDX21 | -3746 |
RIOK1 | -3329 |
UTP14A | -3160 |
FCF1 | -3010 |
RPP14 | -2433 |
MPHOSPH6 | -2335 |
RPL28 | -1952 |
UTP14C | -1630 |
UTP3 | -1460 |
UBA52 | -1437 |
WDR12 | -1301 |
FAU | -1029 |
RPP21 | -200 |
RPL39L | -69 |
ISG20L2 | -43 |
TBL3 | 55 |
EXOSC3 | 280 |
RRP36 | 511 |
C1D | 531 |
RRP1 | 874 |
UTP11 | 1268 |
RPS4Y1 | 1461 |
DDX52 | 1503 |
ERI1 | 1991 |
RPS9 | 2392 |
EXOSC1 | 2569 |
RIOK3 | 2755 |
RPS27L | 2784 |
FTSJ3 | 3515 |
UTP18 | 3740 |
DDX49 | 4194 |
SENP3 | 4233 |
RPL3L | 5700 |
NOL12 | 5766 |
RPL26L1 | 6187 |
CSNK1D | 7458 |
NOC4L | 7461 |
EXOSC4 | 8895 |
XRN2 | 9350 |
SNORD3A | 11429 |
rRNA processing in the nucleus and cytosol
1355 | |
---|---|
set | rRNA processing in the nucleus and cytosol |
setSize | 190 |
pANOVA | 6.06e-45 |
s.dist | -0.59 |
p.adjustANOVA | 8.26e-42 |
Top enriched genes
GeneID | Gene Rank |
---|---|
DKC1 | -9835 |
TSR1 | -9723 |
NOP14 | -9719 |
RPL3 | -9701 |
FBL | -9671 |
RPS2 | -9635 |
RPP40 | -9619 |
RPL14 | -9390 |
RPL23A | -9382 |
GNL3 | -9380 |
NOP58 | -9366 |
RPL5 | -9359 |
NOL11 | -9354 |
UTP4 | -9338 |
NAT10 | -9326 |
THUMPD1 | -9311 |
RPS3A | -9257 |
NOB1 | -9253 |
DIMT1 | -9230 |
WDR75 | -9213 |
GeneID | Gene Rank |
---|---|
DKC1 | -9835 |
TSR1 | -9723 |
NOP14 | -9719 |
RPL3 | -9701 |
FBL | -9671 |
RPS2 | -9635 |
RPP40 | -9619 |
RPL14 | -9390 |
RPL23A | -9382 |
GNL3 | -9380 |
NOP58 | -9366 |
RPL5 | -9359 |
NOL11 | -9354 |
UTP4 | -9338 |
NAT10 | -9326 |
THUMPD1 | -9311 |
RPS3A | -9257 |
NOB1 | -9253 |
DIMT1 | -9230 |
WDR75 | -9213 |
RPS6 | -9170 |
NCL | -9167 |
BMS1 | -9164 |
RPL7 | -9134 |
RPL4 | -9065 |
RPL22 | -8915 |
RPS3 | -8856 |
WDR43 | -8851 |
RPS25 | -8832 |
RPL21 | -8773 |
TEX10 | -8744 |
RPS27A | -8722 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
LAS1L | -8501 |
RPL6 | -8498 |
RPL34 | -8489 |
RPS20 | -8476 |
RPL17 | -8462 |
RPL27A | -8420 |
RIOK2 | -8405 |
RPS12 | -8401 |
NOP56 | -8346 |
RPS14 | -8337 |
RPS23 | -8334 |
RPL10 | -8318 |
UTP15 | -8280 |
EXOSC5 | -8271 |
RPS27 | -8260 |
RPLP2 | -8255 |
IMP4 | -8233 |
EXOSC2 | -8172 |
RPL36A | -8130 |
NIP7 | -8124 |
RRP9 | -8121 |
RPS7 | -8047 |
RPL35A | -8046 |
RPL10A | -7989 |
SNU13 | -7987 |
EXOSC6 | -7982 |
PDCD11 | -7980 |
WDR3 | -7973 |
DDX47 | -7962 |
RPL29 | -7954 |
RPL11 | -7928 |
RPL32 | -7914 |
RPS15A | -7912 |
EXOSC8 | -7905 |
RPL22L1 | -7828 |
RPL30 | -7783 |
RPL18 | -7781 |
RCL1 | -7761 |
RPL35 | -7710 |
RPL26 | -7648 |
RPS4X | -7636 |
RPS10 | -7629 |
RPL24 | -7626 |
RPP25 | -7624 |
RPS16 | -7617 |
RPL18A | -7609 |
CSNK1E | -7527 |
RPL31 | -7521 |
PNO1 | -7506 |
EXOSC9 | -7477 |
RPL9 | -7451 |
RPL15 | -7380 |
RPS13 | -7375 |
HEATR1 | -7360 |
PELP1 | -7329 |
RPL7A | -7296 |
RPS18 | -7288 |
PWP2 | -7199 |
NOL9 | -7193 |
RPP30 | -7173 |
RPS8 | -7161 |
RPS17 | -7134 |
RPL19 | -7006 |
IMP3 | -6997 |
WDR46 | -6977 |
NOL6 | -6945 |
RPL23 | -6933 |
UTP20 | -6898 |
EBNA1BP2 | -6864 |
RPS29 | -6791 |
RPS11 | -6742 |
EMG1 | -6735 |
RPS21 | -6706 |
GAR1 | -6696 |
RPL37 | -6660 |
MPHOSPH10 | -6590 |
RPL38 | -6589 |
EXOSC7 | -6585 |
RPP38 | -6534 |
KRR1 | -6432 |
RPS28 | -6429 |
RPL36 | -6343 |
NOP2 | -6275 |
RPL8 | -6274 |
RPL27 | -6068 |
RPL41 | -6065 |
BYSL | -5863 |
WDR36 | -5853 |
RBM28 | -5810 |
RPL39 | -5790 |
DHX37 | -5761 |
NHP2 | -5747 |
RPS19 | -5616 |
RPL13 | -5550 |
RPS26 | -5524 |
PES1 | -5491 |
UTP6 | -5444 |
RPS15 | -5342 |
RPS24 | -5310 |
BOP1 | -5141 |
EXOSC10 | -5112 |
RPL37A | -4774 |
MTREX | -4734 |
LTV1 | -4592 |
RRP7A | -4574 |
RPSA | -4559 |
WDR18 | -4348 |
DCAF13 | -4245 |
RPL36AL | -4148 |
DIS3 | -3916 |
RPLP1 | -3887 |
DDX21 | -3746 |
RIOK1 | -3329 |
UTP14A | -3160 |
FCF1 | -3010 |
RPP14 | -2433 |
MPHOSPH6 | -2335 |
RPL28 | -1952 |
UTP14C | -1630 |
UTP3 | -1460 |
UBA52 | -1437 |
WDR12 | -1301 |
FAU | -1029 |
TRMT112 | -370 |
TSR3 | -358 |
RPP21 | -200 |
RPL39L | -69 |
ISG20L2 | -43 |
TBL3 | 55 |
EXOSC3 | 280 |
RRP36 | 511 |
C1D | 531 |
RRP1 | 874 |
UTP11 | 1268 |
RPS4Y1 | 1461 |
DDX52 | 1503 |
ERI1 | 1991 |
RPS9 | 2392 |
EXOSC1 | 2569 |
RIOK3 | 2755 |
RPS27L | 2784 |
FTSJ3 | 3515 |
UTP18 | 3740 |
DDX49 | 4194 |
SENP3 | 4233 |
RPL3L | 5700 |
NOL12 | 5766 |
RPL26L1 | 6187 |
CSNK1D | 7458 |
NOC4L | 7461 |
EXOSC4 | 8895 |
XRN2 | 9350 |
NOP10 | 10793 |
SNORD3A | 11429 |
Cap-dependent Translation Initiation
142 | |
---|---|
set | Cap-dependent Translation Initiation |
setSize | 118 |
pANOVA | 5.14e-28 |
s.dist | -0.584 |
p.adjustANOVA | 3.89e-26 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL3 | -9701 |
RPS2 | -9635 |
RPL14 | -9390 |
RPL23A | -9382 |
RPL5 | -9359 |
EIF4A2 | -9355 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
RPL4 | -9065 |
RPL22 | -8915 |
EIF3B | -8874 |
RPS3 | -8856 |
RPS25 | -8832 |
RPL21 | -8773 |
RPS27A | -8722 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
GeneID | Gene Rank |
---|---|
RPL3 | -9701 |
RPS2 | -9635 |
RPL14 | -9390 |
RPL23A | -9382 |
RPL5 | -9359 |
EIF4A2 | -9355 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
RPL4 | -9065 |
RPL22 | -8915 |
EIF3B | -8874 |
RPS3 | -8856 |
RPS25 | -8832 |
RPL21 | -8773 |
RPS27A | -8722 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
EIF3E | -8600 |
RPL6 | -8498 |
RPL34 | -8489 |
RPS20 | -8476 |
RPL17 | -8462 |
RPL27A | -8420 |
RPS12 | -8401 |
EIF1AX | -8394 |
RPS14 | -8337 |
RPS23 | -8334 |
EIF4B | -8328 |
RPL10 | -8318 |
RPS27 | -8260 |
RPLP2 | -8255 |
RPL36A | -8130 |
RPS7 | -8047 |
RPL35A | -8046 |
RPL10A | -7989 |
RPL29 | -7954 |
RPL11 | -7928 |
RPL32 | -7914 |
RPS15A | -7912 |
RPL22L1 | -7828 |
RPL30 | -7783 |
RPL18 | -7781 |
EIF3L | -7766 |
RPL35 | -7710 |
RPL26 | -7648 |
RPS4X | -7636 |
RPS10 | -7629 |
RPL24 | -7626 |
RPS16 | -7617 |
RPL18A | -7609 |
RPL31 | -7521 |
RPL9 | -7451 |
RPL15 | -7380 |
RPS13 | -7375 |
RPL7A | -7296 |
RPS18 | -7288 |
RPS8 | -7161 |
RPS17 | -7134 |
RPL19 | -7006 |
RPL23 | -6933 |
RPS29 | -6791 |
RPS11 | -6742 |
RPS21 | -6706 |
RPL37 | -6660 |
RPL38 | -6589 |
RPS28 | -6429 |
RPL36 | -6343 |
RPL8 | -6274 |
RPL27 | -6068 |
RPL41 | -6065 |
EIF3J | -6001 |
EIF5B | -5931 |
EIF3H | -5894 |
RPL39 | -5790 |
EIF3M | -5620 |
RPS19 | -5616 |
RPL13 | -5550 |
RPS26 | -5524 |
RPS15 | -5342 |
RPS24 | -5310 |
EIF2B3 | -4898 |
RPL37A | -4774 |
RPSA | -4559 |
EIF3D | -4337 |
RPL36AL | -4148 |
RPLP1 | -3887 |
EIF3C | -3750 |
EIF3F | -3748 |
PABPC1 | -3482 |
EIF2S1 | -3350 |
EIF3I | -2671 |
EIF2B5 | -2425 |
RPL28 | -1952 |
EIF3G | -1676 |
EIF3A | -1537 |
UBA52 | -1437 |
FAU | -1029 |
EIF5 | -416 |
EIF3K | -298 |
RPL39L | -69 |
EIF2S2 | 297 |
EIF2S3 | 1308 |
RPS4Y1 | 1461 |
EIF2B1 | 1607 |
EIF4E | 2104 |
RPS9 | 2392 |
RPS27L | 2784 |
EIF2B2 | 5069 |
EIF4EBP1 | 5335 |
RPL3L | 5700 |
EIF4A1 | 5928 |
RPL26L1 | 6187 |
EIF2B4 | 6686 |
EIF4H | 7435 |
EIF4G1 | 9922 |
Eukaryotic Translation Initiation
351 | |
---|---|
set | Eukaryotic Translation Initiation |
setSize | 118 |
pANOVA | 5.14e-28 |
s.dist | -0.584 |
p.adjustANOVA | 3.89e-26 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL3 | -9701 |
RPS2 | -9635 |
RPL14 | -9390 |
RPL23A | -9382 |
RPL5 | -9359 |
EIF4A2 | -9355 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
RPL4 | -9065 |
RPL22 | -8915 |
EIF3B | -8874 |
RPS3 | -8856 |
RPS25 | -8832 |
RPL21 | -8773 |
RPS27A | -8722 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
GeneID | Gene Rank |
---|---|
RPL3 | -9701 |
RPS2 | -9635 |
RPL14 | -9390 |
RPL23A | -9382 |
RPL5 | -9359 |
EIF4A2 | -9355 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
RPL4 | -9065 |
RPL22 | -8915 |
EIF3B | -8874 |
RPS3 | -8856 |
RPS25 | -8832 |
RPL21 | -8773 |
RPS27A | -8722 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
EIF3E | -8600 |
RPL6 | -8498 |
RPL34 | -8489 |
RPS20 | -8476 |
RPL17 | -8462 |
RPL27A | -8420 |
RPS12 | -8401 |
EIF1AX | -8394 |
RPS14 | -8337 |
RPS23 | -8334 |
EIF4B | -8328 |
RPL10 | -8318 |
RPS27 | -8260 |
RPLP2 | -8255 |
RPL36A | -8130 |
RPS7 | -8047 |
RPL35A | -8046 |
RPL10A | -7989 |
RPL29 | -7954 |
RPL11 | -7928 |
RPL32 | -7914 |
RPS15A | -7912 |
RPL22L1 | -7828 |
RPL30 | -7783 |
RPL18 | -7781 |
EIF3L | -7766 |
RPL35 | -7710 |
RPL26 | -7648 |
RPS4X | -7636 |
RPS10 | -7629 |
RPL24 | -7626 |
RPS16 | -7617 |
RPL18A | -7609 |
RPL31 | -7521 |
RPL9 | -7451 |
RPL15 | -7380 |
RPS13 | -7375 |
RPL7A | -7296 |
RPS18 | -7288 |
RPS8 | -7161 |
RPS17 | -7134 |
RPL19 | -7006 |
RPL23 | -6933 |
RPS29 | -6791 |
RPS11 | -6742 |
RPS21 | -6706 |
RPL37 | -6660 |
RPL38 | -6589 |
RPS28 | -6429 |
RPL36 | -6343 |
RPL8 | -6274 |
RPL27 | -6068 |
RPL41 | -6065 |
EIF3J | -6001 |
EIF5B | -5931 |
EIF3H | -5894 |
RPL39 | -5790 |
EIF3M | -5620 |
RPS19 | -5616 |
RPL13 | -5550 |
RPS26 | -5524 |
RPS15 | -5342 |
RPS24 | -5310 |
EIF2B3 | -4898 |
RPL37A | -4774 |
RPSA | -4559 |
EIF3D | -4337 |
RPL36AL | -4148 |
RPLP1 | -3887 |
EIF3C | -3750 |
EIF3F | -3748 |
PABPC1 | -3482 |
EIF2S1 | -3350 |
EIF3I | -2671 |
EIF2B5 | -2425 |
RPL28 | -1952 |
EIF3G | -1676 |
EIF3A | -1537 |
UBA52 | -1437 |
FAU | -1029 |
EIF5 | -416 |
EIF3K | -298 |
RPL39L | -69 |
EIF2S2 | 297 |
EIF2S3 | 1308 |
RPS4Y1 | 1461 |
EIF2B1 | 1607 |
EIF4E | 2104 |
RPS9 | 2392 |
RPS27L | 2784 |
EIF2B2 | 5069 |
EIF4EBP1 | 5335 |
RPL3L | 5700 |
EIF4A1 | 5928 |
RPL26L1 | 6187 |
EIF2B4 | 6686 |
EIF4H | 7435 |
EIF4G1 | 9922 |
Activation of the pre-replicative complex
50 | |
---|---|
set | Activation of the pre-replicative complex |
setSize | 32 |
pANOVA | 1.2e-08 |
s.dist | -0.582 |
p.adjustANOVA | 3.89e-07 |
Top enriched genes
GeneID | Gene Rank |
---|---|
MCM3 | -9769 |
POLA1 | -9660 |
RPA1 | -9657 |
MCM6 | -9297 |
POLE3 | -8924 |
DBF4 | -8484 |
PRIM1 | -8268 |
ORC2 | -8097 |
ORC5 | -8089 |
RPA3 | -8069 |
MCM7 | -7720 |
MCM4 | -7627 |
ORC3 | -7568 |
MCM2 | -7557 |
MCM10 | -6777 |
POLE2 | -6659 |
POLA2 | -6222 |
MCM8 | -6138 |
ORC4 | -5692 |
PRIM2 | -5653 |
GeneID | Gene Rank |
---|---|
MCM3 | -9769 |
POLA1 | -9660 |
RPA1 | -9657 |
MCM6 | -9297 |
POLE3 | -8924 |
DBF4 | -8484 |
PRIM1 | -8268 |
ORC2 | -8097 |
ORC5 | -8089 |
RPA3 | -8069 |
MCM7 | -7720 |
MCM4 | -7627 |
ORC3 | -7568 |
MCM2 | -7557 |
MCM10 | -6777 |
POLE2 | -6659 |
POLA2 | -6222 |
MCM8 | -6138 |
ORC4 | -5692 |
PRIM2 | -5653 |
CDC45 | -5643 |
CDC6 | -5479 |
ORC1 | -5158 |
RPA2 | -4620 |
CDT1 | -4032 |
CDK2 | -3694 |
POLE | -1479 |
POLE4 | -1186 |
CDC7 | 815 |
MCM5 | 1277 |
GMNN | 5280 |
ORC6 | 8542 |
WNT5A-dependent internalization of FZD2, FZD5 and ROR2
1323 | |
---|---|
set | WNT5A-dependent internalization of FZD2, FZD5 and ROR2 |
setSize | 11 |
pANOVA | 0.00104 |
s.dist | 0.571 |
p.adjustANOVA | 0.00786 |
Top enriched genes
GeneID | Gene Rank |
---|---|
AP2A1 | 11707 |
FZD5 | 11699 |
AP2A2 | 10434 |
AP2S1 | 9504 |
CLTC | 9346 |
CLTB | 8275 |
CLTA | 7680 |
AP2M1 | 7323 |
FZD2 | 3981 |
ROR1 | 1902 |
AP2B1 | -3690 |
GeneID | Gene Rank |
---|---|
AP2A1 | 11707 |
FZD5 | 11699 |
AP2A2 | 10434 |
AP2S1 | 9504 |
CLTC | 9346 |
CLTB | 8275 |
CLTA | 7680 |
AP2M1 | 7323 |
FZD2 | 3981 |
ROR1 | 1902 |
AP2B1 | -3690 |
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
742 | |
---|---|
set | Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) |
setSize | 114 |
pANOVA | 1.01e-25 |
s.dist | -0.568 |
p.adjustANOVA | 5.96e-24 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL3 | -9701 |
RPS2 | -9635 |
RPL14 | -9390 |
RPL23A | -9382 |
RPL5 | -9359 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
RPL4 | -9065 |
RPL22 | -8915 |
RPS3 | -8856 |
RPS25 | -8832 |
RPL21 | -8773 |
RPS27A | -8722 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
RPL6 | -8498 |
RPL34 | -8489 |
GeneID | Gene Rank |
---|---|
RPL3 | -9701 |
RPS2 | -9635 |
RPL14 | -9390 |
RPL23A | -9382 |
RPL5 | -9359 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
RPL4 | -9065 |
RPL22 | -8915 |
RPS3 | -8856 |
RPS25 | -8832 |
RPL21 | -8773 |
RPS27A | -8722 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
RPL6 | -8498 |
RPL34 | -8489 |
RPS20 | -8476 |
RPL17 | -8462 |
RPL27A | -8420 |
RPS12 | -8401 |
RPS14 | -8337 |
GSPT2 | -8336 |
RPS23 | -8334 |
RPL10 | -8318 |
RPS27 | -8260 |
RPLP2 | -8255 |
NCBP2 | -8212 |
RPL36A | -8130 |
RPS7 | -8047 |
RPL35A | -8046 |
RPL10A | -7989 |
RPL29 | -7954 |
RPL11 | -7928 |
RPL32 | -7914 |
RPS15A | -7912 |
UPF3A | -7835 |
RPL22L1 | -7828 |
RPL30 | -7783 |
RPL18 | -7781 |
RPL35 | -7710 |
RPL26 | -7648 |
RPS4X | -7636 |
RPS10 | -7629 |
RPL24 | -7626 |
RPS16 | -7617 |
RPL18A | -7609 |
RPL31 | -7521 |
RPL9 | -7451 |
RPL15 | -7380 |
RPS13 | -7375 |
DCP1A | -7356 |
RPL7A | -7296 |
RPS18 | -7288 |
RPS8 | -7161 |
RPS17 | -7134 |
RNPS1 | -7032 |
RPL19 | -7006 |
RPL23 | -6933 |
RPS29 | -6791 |
RPS11 | -6742 |
RPS21 | -6706 |
RPL37 | -6660 |
RPL38 | -6589 |
GSPT1 | -6576 |
RPS28 | -6429 |
RPL36 | -6343 |
RPL8 | -6274 |
RPL27 | -6068 |
RPL41 | -6065 |
RPL39 | -5790 |
RPS19 | -5616 |
RPL13 | -5550 |
RPS26 | -5524 |
RPS15 | -5342 |
RPS24 | -5310 |
PNRC2 | -5116 |
RPL37A | -4774 |
RPSA | -4559 |
SMG6 | -4443 |
RPL36AL | -4148 |
MAGOHB | -4045 |
RPLP1 | -3887 |
PABPC1 | -3482 |
UPF3B | -3065 |
RBM8A | -2980 |
RPL28 | -1952 |
MAGOH | -1931 |
SMG5 | -1876 |
SMG1 | -1661 |
UBA52 | -1437 |
PPP2R2A | -1333 |
NCBP1 | -1125 |
FAU | -1029 |
EIF4A3 | -915 |
UPF2 | -229 |
RPL39L | -69 |
SMG8 | 663 |
RPS4Y1 | 1461 |
RPS9 | 2392 |
RPS27L | 2784 |
ETF1 | 4300 |
PPP2R1A | 4593 |
PPP2CA | 4882 |
RPL3L | 5700 |
RPL26L1 | 6187 |
UPF1 | 6979 |
CASC3 | 7085 |
SMG9 | 9218 |
SMG7 | 9427 |
EIF4G1 | 9922 |
Nonsense-Mediated Decay (NMD)
744 | |
---|---|
set | Nonsense-Mediated Decay (NMD) |
setSize | 114 |
pANOVA | 1.01e-25 |
s.dist | -0.568 |
p.adjustANOVA | 5.96e-24 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL3 | -9701 |
RPS2 | -9635 |
RPL14 | -9390 |
RPL23A | -9382 |
RPL5 | -9359 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
RPL4 | -9065 |
RPL22 | -8915 |
RPS3 | -8856 |
RPS25 | -8832 |
RPL21 | -8773 |
RPS27A | -8722 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
RPL6 | -8498 |
RPL34 | -8489 |
GeneID | Gene Rank |
---|---|
RPL3 | -9701 |
RPS2 | -9635 |
RPL14 | -9390 |
RPL23A | -9382 |
RPL5 | -9359 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
RPL4 | -9065 |
RPL22 | -8915 |
RPS3 | -8856 |
RPS25 | -8832 |
RPL21 | -8773 |
RPS27A | -8722 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
RPL6 | -8498 |
RPL34 | -8489 |
RPS20 | -8476 |
RPL17 | -8462 |
RPL27A | -8420 |
RPS12 | -8401 |
RPS14 | -8337 |
GSPT2 | -8336 |
RPS23 | -8334 |
RPL10 | -8318 |
RPS27 | -8260 |
RPLP2 | -8255 |
NCBP2 | -8212 |
RPL36A | -8130 |
RPS7 | -8047 |
RPL35A | -8046 |
RPL10A | -7989 |
RPL29 | -7954 |
RPL11 | -7928 |
RPL32 | -7914 |
RPS15A | -7912 |
UPF3A | -7835 |
RPL22L1 | -7828 |
RPL30 | -7783 |
RPL18 | -7781 |
RPL35 | -7710 |
RPL26 | -7648 |
RPS4X | -7636 |
RPS10 | -7629 |
RPL24 | -7626 |
RPS16 | -7617 |
RPL18A | -7609 |
RPL31 | -7521 |
RPL9 | -7451 |
RPL15 | -7380 |
RPS13 | -7375 |
DCP1A | -7356 |
RPL7A | -7296 |
RPS18 | -7288 |
RPS8 | -7161 |
RPS17 | -7134 |
RNPS1 | -7032 |
RPL19 | -7006 |
RPL23 | -6933 |
RPS29 | -6791 |
RPS11 | -6742 |
RPS21 | -6706 |
RPL37 | -6660 |
RPL38 | -6589 |
GSPT1 | -6576 |
RPS28 | -6429 |
RPL36 | -6343 |
RPL8 | -6274 |
RPL27 | -6068 |
RPL41 | -6065 |
RPL39 | -5790 |
RPS19 | -5616 |
RPL13 | -5550 |
RPS26 | -5524 |
RPS15 | -5342 |
RPS24 | -5310 |
PNRC2 | -5116 |
RPL37A | -4774 |
RPSA | -4559 |
SMG6 | -4443 |
RPL36AL | -4148 |
MAGOHB | -4045 |
RPLP1 | -3887 |
PABPC1 | -3482 |
UPF3B | -3065 |
RBM8A | -2980 |
RPL28 | -1952 |
MAGOH | -1931 |
SMG5 | -1876 |
SMG1 | -1661 |
UBA52 | -1437 |
PPP2R2A | -1333 |
NCBP1 | -1125 |
FAU | -1029 |
EIF4A3 | -915 |
UPF2 | -229 |
RPL39L | -69 |
SMG8 | 663 |
RPS4Y1 | 1461 |
RPS9 | 2392 |
RPS27L | 2784 |
ETF1 | 4300 |
PPP2R1A | 4593 |
PPP2CA | 4882 |
RPL3L | 5700 |
RPL26L1 | 6187 |
UPF1 | 6979 |
CASC3 | 7085 |
SMG9 | 9218 |
SMG7 | 9427 |
EIF4G1 | 9922 |
SRP-dependent cotranslational protein targeting to membrane
1040 | |
---|---|
set | SRP-dependent cotranslational protein targeting to membrane |
setSize | 111 |
pANOVA | 1.26e-24 |
s.dist | -0.562 |
p.adjustANOVA | 6.59e-23 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL3 | -9701 |
RPS2 | -9635 |
RPL14 | -9390 |
RPL23A | -9382 |
RPL5 | -9359 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
RPL4 | -9065 |
RPL22 | -8915 |
RPS3 | -8856 |
RPS25 | -8832 |
RPL21 | -8773 |
RPS27A | -8722 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
SRPRB | -8515 |
RPL6 | -8498 |
GeneID | Gene Rank |
---|---|
RPL3 | -9701 |
RPS2 | -9635 |
RPL14 | -9390 |
RPL23A | -9382 |
RPL5 | -9359 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
RPL4 | -9065 |
RPL22 | -8915 |
RPS3 | -8856 |
RPS25 | -8832 |
RPL21 | -8773 |
RPS27A | -8722 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
SRPRB | -8515 |
RPL6 | -8498 |
RPL34 | -8489 |
RPS20 | -8476 |
RPL17 | -8462 |
RPL27A | -8420 |
RPS12 | -8401 |
RPS14 | -8337 |
RPS23 | -8334 |
RPL10 | -8318 |
RPS27 | -8260 |
RPLP2 | -8255 |
RPL36A | -8130 |
RPS7 | -8047 |
RPL35A | -8046 |
RPL10A | -7989 |
RPL29 | -7954 |
RPL11 | -7928 |
RPL32 | -7914 |
RPS15A | -7912 |
TRAM1 | -7911 |
RPL22L1 | -7828 |
RPL30 | -7783 |
RPL18 | -7781 |
RPL35 | -7710 |
RPL26 | -7648 |
RPS4X | -7636 |
RPS10 | -7629 |
RPL24 | -7626 |
RPS16 | -7617 |
RPL18A | -7609 |
RPL31 | -7521 |
RPL9 | -7451 |
RPL15 | -7380 |
RPS13 | -7375 |
RPL7A | -7296 |
RPS18 | -7288 |
RPS8 | -7161 |
RPS17 | -7134 |
RPL19 | -7006 |
RPL23 | -6933 |
RPS29 | -6791 |
RPS11 | -6742 |
RPS21 | -6706 |
RPL37 | -6660 |
RPL38 | -6589 |
RPS28 | -6429 |
RPL36 | -6343 |
RPL8 | -6274 |
RPL27 | -6068 |
RPL41 | -6065 |
RPL39 | -5790 |
RPS19 | -5616 |
RPL13 | -5550 |
RPS26 | -5524 |
RPS15 | -5342 |
RPS24 | -5310 |
SEC11C | -5303 |
SRP72 | -4824 |
RPL37A | -4774 |
RPSA | -4559 |
SRP9 | -4398 |
RPL36AL | -4148 |
RPLP1 | -3887 |
SEC61A2 | -3262 |
SSR1 | -2645 |
SRP68 | -2562 |
SPCS2 | -2449 |
SSR2 | -2362 |
SEC61G | -2328 |
SPCS1 | -2007 |
RPL28 | -1952 |
SPCS3 | -1816 |
UBA52 | -1437 |
FAU | -1029 |
SSR3 | -664 |
SRP19 | -483 |
RPL39L | -69 |
RPS4Y1 | 1461 |
SSR4 | 1961 |
RPS9 | 2392 |
RPS27L | 2784 |
SEC61A1 | 3976 |
RPN1 | 4038 |
SEC61B | 4523 |
SRP14 | 5005 |
SRPRA | 5496 |
RPL3L | 5700 |
RPL26L1 | 6187 |
SRP54 | 6468 |
RPN2 | 7108 |
SEC11A | 7174 |
DDOST | 7465 |
rRNA modification in the nucleus and cytosol
1352 | |
---|---|
set | rRNA modification in the nucleus and cytosol |
setSize | 59 |
pANOVA | 1.02e-13 |
s.dist | -0.56 |
p.adjustANOVA | 4.48e-12 |
Top enriched genes
GeneID | Gene Rank |
---|---|
DKC1 | -9835 |
NOP14 | -9719 |
FBL | -9671 |
RPS2 | -9635 |
NOP58 | -9366 |
NOL11 | -9354 |
UTP4 | -9338 |
NAT10 | -9326 |
THUMPD1 | -9311 |
DIMT1 | -9230 |
WDR75 | -9213 |
RPS6 | -9170 |
BMS1 | -9164 |
WDR43 | -8851 |
NOP56 | -8346 |
RPS14 | -8337 |
UTP15 | -8280 |
IMP4 | -8233 |
RRP9 | -8121 |
RPS7 | -8047 |
GeneID | Gene Rank |
---|---|
DKC1 | -9835 |
NOP14 | -9719 |
FBL | -9671 |
RPS2 | -9635 |
NOP58 | -9366 |
NOL11 | -9354 |
UTP4 | -9338 |
NAT10 | -9326 |
THUMPD1 | -9311 |
DIMT1 | -9230 |
WDR75 | -9213 |
RPS6 | -9170 |
BMS1 | -9164 |
WDR43 | -8851 |
NOP56 | -8346 |
RPS14 | -8337 |
UTP15 | -8280 |
IMP4 | -8233 |
RRP9 | -8121 |
RPS7 | -8047 |
SNU13 | -7987 |
PDCD11 | -7980 |
WDR3 | -7973 |
DDX47 | -7962 |
RCL1 | -7761 |
PNO1 | -7506 |
HEATR1 | -7360 |
PWP2 | -7199 |
IMP3 | -6997 |
WDR46 | -6977 |
NOL6 | -6945 |
UTP20 | -6898 |
EMG1 | -6735 |
GAR1 | -6696 |
MPHOSPH10 | -6590 |
KRR1 | -6432 |
NOP2 | -6275 |
WDR36 | -5853 |
DHX37 | -5761 |
NHP2 | -5747 |
UTP6 | -5444 |
RRP7A | -4574 |
DCAF13 | -4245 |
UTP14A | -3160 |
FCF1 | -3010 |
UTP14C | -1630 |
UTP3 | -1460 |
TRMT112 | -370 |
TSR3 | -358 |
TBL3 | 55 |
RRP36 | 511 |
UTP11 | 1268 |
DDX52 | 1503 |
RPS9 | 2392 |
UTP18 | 3740 |
DDX49 | 4194 |
NOC4L | 7461 |
NOP10 | 10793 |
SNORD3A | 11429 |
Selenoamino acid metabolism
1059 | |
---|---|
set | Selenoamino acid metabolism |
setSize | 114 |
pANOVA | 1.1e-24 |
s.dist | -0.555 |
p.adjustANOVA | 6.01e-23 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL3 | -9701 |
RPS2 | -9635 |
RPL14 | -9390 |
RPL23A | -9382 |
RPL5 | -9359 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
RPL4 | -9065 |
RPL22 | -8915 |
LARS1 | -8879 |
RPS3 | -8856 |
RPS25 | -8832 |
RPL21 | -8773 |
RPS27A | -8722 |
IARS1 | -8710 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
GeneID | Gene Rank |
---|---|
RPL3 | -9701 |
RPS2 | -9635 |
RPL14 | -9390 |
RPL23A | -9382 |
RPL5 | -9359 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
RPL4 | -9065 |
RPL22 | -8915 |
LARS1 | -8879 |
RPS3 | -8856 |
RPS25 | -8832 |
RPL21 | -8773 |
RPS27A | -8722 |
IARS1 | -8710 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
RPL6 | -8498 |
RPL34 | -8489 |
RPS20 | -8476 |
RPL17 | -8462 |
RPL27A | -8420 |
RPS12 | -8401 |
RPS14 | -8337 |
RPS23 | -8334 |
RPL10 | -8318 |
RPS27 | -8260 |
RPLP2 | -8255 |
RPL36A | -8130 |
RPS7 | -8047 |
RPL35A | -8046 |
RPL10A | -7989 |
RPL29 | -7954 |
RPL11 | -7928 |
RPL32 | -7914 |
RPS15A | -7912 |
RPL22L1 | -7828 |
RPL30 | -7783 |
RPL18 | -7781 |
RPL35 | -7710 |
RPL26 | -7648 |
KARS1 | -7645 |
RPS4X | -7636 |
RPS10 | -7629 |
RPL24 | -7626 |
RPS16 | -7617 |
RPL18A | -7609 |
RPL31 | -7521 |
RPL9 | -7451 |
RPL15 | -7380 |
RPS13 | -7375 |
RPL7A | -7296 |
RPS18 | -7288 |
RPS8 | -7161 |
RPS17 | -7134 |
SEPSECS | -7064 |
RPL19 | -7006 |
RPL23 | -6933 |
EPRS1 | -6849 |
RPS29 | -6791 |
DARS1 | -6758 |
RPS11 | -6742 |
RPS21 | -6706 |
RPL37 | -6660 |
RPL38 | -6589 |
RPS28 | -6429 |
SARS1 | -6425 |
RPL36 | -6343 |
RPL8 | -6274 |
SECISBP2 | -6069 |
RPL27 | -6068 |
RPL41 | -6065 |
SCLY | -5892 |
RPL39 | -5790 |
RPS19 | -5616 |
RPL13 | -5550 |
RPS26 | -5524 |
RPS15 | -5342 |
RPS24 | -5310 |
EEFSEC | -5238 |
AIMP1 | -5088 |
RPL37A | -4774 |
RPSA | -4559 |
RPL36AL | -4148 |
RPLP1 | -3887 |
PSTK | -3075 |
QARS1 | -3062 |
AHCY | -2734 |
AIMP2 | -2623 |
CTH | -2211 |
RPL28 | -1952 |
INMT | -1946 |
UBA52 | -1437 |
RARS1 | -1110 |
FAU | -1029 |
RPL39L | -69 |
RPS4Y1 | 1461 |
EEF1E1 | 2209 |
RPS9 | 2392 |
RPS27L | 2784 |
RPL3L | 5700 |
RPL26L1 | 6187 |
SEPHS2 | 7242 |
GNMT | 7343 |
HNMT | 8194 |
TXNRD1 | 8216 |
PAPSS1 | 9661 |
MARS1 | 9700 |
GSR | 10772 |
CBS | 10976 |
PAPSS2 | 11736 |
rRNA processing
1353 | |
---|---|
set | rRNA processing |
setSize | 217 |
pANOVA | 4.38e-44 |
s.dist | -0.547 |
p.adjustANOVA | 2.99e-41 |
Top enriched genes
GeneID | Gene Rank |
---|---|
DKC1 | -9835 |
TSR1 | -9723 |
NOP14 | -9719 |
RPL3 | -9701 |
FBL | -9671 |
RPS2 | -9635 |
RPP40 | -9619 |
MTERF4 | -9490 |
RPL14 | -9390 |
RPL23A | -9382 |
GNL3 | -9380 |
NOP58 | -9366 |
RPL5 | -9359 |
NOL11 | -9354 |
UTP4 | -9338 |
NAT10 | -9326 |
THUMPD1 | -9311 |
RPS3A | -9257 |
NOB1 | -9253 |
DIMT1 | -9230 |
GeneID | Gene Rank |
---|---|
DKC1 | -9835 |
TSR1 | -9723 |
NOP14 | -9719 |
RPL3 | -9701 |
FBL | -9671 |
RPS2 | -9635 |
RPP40 | -9619 |
MTERF4 | -9490 |
RPL14 | -9390 |
RPL23A | -9382 |
GNL3 | -9380 |
NOP58 | -9366 |
RPL5 | -9359 |
NOL11 | -9354 |
UTP4 | -9338 |
NAT10 | -9326 |
THUMPD1 | -9311 |
RPS3A | -9257 |
NOB1 | -9253 |
DIMT1 | -9230 |
WDR75 | -9213 |
RPS6 | -9170 |
NCL | -9167 |
BMS1 | -9164 |
RPL7 | -9134 |
RPL4 | -9065 |
RPL22 | -8915 |
RPS3 | -8856 |
WDR43 | -8851 |
RPS25 | -8832 |
RPL21 | -8773 |
TEX10 | -8744 |
RPS27A | -8722 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
LAS1L | -8501 |
RPL6 | -8498 |
RPL34 | -8489 |
RPS20 | -8476 |
RPL17 | -8462 |
RPL27A | -8420 |
RIOK2 | -8405 |
RPS12 | -8401 |
NOP56 | -8346 |
RPS14 | -8337 |
RPS23 | -8334 |
RPL10 | -8318 |
UTP15 | -8280 |
EXOSC5 | -8271 |
TRMT10C | -8270 |
RPS27 | -8260 |
RPLP2 | -8255 |
IMP4 | -8233 |
EXOSC2 | -8172 |
RPL36A | -8130 |
NIP7 | -8124 |
RRP9 | -8121 |
RPS7 | -8047 |
RPL35A | -8046 |
RPL10A | -7989 |
SNU13 | -7987 |
EXOSC6 | -7982 |
PDCD11 | -7980 |
WDR3 | -7973 |
DDX47 | -7962 |
RPL29 | -7954 |
RPL11 | -7928 |
RPL32 | -7914 |
RPS15A | -7912 |
EXOSC8 | -7905 |
RPL22L1 | -7828 |
RPL30 | -7783 |
RPL18 | -7781 |
RCL1 | -7761 |
RPL35 | -7710 |
RPL26 | -7648 |
RPS4X | -7636 |
RPS10 | -7629 |
RPL24 | -7626 |
RPP25 | -7624 |
RPS16 | -7617 |
RPL18A | -7609 |
CSNK1E | -7527 |
RPL31 | -7521 |
PNO1 | -7506 |
EXOSC9 | -7477 |
RPL9 | -7451 |
RPL15 | -7380 |
RPS13 | -7375 |
HEATR1 | -7360 |
PELP1 | -7329 |
RPL7A | -7296 |
RPS18 | -7288 |
PWP2 | -7199 |
NOL9 | -7193 |
MRM1 | -7180 |
RPP30 | -7173 |
RPS8 | -7161 |
RPS17 | -7134 |
RPL19 | -7006 |
IMP3 | -6997 |
WDR46 | -6977 |
NOL6 | -6945 |
RPL23 | -6933 |
UTP20 | -6898 |
EBNA1BP2 | -6864 |
RPS29 | -6791 |
RPS11 | -6742 |
EMG1 | -6735 |
MT-ND2 | -6727 |
RPS21 | -6706 |
GAR1 | -6696 |
RPL37 | -6660 |
MPHOSPH10 | -6590 |
RPL38 | -6589 |
EXOSC7 | -6585 |
RPP38 | -6534 |
MT-RNR1 | -6484 |
KRR1 | -6432 |
RPS28 | -6429 |
RPL36 | -6343 |
NOP2 | -6275 |
RPL8 | -6274 |
RPL27 | -6068 |
RPL41 | -6065 |
BYSL | -5863 |
WDR36 | -5853 |
MT-ND1 | -5852 |
RBM28 | -5810 |
RPL39 | -5790 |
DHX37 | -5761 |
NHP2 | -5747 |
RPS19 | -5616 |
RPL13 | -5550 |
RPS26 | -5524 |
MRM3 | -5496 |
PES1 | -5491 |
UTP6 | -5444 |
RPS15 | -5342 |
RPS24 | -5310 |
BOP1 | -5141 |
EXOSC10 | -5112 |
RPL37A | -4774 |
MTREX | -4734 |
TFB1M | -4603 |
LTV1 | -4592 |
RRP7A | -4574 |
RPSA | -4559 |
WDR18 | -4348 |
MT-CO3 | -4247 |
DCAF13 | -4245 |
RPL36AL | -4148 |
DIS3 | -3916 |
RPLP1 | -3887 |
DDX21 | -3746 |
ELAC2 | -3686 |
PRORP | -3614 |
RIOK1 | -3329 |
MRM2 | -3190 |
MT-ND5 | -3188 |
UTP14A | -3160 |
FCF1 | -3010 |
MT-ND3 | -2969 |
RPP14 | -2433 |
MPHOSPH6 | -2335 |
MT-CYB | -2095 |
RPL28 | -1952 |
UTP14C | -1630 |
UTP3 | -1460 |
UBA52 | -1437 |
WDR12 | -1301 |
FAU | -1029 |
TRMT112 | -370 |
TSR3 | -358 |
RPP21 | -200 |
MT-RNR2 | -141 |
RPL39L | -69 |
ISG20L2 | -43 |
MT-ATP6 | 36 |
TBL3 | 55 |
EXOSC3 | 280 |
MT-CO1 | 507 |
RRP36 | 511 |
C1D | 531 |
MT-CO2 | 729 |
RRP1 | 874 |
MT-TF | 1008 |
UTP11 | 1268 |
RPS4Y1 | 1461 |
DDX52 | 1503 |
MT-ATP8 | 1944 |
ERI1 | 1991 |
RPS9 | 2392 |
EXOSC1 | 2569 |
RIOK3 | 2755 |
RPS27L | 2784 |
MT-ND4L | 3155 |
FTSJ3 | 3515 |
UTP18 | 3740 |
NSUN4 | 4135 |
DDX49 | 4194 |
SENP3 | 4233 |
MT-TV | 4515 |
MT-TL1 | 5025 |
RPL3L | 5700 |
NOL12 | 5766 |
MT-ND4 | 5850 |
RPL26L1 | 6187 |
HSD17B10 | 6466 |
CSNK1D | 7458 |
NOC4L | 7461 |
EXOSC4 | 8895 |
XRN2 | 9350 |
NOP10 | 10793 |
SNORD3A | 11429 |
Influenza Viral RNA Transcription and Replication
527 | |
---|---|
set | Influenza Viral RNA Transcription and Replication |
setSize | 135 |
pANOVA | 4.19e-28 |
s.dist | -0.547 |
p.adjustANOVA | 3.57e-26 |
Top enriched genes
GeneID | Gene Rank |
---|---|
IPO5 | -9839 |
NDC1 | -9817 |
RPL3 | -9701 |
RPS2 | -9635 |
NUP35 | -9626 |
NUP88 | -9430 |
RPL14 | -9390 |
RPL23A | -9382 |
RPL5 | -9359 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
PARP1 | -9133 |
RPL4 | -9065 |
RPL22 | -8915 |
RPS3 | -8856 |
RPS25 | -8832 |
NUP107 | -8801 |
SEH1L | -8792 |
RPL21 | -8773 |
GeneID | Gene Rank |
---|---|
IPO5 | -9839 |
NDC1 | -9817 |
RPL3 | -9701 |
RPS2 | -9635 |
NUP35 | -9626 |
NUP88 | -9430 |
RPL14 | -9390 |
RPL23A | -9382 |
RPL5 | -9359 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
PARP1 | -9133 |
RPL4 | -9065 |
RPL22 | -8915 |
RPS3 | -8856 |
RPS25 | -8832 |
NUP107 | -8801 |
SEH1L | -8792 |
RPL21 | -8773 |
RPS27A | -8722 |
NUP160 | -8699 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
RPL6 | -8498 |
RPL34 | -8489 |
RPS20 | -8476 |
RPL17 | -8462 |
RPL27A | -8420 |
RPS12 | -8401 |
RPS14 | -8337 |
RPS23 | -8334 |
RPL10 | -8318 |
RPS27 | -8260 |
RPLP2 | -8255 |
POLR2D | -8160 |
RPL36A | -8130 |
RPS7 | -8047 |
RPL35A | -8046 |
RPL10A | -7989 |
RPL29 | -7954 |
RPL11 | -7928 |
RPL32 | -7914 |
RPS15A | -7912 |
RPL22L1 | -7828 |
NUP43 | -7792 |
RPL30 | -7783 |
RPL18 | -7781 |
RPL35 | -7710 |
RPL26 | -7648 |
RPS4X | -7636 |
NUP155 | -7633 |
RPS10 | -7629 |
RPL24 | -7626 |
RPS16 | -7617 |
RPL18A | -7609 |
RPL31 | -7521 |
RPL9 | -7451 |
RPL15 | -7380 |
RPS13 | -7375 |
RPL7A | -7296 |
NUP188 | -7295 |
RPS18 | -7288 |
RPS8 | -7161 |
RPS17 | -7134 |
NUP205 | -7051 |
RPL19 | -7006 |
RPL23 | -6933 |
RPS29 | -6791 |
RPS11 | -6742 |
RPS21 | -6706 |
RPL37 | -6660 |
RPL38 | -6589 |
RPS28 | -6429 |
RPL36 | -6343 |
RPL8 | -6274 |
POM121C | -6074 |
RPL27 | -6068 |
RPL41 | -6065 |
RPL39 | -5790 |
NUP133 | -5674 |
RPS19 | -5616 |
RPL13 | -5550 |
RPS26 | -5524 |
RPS15 | -5342 |
NUP54 | -5340 |
RPS24 | -5310 |
POLR2B | -5111 |
HSP90AA1 | -5083 |
RPL37A | -4774 |
RPSA | -4559 |
NUP153 | -4433 |
NUP210 | -4373 |
RPL36AL | -4148 |
TPR | -4127 |
POLR2K | -3902 |
RPLP1 | -3887 |
POLR2H | -3611 |
NUP93 | -3163 |
GRSF1 | -3125 |
RANBP2 | -3109 |
NUP42 | -2718 |
POLR2C | -2566 |
POM121 | -2295 |
RPL28 | -1952 |
NUP85 | -1717 |
POLR2I | -1599 |
UBA52 | -1437 |
NUP37 | -1424 |
NUP50 | -1242 |
FAU | -1029 |
RPL39L | -69 |
NUP98 | 175 |
NUP62 | 395 |
AAAS | 627 |
RPS4Y1 | 1461 |
RPS9 | 2392 |
RPS27L | 2784 |
POLR2L | 3450 |
RAE1 | 5040 |
POLR2E | 5238 |
GTF2F2 | 5263 |
GTF2F1 | 5494 |
POLR2G | 5695 |
RPL3L | 5700 |
POLR2F | 5738 |
RPL26L1 | 6187 |
POLR2A | 6387 |
SEC13 | 6793 |
NUP58 | 7628 |
POLR2J | 7983 |
DNAJC3 | 8291 |
NUP214 | 10124 |
NOTCH4 Activation and Transmission of Signal to the Nucleus
706 | |
---|---|
set | NOTCH4 Activation and Transmission of Signal to the Nucleus |
setSize | 10 |
pANOVA | 0.00284 |
s.dist | 0.545 |
p.adjustANOVA | 0.0173 |
Top enriched genes
GeneID | Gene Rank |
---|---|
NCSTN | 11715 |
NOTCH4 | 11483 |
PSEN1 | 10871 |
PSENEN | 9844 |
APH1B | 9199 |
ADAM10 | 9130 |
JAG1 | 7859 |
APH1A | 2205 |
YWHAZ | -647 |
PSEN2 | -3426 |
GeneID | Gene Rank |
---|---|
NCSTN | 11715 |
NOTCH4 | 11483 |
PSEN1 | 10871 |
PSENEN | 9844 |
APH1B | 9199 |
ADAM10 | 9130 |
JAG1 | 7859 |
APH1A | 2205 |
YWHAZ | -647 |
PSEN2 | -3426 |
Translation initiation complex formation
1269 | |
---|---|
set | Translation initiation complex formation |
setSize | 58 |
pANOVA | 6.84e-13 |
s.dist | -0.545 |
p.adjustANOVA | 2.91e-11 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS2 | -9635 |
EIF4A2 | -9355 |
RPS3A | -9257 |
RPS6 | -9170 |
EIF3B | -8874 |
RPS3 | -8856 |
RPS25 | -8832 |
RPS27A | -8722 |
RPS5 | -8698 |
EIF3E | -8600 |
RPS20 | -8476 |
RPS12 | -8401 |
EIF1AX | -8394 |
RPS14 | -8337 |
RPS23 | -8334 |
EIF4B | -8328 |
RPS27 | -8260 |
RPS7 | -8047 |
RPS15A | -7912 |
EIF3L | -7766 |
GeneID | Gene Rank |
---|---|
RPS2 | -9635 |
EIF4A2 | -9355 |
RPS3A | -9257 |
RPS6 | -9170 |
EIF3B | -8874 |
RPS3 | -8856 |
RPS25 | -8832 |
RPS27A | -8722 |
RPS5 | -8698 |
EIF3E | -8600 |
RPS20 | -8476 |
RPS12 | -8401 |
EIF1AX | -8394 |
RPS14 | -8337 |
RPS23 | -8334 |
EIF4B | -8328 |
RPS27 | -8260 |
RPS7 | -8047 |
RPS15A | -7912 |
EIF3L | -7766 |
RPS4X | -7636 |
RPS10 | -7629 |
RPS16 | -7617 |
RPS13 | -7375 |
RPS18 | -7288 |
RPS8 | -7161 |
RPS17 | -7134 |
RPS29 | -6791 |
RPS11 | -6742 |
RPS21 | -6706 |
RPS28 | -6429 |
EIF3J | -6001 |
EIF3H | -5894 |
EIF3M | -5620 |
RPS19 | -5616 |
RPS26 | -5524 |
RPS15 | -5342 |
RPS24 | -5310 |
RPSA | -4559 |
EIF3D | -4337 |
EIF3C | -3750 |
EIF3F | -3748 |
PABPC1 | -3482 |
EIF2S1 | -3350 |
EIF3I | -2671 |
EIF3G | -1676 |
EIF3A | -1537 |
FAU | -1029 |
EIF3K | -298 |
EIF2S2 | 297 |
EIF2S3 | 1308 |
RPS4Y1 | 1461 |
EIF4E | 2104 |
RPS9 | 2392 |
RPS27L | 2784 |
EIF4A1 | 5928 |
EIF4H | 7435 |
EIF4G1 | 9922 |
Ribosomal scanning and start codon recognition
1015 | |
---|---|
set | Ribosomal scanning and start codon recognition |
setSize | 58 |
pANOVA | 1.1e-12 |
s.dist | -0.54 |
p.adjustANOVA | 4.39e-11 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS2 | -9635 |
EIF4A2 | -9355 |
RPS3A | -9257 |
RPS6 | -9170 |
EIF3B | -8874 |
RPS3 | -8856 |
RPS25 | -8832 |
RPS27A | -8722 |
RPS5 | -8698 |
EIF3E | -8600 |
RPS20 | -8476 |
RPS12 | -8401 |
EIF1AX | -8394 |
RPS14 | -8337 |
RPS23 | -8334 |
EIF4B | -8328 |
RPS27 | -8260 |
RPS7 | -8047 |
RPS15A | -7912 |
EIF3L | -7766 |
GeneID | Gene Rank |
---|---|
RPS2 | -9635 |
EIF4A2 | -9355 |
RPS3A | -9257 |
RPS6 | -9170 |
EIF3B | -8874 |
RPS3 | -8856 |
RPS25 | -8832 |
RPS27A | -8722 |
RPS5 | -8698 |
EIF3E | -8600 |
RPS20 | -8476 |
RPS12 | -8401 |
EIF1AX | -8394 |
RPS14 | -8337 |
RPS23 | -8334 |
EIF4B | -8328 |
RPS27 | -8260 |
RPS7 | -8047 |
RPS15A | -7912 |
EIF3L | -7766 |
RPS4X | -7636 |
RPS10 | -7629 |
RPS16 | -7617 |
RPS13 | -7375 |
RPS18 | -7288 |
RPS8 | -7161 |
RPS17 | -7134 |
RPS29 | -6791 |
RPS11 | -6742 |
RPS21 | -6706 |
RPS28 | -6429 |
EIF3J | -6001 |
EIF3H | -5894 |
EIF3M | -5620 |
RPS19 | -5616 |
RPS26 | -5524 |
RPS15 | -5342 |
RPS24 | -5310 |
RPSA | -4559 |
EIF3D | -4337 |
EIF3C | -3750 |
EIF3F | -3748 |
EIF2S1 | -3350 |
EIF3I | -2671 |
EIF3G | -1676 |
EIF3A | -1537 |
FAU | -1029 |
EIF5 | -416 |
EIF3K | -298 |
EIF2S2 | 297 |
EIF2S3 | 1308 |
RPS4Y1 | 1461 |
EIF4E | 2104 |
RPS9 | 2392 |
RPS27L | 2784 |
EIF4A1 | 5928 |
EIF4H | 7435 |
EIF4G1 | 9922 |
DNA strand elongation
245 | |
---|---|
set | DNA strand elongation |
setSize | 32 |
pANOVA | 1.35e-07 |
s.dist | -0.538 |
p.adjustANOVA | 3.4e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
MCM3 | -9769 |
POLD2 | -9742 |
POLA1 | -9660 |
RPA1 | -9657 |
MCM6 | -9297 |
RFC3 | -8694 |
LIG1 | -8618 |
PRIM1 | -8268 |
GINS4 | -8200 |
RPA3 | -8069 |
RFC4 | -7736 |
MCM7 | -7720 |
MCM4 | -7627 |
MCM2 | -7557 |
FEN1 | -7122 |
PCNA | -6841 |
POLA2 | -6222 |
MCM8 | -6138 |
PRIM2 | -5653 |
CDC45 | -5643 |
GeneID | Gene Rank |
---|---|
MCM3 | -9769 |
POLD2 | -9742 |
POLA1 | -9660 |
RPA1 | -9657 |
MCM6 | -9297 |
RFC3 | -8694 |
LIG1 | -8618 |
PRIM1 | -8268 |
GINS4 | -8200 |
RPA3 | -8069 |
RFC4 | -7736 |
MCM7 | -7720 |
MCM4 | -7627 |
MCM2 | -7557 |
FEN1 | -7122 |
PCNA | -6841 |
POLA2 | -6222 |
MCM8 | -6138 |
PRIM2 | -5653 |
CDC45 | -5643 |
RFC1 | -5493 |
RPA2 | -4620 |
DNA2 | -4017 |
GINS3 | -3998 |
RFC5 | -3986 |
GINS2 | -3279 |
GINS1 | -976 |
POLD1 | 646 |
MCM5 | 1277 |
RFC2 | 4835 |
POLD4 | 10344 |
POLD3 | 11274 |
Hyaluronan uptake and degradation
504 | |
---|---|
set | Hyaluronan uptake and degradation |
setSize | 12 |
pANOVA | 0.00132 |
s.dist | 0.535 |
p.adjustANOVA | 0.00929 |
Top enriched genes
GeneID | Gene Rank |
---|---|
HYAL2 | 11702 |
SLC9A1 | 11489 |
GUSB | 11435 |
LYVE1 | 10683 |
CHP1 | 9397 |
HYAL1 | 8617 |
CD44 | 8470 |
HEXB | 6925 |
STAB2 | 5526 |
HYAL3 | 304 |
HEXA | -442 |
HMMR | -3479 |
GeneID | Gene Rank |
---|---|
HYAL2 | 11702 |
SLC9A1 | 11489 |
GUSB | 11435 |
LYVE1 | 10683 |
CHP1 | 9397 |
HYAL1 | 8617 |
CD44 | 8470 |
HEXB | 6925 |
STAB2 | 5526 |
HYAL3 | 304 |
HEXA | -442 |
HMMR | -3479 |
Heme degradation
494 | |
---|---|
set | Heme degradation |
setSize | 10 |
pANOVA | 0.00364 |
s.dist | 0.531 |
p.adjustANOVA | 0.0212 |
Top enriched genes
GeneID | Gene Rank |
---|---|
HMOX1 | 11521 |
GUSB | 11435 |
BLVRA | 10731 |
SLCO2B1 | 10574 |
ALB | 9450 |
BLVRB | 8156 |
ABCC1 | 7821 |
ABCC2 | 5072 |
ABCG2 | 1182 |
HMOX2 | -9212 |
GeneID | Gene Rank |
---|---|
HMOX1 | 11521 |
GUSB | 11435 |
BLVRA | 10731 |
SLCO2B1 | 10574 |
ALB | 9450 |
BLVRB | 8156 |
ABCC1 | 7821 |
ABCC2 | 5072 |
ABCG2 | 1182 |
HMOX2 | -9212 |
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S
49 | |
---|---|
set | Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
setSize | 59 |
pANOVA | 2.07e-12 |
s.dist | -0.529 |
p.adjustANOVA | 8.07e-11 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPS2 | -9635 |
EIF4A2 | -9355 |
RPS3A | -9257 |
RPS6 | -9170 |
EIF3B | -8874 |
RPS3 | -8856 |
RPS25 | -8832 |
RPS27A | -8722 |
RPS5 | -8698 |
EIF3E | -8600 |
RPS20 | -8476 |
RPS12 | -8401 |
EIF1AX | -8394 |
RPS14 | -8337 |
RPS23 | -8334 |
EIF4B | -8328 |
RPS27 | -8260 |
RPS7 | -8047 |
RPS15A | -7912 |
EIF3L | -7766 |
GeneID | Gene Rank |
---|---|
RPS2 | -9635 |
EIF4A2 | -9355 |
RPS3A | -9257 |
RPS6 | -9170 |
EIF3B | -8874 |
RPS3 | -8856 |
RPS25 | -8832 |
RPS27A | -8722 |
RPS5 | -8698 |
EIF3E | -8600 |
RPS20 | -8476 |
RPS12 | -8401 |
EIF1AX | -8394 |
RPS14 | -8337 |
RPS23 | -8334 |
EIF4B | -8328 |
RPS27 | -8260 |
RPS7 | -8047 |
RPS15A | -7912 |
EIF3L | -7766 |
RPS4X | -7636 |
RPS10 | -7629 |
RPS16 | -7617 |
RPS13 | -7375 |
RPS18 | -7288 |
RPS8 | -7161 |
RPS17 | -7134 |
RPS29 | -6791 |
RPS11 | -6742 |
RPS21 | -6706 |
RPS28 | -6429 |
EIF3J | -6001 |
EIF3H | -5894 |
EIF3M | -5620 |
RPS19 | -5616 |
RPS26 | -5524 |
RPS15 | -5342 |
RPS24 | -5310 |
RPSA | -4559 |
EIF3D | -4337 |
EIF3C | -3750 |
EIF3F | -3748 |
PABPC1 | -3482 |
EIF2S1 | -3350 |
EIF3I | -2671 |
EIF3G | -1676 |
EIF3A | -1537 |
FAU | -1029 |
EIF3K | -298 |
EIF2S2 | 297 |
EIF2S3 | 1308 |
RPS4Y1 | 1461 |
EIF4E | 2104 |
RPS9 | 2392 |
RPS27L | 2784 |
EIF4EBP1 | 5335 |
EIF4A1 | 5928 |
EIF4H | 7435 |
EIF4G1 | 9922 |
PD-1 signaling
778 | |
---|---|
set | PD-1 signaling |
setSize | 28 |
pANOVA | 1.37e-06 |
s.dist | -0.527 |
p.adjustANOVA | 2.92e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
TRBV12-3 | -9724 |
CD247 | -9497 |
LCK | -9485 |
HLA-DQA2 | -9407 |
TRAV19 | -9396 |
CD3E | -9378 |
TRAC | -9330 |
CD3G | -9125 |
HLA-DQB2 | -9021 |
CD3D | -8747 |
TRBC1 | -8666 |
TRAV29DV5 | -8326 |
PDCD1 | -7990 |
TRAV8-4 | -7607 |
CD274 | -7428 |
HLA-DPB1 | -7109 |
TRBV7-9 | -6741 |
HLA-DRA | -6613 |
HLA-DPA1 | -5854 |
CD4 | -4882 |
GeneID | Gene Rank |
---|---|
TRBV12-3 | -9724 |
CD247 | -9497 |
LCK | -9485 |
HLA-DQA2 | -9407 |
TRAV19 | -9396 |
CD3E | -9378 |
TRAC | -9330 |
CD3G | -9125 |
HLA-DQB2 | -9021 |
CD3D | -8747 |
TRBC1 | -8666 |
TRAV29DV5 | -8326 |
PDCD1 | -7990 |
TRAV8-4 | -7607 |
CD274 | -7428 |
HLA-DPB1 | -7109 |
TRBV7-9 | -6741 |
HLA-DRA | -6613 |
HLA-DPA1 | -5854 |
CD4 | -4882 |
HLA-DQA1 | -1465 |
HLA-DRB5 | -1119 |
HLA-DRB1 | 1353 |
PTPN11 | 2859 |
HLA-DQB1 | 3660 |
PDCD1LG2 | 4134 |
CSK | 10310 |
PTPN6 | 11254 |
VLDLR internalisation and degradation
1310 | |
---|---|
set | VLDLR internalisation and degradation |
setSize | 12 |
pANOVA | 0.00178 |
s.dist | 0.521 |
p.adjustANOVA | 0.0116 |
Top enriched genes
GeneID | Gene Rank |
---|---|
AP2A1 | 11707 |
PCSK9 | 11538 |
AP2A2 | 10434 |
AP2S1 | 9504 |
NR1H2 | 9385 |
CLTC | 9346 |
CLTA | 7680 |
VLDLR | 7597 |
AP2M1 | 7323 |
NR1H3 | 5458 |
AP2B1 | -3690 |
MYLIP | -7517 |
GeneID | Gene Rank |
---|---|
AP2A1 | 11707 |
PCSK9 | 11538 |
AP2A2 | 10434 |
AP2S1 | 9504 |
NR1H2 | 9385 |
CLTC | 9346 |
CLTA | 7680 |
VLDLR | 7597 |
AP2M1 | 7323 |
NR1H3 | 5458 |
AP2B1 | -3690 |
MYLIP | -7517 |
Telomere C-strand synthesis initiation
1220 | |
---|---|
set | Telomere C-strand synthesis initiation |
setSize | 13 |
pANOVA | 0.00136 |
s.dist | -0.513 |
p.adjustANOVA | 0.00936 |
Top enriched genes
GeneID | Gene Rank |
---|---|
POLA1 | -9660 |
STN1 | -9499 |
PRIM1 | -8268 |
CTC1 | -8006 |
POLA2 | -6222 |
POT1 | -5841 |
PRIM2 | -5653 |
TERF2 | -4926 |
ACD | -3963 |
TERF1 | -3813 |
TERF2IP | -1108 |
TEN1 | 1027 |
TINF2 | 5948 |
GeneID | Gene Rank |
---|---|
POLA1 | -9660 |
STN1 | -9499 |
PRIM1 | -8268 |
CTC1 | -8006 |
POLA2 | -6222 |
POT1 | -5841 |
PRIM2 | -5653 |
TERF2 | -4926 |
ACD | -3963 |
TERF1 | -3813 |
TERF2IP | -1108 |
TEN1 | 1027 |
TINF2 | 5948 |
Nucleobase biosynthesis
754 | |
---|---|
set | Nucleobase biosynthesis |
setSize | 13 |
pANOVA | 0.00145 |
s.dist | -0.51 |
p.adjustANOVA | 0.00989 |
Top enriched genes
GeneID | Gene Rank |
---|---|
IMPDH2 | -9848 |
ATIC | -9759 |
PPAT | -9694 |
UMPS | -9690 |
PAICS | -9126 |
PFAS | -8632 |
CAD | -8324 |
GMPS | -6586 |
ADSL | -3203 |
DHODH | -2273 |
LHPP | 423 |
GART | 5826 |
IMPDH1 | 11335 |
GeneID | Gene Rank |
---|---|
IMPDH2 | -9848 |
ATIC | -9759 |
PPAT | -9694 |
UMPS | -9690 |
PAICS | -9126 |
PFAS | -8632 |
CAD | -8324 |
GMPS | -6586 |
ADSL | -3203 |
DHODH | -2273 |
LHPP | 423 |
GART | 5826 |
IMPDH1 | 11335 |
MET activates RAP1 and RAC1
619 | |
---|---|
set | MET activates RAP1 and RAC1 |
setSize | 10 |
pANOVA | 0.00525 |
s.dist | 0.51 |
p.adjustANOVA | 0.0286 |
Top enriched genes
GeneID | Gene Rank |
---|---|
GRB2 | 10925 |
RAC1 | 10907 |
HGF | 10314 |
GAB1 | 9727 |
CRK | 9373 |
RAP1A | 7021 |
RAP1B | 5363 |
RAPGEF1 | 3848 |
CRKL | -238 |
DOCK7 | -2815 |
GeneID | Gene Rank |
---|---|
GRB2 | 10925 |
RAC1 | 10907 |
HGF | 10314 |
GAB1 | 9727 |
CRK | 9373 |
RAP1A | 7021 |
RAP1B | 5363 |
RAPGEF1 | 3848 |
CRKL | -238 |
DOCK7 | -2815 |
Influenza Infection
526 | |
---|---|
set | Influenza Infection |
setSize | 154 |
pANOVA | 5.85e-27 |
s.dist | -0.501 |
p.adjustANOVA | 3.8e-25 |
Top enriched genes
GeneID | Gene Rank |
---|---|
IPO5 | -9839 |
NDC1 | -9817 |
RPL3 | -9701 |
RPS2 | -9635 |
NUP35 | -9626 |
NUP88 | -9430 |
RPL14 | -9390 |
RPL23A | -9382 |
RPL5 | -9359 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
PARP1 | -9133 |
RPL4 | -9065 |
RPL22 | -8915 |
RPS3 | -8856 |
RPS25 | -8832 |
NUP107 | -8801 |
SEH1L | -8792 |
RPL21 | -8773 |
GeneID | Gene Rank |
---|---|
IPO5 | -9839 |
NDC1 | -9817 |
RPL3 | -9701 |
RPS2 | -9635 |
NUP35 | -9626 |
NUP88 | -9430 |
RPL14 | -9390 |
RPL23A | -9382 |
RPL5 | -9359 |
RPS3A | -9257 |
RPS6 | -9170 |
RPL7 | -9134 |
PARP1 | -9133 |
RPL4 | -9065 |
RPL22 | -8915 |
RPS3 | -8856 |
RPS25 | -8832 |
NUP107 | -8801 |
SEH1L | -8792 |
RPL21 | -8773 |
RPS27A | -8722 |
NUP160 | -8699 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
RPL6 | -8498 |
RPL34 | -8489 |
RPS20 | -8476 |
RPL17 | -8462 |
RPL27A | -8420 |
RPS12 | -8401 |
RPS14 | -8337 |
RPS23 | -8334 |
RPL10 | -8318 |
RPS27 | -8260 |
RPLP2 | -8255 |
POLR2D | -8160 |
RPL36A | -8130 |
RPS7 | -8047 |
RPL35A | -8046 |
RPL10A | -7989 |
RPL29 | -7954 |
RPL11 | -7928 |
RPL32 | -7914 |
RPS15A | -7912 |
RPL22L1 | -7828 |
NUP43 | -7792 |
RPL30 | -7783 |
RPL18 | -7781 |
RPL35 | -7710 |
RPL26 | -7648 |
RPS4X | -7636 |
NUP155 | -7633 |
RPS10 | -7629 |
RPL24 | -7626 |
RPS16 | -7617 |
RPL18A | -7609 |
RAN | -7577 |
KPNA5 | -7556 |
RPL31 | -7521 |
RPL9 | -7451 |
RPL15 | -7380 |
RPS13 | -7375 |
RPL7A | -7296 |
NUP188 | -7295 |
RPS18 | -7288 |
RPS8 | -7161 |
RPS17 | -7134 |
NUP205 | -7051 |
RPL19 | -7006 |
RPL23 | -6933 |
ISG15 | -6814 |
RPS29 | -6791 |
RPS11 | -6742 |
RPS21 | -6706 |
RPL37 | -6660 |
RPL38 | -6589 |
RPS28 | -6429 |
RPL36 | -6343 |
RPL8 | -6274 |
POM121C | -6074 |
RPL27 | -6068 |
RPL41 | -6065 |
RPL39 | -5790 |
NUP133 | -5674 |
RPS19 | -5616 |
SLC25A6 | -5581 |
RPL13 | -5550 |
RPS26 | -5524 |
RPS15 | -5342 |
NUP54 | -5340 |
RPS24 | -5310 |
POLR2B | -5111 |
HSP90AA1 | -5083 |
RPL37A | -4774 |
RPSA | -4559 |
NUP153 | -4433 |
NUP210 | -4373 |
KPNA1 | -4278 |
KPNA3 | -4263 |
XPO1 | -4204 |
RPL36AL | -4148 |
TPR | -4127 |
POLR2K | -3902 |
RPLP1 | -3887 |
KPNA2 | -3851 |
POLR2H | -3611 |
NUP93 | -3163 |
GRSF1 | -3125 |
RANBP2 | -3109 |
NUP42 | -2718 |
POLR2C | -2566 |
CPSF4 | -2319 |
POM121 | -2295 |
RPL28 | -1952 |
NUP85 | -1717 |
POLR2I | -1599 |
UBA52 | -1437 |
NUP37 | -1424 |
CANX | -1278 |
NUP50 | -1242 |
FAU | -1029 |
KPNA4 | -701 |
TGFB1 | -615 |
KPNB1 | -109 |
RPL39L | -69 |
NUP98 | 175 |
NUP62 | 395 |
EIF2AK2 | 426 |
AAAS | 627 |
RPS4Y1 | 1461 |
RPS9 | 2392 |
PABPN1 | 2573 |
RPS27L | 2784 |
POLR2L | 3450 |
CALR | 4966 |
RAE1 | 5040 |
POLR2E | 5238 |
GTF2F2 | 5263 |
GTF2F1 | 5494 |
POLR2G | 5695 |
RPL3L | 5700 |
POLR2F | 5738 |
RPL26L1 | 6187 |
POLR2A | 6387 |
HSPA1A | 6708 |
SEC13 | 6793 |
NUP58 | 7628 |
CLTA | 7680 |
POLR2J | 7983 |
DNAJC3 | 8291 |
CLTC | 9346 |
NUP214 | 10124 |
Processive synthesis on the lagging strand
859 | |
---|---|
set | Processive synthesis on the lagging strand |
setSize | 15 |
pANOVA | 0.000907 |
s.dist | -0.495 |
p.adjustANOVA | 0.00711 |
Top enriched genes
GeneID | Gene Rank |
---|---|
POLD2 | -9742 |
POLA1 | -9660 |
RPA1 | -9657 |
LIG1 | -8618 |
PRIM1 | -8268 |
RPA3 | -8069 |
FEN1 | -7122 |
PCNA | -6841 |
POLA2 | -6222 |
PRIM2 | -5653 |
RPA2 | -4620 |
DNA2 | -4017 |
POLD1 | 646 |
POLD4 | 10344 |
POLD3 | 11274 |
GeneID | Gene Rank |
---|---|
POLD2 | -9742 |
POLA1 | -9660 |
RPA1 | -9657 |
LIG1 | -8618 |
PRIM1 | -8268 |
RPA3 | -8069 |
FEN1 | -7122 |
PCNA | -6841 |
POLA2 | -6222 |
PRIM2 | -5653 |
RPA2 | -4620 |
DNA2 | -4017 |
POLD1 | 646 |
POLD4 | 10344 |
POLD3 | 11274 |
Activation of ATR in response to replication stress
33 | |
---|---|
set | Activation of ATR in response to replication stress |
setSize | 37 |
pANOVA | 1.91e-07 |
s.dist | -0.495 |
p.adjustANOVA | 4.72e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
MCM3 | -9769 |
RPA1 | -9657 |
RAD1 | -9471 |
MCM6 | -9297 |
RFC3 | -8694 |
DBF4 | -8484 |
ORC2 | -8097 |
ORC5 | -8089 |
RPA3 | -8069 |
RAD17 | -7742 |
RFC4 | -7736 |
MCM7 | -7720 |
MCM4 | -7627 |
ORC3 | -7568 |
MCM2 | -7557 |
MCM10 | -6777 |
MCM8 | -6138 |
CHEK1 | -6036 |
ORC4 | -5692 |
CDC45 | -5643 |
GeneID | Gene Rank |
---|---|
MCM3 | -9769 |
RPA1 | -9657 |
RAD1 | -9471 |
MCM6 | -9297 |
RFC3 | -8694 |
DBF4 | -8484 |
ORC2 | -8097 |
ORC5 | -8089 |
RPA3 | -8069 |
RAD17 | -7742 |
RFC4 | -7736 |
MCM7 | -7720 |
MCM4 | -7627 |
ORC3 | -7568 |
MCM2 | -7557 |
MCM10 | -6777 |
MCM8 | -6138 |
CHEK1 | -6036 |
ORC4 | -5692 |
CDC45 | -5643 |
CDC6 | -5479 |
ORC1 | -5158 |
RAD9A | -5073 |
RPA2 | -4620 |
RFC5 | -3986 |
CDK2 | -3694 |
ATR | -2784 |
CDC25A | -2547 |
ATRIP | -1520 |
CLSPN | -178 |
CDC7 | 815 |
MCM5 | 1277 |
CDC25C | 1278 |
HUS1 | 2327 |
RFC2 | 4835 |
ORC6 | 8542 |
RAD9B | 8706 |
Lagging Strand Synthesis
591 | |
---|---|
set | Lagging Strand Synthesis |
setSize | 20 |
pANOVA | 0.000147 |
s.dist | -0.49 |
p.adjustANOVA | 0.00167 |
Top enriched genes
GeneID | Gene Rank |
---|---|
POLD2 | -9742 |
POLA1 | -9660 |
RPA1 | -9657 |
RFC3 | -8694 |
LIG1 | -8618 |
PRIM1 | -8268 |
RPA3 | -8069 |
RFC4 | -7736 |
FEN1 | -7122 |
PCNA | -6841 |
POLA2 | -6222 |
PRIM2 | -5653 |
RFC1 | -5493 |
RPA2 | -4620 |
DNA2 | -4017 |
RFC5 | -3986 |
POLD1 | 646 |
RFC2 | 4835 |
POLD4 | 10344 |
POLD3 | 11274 |
GeneID | Gene Rank |
---|---|
POLD2 | -9742 |
POLA1 | -9660 |
RPA1 | -9657 |
RFC3 | -8694 |
LIG1 | -8618 |
PRIM1 | -8268 |
RPA3 | -8069 |
RFC4 | -7736 |
FEN1 | -7122 |
PCNA | -6841 |
POLA2 | -6222 |
PRIM2 | -5653 |
RFC1 | -5493 |
RPA2 | -4620 |
DNA2 | -4017 |
RFC5 | -3986 |
POLD1 | 646 |
RFC2 | 4835 |
POLD4 | 10344 |
POLD3 | 11274 |
Telomere C-strand (Lagging Strand) Synthesis
1219 | |
---|---|
set | Telomere C-strand (Lagging Strand) Synthesis |
setSize | 34 |
pANOVA | 7.85e-07 |
s.dist | -0.489 |
p.adjustANOVA | 1.81e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
POLD2 | -9742 |
POLA1 | -9660 |
RPA1 | -9657 |
STN1 | -9499 |
WRN | -9097 |
CHTF18 | -8785 |
RFC3 | -8694 |
LIG1 | -8618 |
PRIM1 | -8268 |
RPA3 | -8069 |
CTC1 | -8006 |
RFC4 | -7736 |
DSCC1 | -7671 |
FEN1 | -7122 |
PCNA | -6841 |
POLA2 | -6222 |
POT1 | -5841 |
PRIM2 | -5653 |
RFC1 | -5493 |
TERF2 | -4926 |
GeneID | Gene Rank |
---|---|
POLD2 | -9742 |
POLA1 | -9660 |
RPA1 | -9657 |
STN1 | -9499 |
WRN | -9097 |
CHTF18 | -8785 |
RFC3 | -8694 |
LIG1 | -8618 |
PRIM1 | -8268 |
RPA3 | -8069 |
CTC1 | -8006 |
RFC4 | -7736 |
DSCC1 | -7671 |
FEN1 | -7122 |
PCNA | -6841 |
POLA2 | -6222 |
POT1 | -5841 |
PRIM2 | -5653 |
RFC1 | -5493 |
TERF2 | -4926 |
RPA2 | -4620 |
BLM | -4432 |
DNA2 | -4017 |
RFC5 | -3986 |
ACD | -3963 |
TERF1 | -3813 |
TERF2IP | -1108 |
CHTF8 | -503 |
POLD1 | 646 |
TEN1 | 1027 |
RFC2 | 4835 |
TINF2 | 5948 |
POLD4 | 10344 |
POLD3 | 11274 |
RHO GTPases Activate ROCKs
887 | |
---|---|
set | RHO GTPases Activate ROCKs |
setSize | 18 |
pANOVA | 0.000359 |
s.dist | 0.486 |
p.adjustANOVA | 0.00318 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PAK1 | 10704 |
MYL6 | 10033 |
CFL1 | 9683 |
LIMK1 | 9261 |
RHOC | 8798 |
RHOA | 8752 |
LIMK2 | 8172 |
MYH10 | 7202 |
PPP1R12B | 7089 |
ROCK1 | 7020 |
MYH9 | 6290 |
RHOB | 5919 |
ROCK2 | 5519 |
MYL12B | 4733 |
PPP1R12A | 4439 |
PPP1CB | 2847 |
MYH11 | -619 |
MYL9 | -4572 |
GeneID | Gene Rank |
---|---|
PAK1 | 10704 |
MYL6 | 10033 |
CFL1 | 9683 |
LIMK1 | 9261 |
RHOC | 8798 |
RHOA | 8752 |
LIMK2 | 8172 |
MYH10 | 7202 |
PPP1R12B | 7089 |
ROCK1 | 7020 |
MYH9 | 6290 |
RHOB | 5919 |
ROCK2 | 5519 |
MYL12B | 4733 |
PPP1R12A | 4439 |
PPP1CB | 2847 |
MYH11 | -619 |
MYL9 | -4572 |
Phosphorylation of CD3 and TCR zeta chains
820 | |
---|---|
set | Phosphorylation of CD3 and TCR zeta chains |
setSize | 27 |
pANOVA | 1.96e-05 |
s.dist | -0.475 |
p.adjustANOVA | 0.000296 |
Top enriched genes
GeneID | Gene Rank |
---|---|
TRBV12-3 | -9724 |
CD247 | -9497 |
LCK | -9485 |
HLA-DQA2 | -9407 |
TRAV19 | -9396 |
CD3E | -9378 |
TRAC | -9330 |
CD3G | -9125 |
HLA-DQB2 | -9021 |
CD3D | -8747 |
TRBC1 | -8666 |
TRAV29DV5 | -8326 |
TRAV8-4 | -7607 |
HLA-DPB1 | -7109 |
TRBV7-9 | -6741 |
HLA-DRA | -6613 |
HLA-DPA1 | -5854 |
CD4 | -4882 |
HLA-DQA1 | -1465 |
HLA-DRB5 | -1119 |
GeneID | Gene Rank |
---|---|
TRBV12-3 | -9724 |
CD247 | -9497 |
LCK | -9485 |
HLA-DQA2 | -9407 |
TRAV19 | -9396 |
CD3E | -9378 |
TRAC | -9330 |
CD3G | -9125 |
HLA-DQB2 | -9021 |
CD3D | -8747 |
TRBC1 | -8666 |
TRAV29DV5 | -8326 |
TRAV8-4 | -7607 |
HLA-DPB1 | -7109 |
TRBV7-9 | -6741 |
HLA-DRA | -6613 |
HLA-DPA1 | -5854 |
CD4 | -4882 |
HLA-DQA1 | -1465 |
HLA-DRB5 | -1119 |
PAG1 | 322 |
HLA-DRB1 | 1353 |
HLA-DQB1 | 3660 |
PTPN22 | 5604 |
PTPRC | 7546 |
PTPRJ | 9428 |
CSK | 10310 |
Resolution of AP sites via the multiple-nucleotide patch replacement pathway
998 | |
---|---|
set | Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
setSize | 24 |
pANOVA | 6.05e-05 |
s.dist | -0.473 |
p.adjustANOVA | 0.000809 |
Top enriched genes
GeneID | Gene Rank |
---|---|
POLD2 | -9742 |
APEX1 | -9705 |
RPA1 | -9657 |
PARP1 | -9133 |
POLE3 | -8924 |
RFC3 | -8694 |
LIG1 | -8618 |
RPA3 | -8069 |
RFC4 | -7736 |
FEN1 | -7122 |
PCNA | -6841 |
POLE2 | -6659 |
RFC1 | -5493 |
PARP2 | -5385 |
RPA2 | -4620 |
POLB | -4374 |
RFC5 | -3986 |
POLE | -1479 |
POLE4 | -1186 |
PARG | 84 |
GeneID | Gene Rank |
---|---|
POLD2 | -9742 |
APEX1 | -9705 |
RPA1 | -9657 |
PARP1 | -9133 |
POLE3 | -8924 |
RFC3 | -8694 |
LIG1 | -8618 |
RPA3 | -8069 |
RFC4 | -7736 |
FEN1 | -7122 |
PCNA | -6841 |
POLE2 | -6659 |
RFC1 | -5493 |
PARP2 | -5385 |
RPA2 | -4620 |
POLB | -4374 |
RFC5 | -3986 |
POLE | -1479 |
POLE4 | -1186 |
PARG | 84 |
POLD1 | 646 |
RFC2 | 4835 |
POLD4 | 10344 |
POLD3 | 11274 |
Removal of the Flap Intermediate
994 | |
---|---|
set | Removal of the Flap Intermediate |
setSize | 14 |
pANOVA | 0.00248 |
s.dist | -0.467 |
p.adjustANOVA | 0.0157 |
Top enriched genes
GeneID | Gene Rank |
---|---|
POLD2 | -9742 |
POLA1 | -9660 |
RPA1 | -9657 |
PRIM1 | -8268 |
RPA3 | -8069 |
FEN1 | -7122 |
PCNA | -6841 |
POLA2 | -6222 |
PRIM2 | -5653 |
RPA2 | -4620 |
DNA2 | -4017 |
POLD1 | 646 |
POLD4 | 10344 |
POLD3 | 11274 |
GeneID | Gene Rank |
---|---|
POLD2 | -9742 |
POLA1 | -9660 |
RPA1 | -9657 |
PRIM1 | -8268 |
RPA3 | -8069 |
FEN1 | -7122 |
PCNA | -6841 |
POLA2 | -6222 |
PRIM2 | -5653 |
RPA2 | -4620 |
DNA2 | -4017 |
POLD1 | 646 |
POLD4 | 10344 |
POLD3 | 11274 |
PCNA-Dependent Long Patch Base Excision Repair
776 | |
---|---|
set | PCNA-Dependent Long Patch Base Excision Repair |
setSize | 21 |
pANOVA | 0.000229 |
s.dist | -0.464 |
p.adjustANOVA | 0.00229 |
Top enriched genes
GeneID | Gene Rank |
---|---|
POLD2 | -9742 |
APEX1 | -9705 |
RPA1 | -9657 |
POLE3 | -8924 |
RFC3 | -8694 |
LIG1 | -8618 |
RPA3 | -8069 |
RFC4 | -7736 |
FEN1 | -7122 |
PCNA | -6841 |
POLE2 | -6659 |
RFC1 | -5493 |
RPA2 | -4620 |
POLB | -4374 |
RFC5 | -3986 |
POLE | -1479 |
POLE4 | -1186 |
POLD1 | 646 |
RFC2 | 4835 |
POLD4 | 10344 |
GeneID | Gene Rank |
---|---|
POLD2 | -9742 |
APEX1 | -9705 |
RPA1 | -9657 |
POLE3 | -8924 |
RFC3 | -8694 |
LIG1 | -8618 |
RPA3 | -8069 |
RFC4 | -7736 |
FEN1 | -7122 |
PCNA | -6841 |
POLE2 | -6659 |
RFC1 | -5493 |
RPA2 | -4620 |
POLB | -4374 |
RFC5 | -3986 |
POLE | -1479 |
POLE4 | -1186 |
POLD1 | 646 |
RFC2 | 4835 |
POLD4 | 10344 |
POLD3 | 11274 |
BBSome-mediated cargo-targeting to cilium
98 | |
---|---|
set | BBSome-mediated cargo-targeting to cilium |
setSize | 22 |
pANOVA | 0.00019 |
s.dist | -0.46 |
p.adjustANOVA | 0.00202 |
Top enriched genes
GeneID | Gene Rank |
---|---|
CCT2 | -9661 |
BBS9 | -7939 |
LZTFL1 | -7906 |
CCT4 | -7510 |
SSTR3 | -7486 |
MKKS | -7400 |
BBS5 | -6824 |
BBS2 | -6808 |
CCT3 | -6559 |
BBS1 | -5958 |
TCP1 | -5286 |
ARL6 | -4721 |
BBS10 | -3126 |
BBIP1 | -2982 |
MCHR1 | -1970 |
BBS12 | -1918 |
RAB3IP | -1300 |
BBS4 | -418 |
CCT8 | -260 |
BBS7 | 1167 |
GeneID | Gene Rank |
---|---|
CCT2 | -9661 |
BBS9 | -7939 |
LZTFL1 | -7906 |
CCT4 | -7510 |
SSTR3 | -7486 |
MKKS | -7400 |
BBS5 | -6824 |
BBS2 | -6808 |
CCT3 | -6559 |
BBS1 | -5958 |
TCP1 | -5286 |
ARL6 | -4721 |
BBS10 | -3126 |
BBIP1 | -2982 |
MCHR1 | -1970 |
BBS12 | -1918 |
RAB3IP | -1300 |
BBS4 | -418 |
CCT8 | -260 |
BBS7 | 1167 |
CCT5 | 2169 |
TTC8 | 3955 |
Generation of second messenger molecules
444 | |
---|---|
set | Generation of second messenger molecules |
setSize | 38 |
pANOVA | 1.37e-06 |
s.dist | -0.453 |
p.adjustANOVA | 2.92e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
TRBV12-3 | -9724 |
CD247 | -9497 |
LCK | -9485 |
HLA-DQA2 | -9407 |
TRAV19 | -9396 |
CD3E | -9378 |
TRAC | -9330 |
ITK | -9231 |
LAT | -9159 |
CD3G | -9125 |
HLA-DQB2 | -9021 |
NCK1 | -8821 |
CD3D | -8747 |
TRBC1 | -8666 |
ZAP70 | -8662 |
EVL | -8581 |
PLCG1 | -8497 |
TRAV29DV5 | -8326 |
TRAV8-4 | -7607 |
HLA-DPB1 | -7109 |
GeneID | Gene Rank |
---|---|
TRBV12-3 | -9724 |
CD247 | -9497 |
LCK | -9485 |
HLA-DQA2 | -9407 |
TRAV19 | -9396 |
CD3E | -9378 |
TRAC | -9330 |
ITK | -9231 |
LAT | -9159 |
CD3G | -9125 |
HLA-DQB2 | -9021 |
NCK1 | -8821 |
CD3D | -8747 |
TRBC1 | -8666 |
ZAP70 | -8662 |
EVL | -8581 |
PLCG1 | -8497 |
TRAV29DV5 | -8326 |
TRAV8-4 | -7607 |
HLA-DPB1 | -7109 |
TRBV7-9 | -6741 |
HLA-DRA | -6613 |
GRAP2 | -6236 |
HLA-DPA1 | -5854 |
CD4 | -4882 |
HLA-DQA1 | -1465 |
HLA-DRB5 | -1119 |
PAK3 | -533 |
LCP2 | 514 |
CD101 | 551 |
HLA-DRB1 | 1353 |
HLA-DQB1 | 3660 |
PAK2 | 5789 |
ENAH | 6964 |
VASP | 9774 |
PLCG2 | 10376 |
PAK1 | 10704 |
WAS | 11238 |
Advanced glycosylation endproduct receptor signaling
60 | |
---|---|
set | Advanced glycosylation endproduct receptor signaling |
setSize | 12 |
pANOVA | 0.00676 |
s.dist | 0.451 |
p.adjustANOVA | 0.0351 |
Top enriched genes
GeneID | Gene Rank |
---|---|
S100A12 | 11077 |
MAPK1 | 10847 |
MAPK3 | 9636 |
LGALS3 | 9294 |
CAPZA1 | 8032 |
CAPZA2 | 7999 |
AGER | 7730 |
DDOST | 7465 |
PRKCSH | 5698 |
APP | 3315 |
S100B | -3661 |
HMGB1 | -7684 |
GeneID | Gene Rank |
---|---|
S100A12 | 11077 |
MAPK1 | 10847 |
MAPK3 | 9636 |
LGALS3 | 9294 |
CAPZA1 | 8032 |
CAPZA2 | 7999 |
AGER | 7730 |
DDOST | 7465 |
PRKCSH | 5698 |
APP | 3315 |
S100B | -3661 |
HMGB1 | -7684 |
Gap junction trafficking
436 | |
---|---|
set | Gap junction trafficking |
setSize | 13 |
pANOVA | 0.00493 |
s.dist | 0.45 |
p.adjustANOVA | 0.0271 |
Top enriched genes
GeneID | Gene Rank |
---|---|
DAB2 | 10889 |
GJD3 | 10882 |
DNM2 | 9736 |
CLTC | 9346 |
CLTCL1 | 9020 |
CLTB | 8275 |
CLTA | 7680 |
AP2M1 | 7323 |
GJC1 | 5867 |
DNM1 | 5834 |
GJC2 | 2387 |
GJB6 | -4155 |
MYO6 | -7690 |
GeneID | Gene Rank |
---|---|
DAB2 | 10889 |
GJD3 | 10882 |
DNM2 | 9736 |
CLTC | 9346 |
CLTCL1 | 9020 |
CLTB | 8275 |
CLTA | 7680 |
AP2M1 | 7323 |
GJC1 | 5867 |
DNM1 | 5834 |
GJC2 | 2387 |
GJB6 | -4155 |
MYO6 | -7690 |
Purine ribonucleoside monophosphate biosynthesis
870 | |
---|---|
set | Purine ribonucleoside monophosphate biosynthesis |
setSize | 10 |
pANOVA | 0.0139 |
s.dist | -0.449 |
p.adjustANOVA | 0.0599 |
Top enriched genes
GeneID | Gene Rank |
---|---|
IMPDH2 | -9848 |
ATIC | -9759 |
PPAT | -9694 |
PAICS | -9126 |
PFAS | -8632 |
GMPS | -6586 |
ADSL | -3203 |
LHPP | 423 |
GART | 5826 |
IMPDH1 | 11335 |
GeneID | Gene Rank |
---|---|
IMPDH2 | -9848 |
ATIC | -9759 |
PPAT | -9694 |
PAICS | -9126 |
PFAS | -8632 |
GMPS | -6586 |
ADSL | -3203 |
LHPP | 423 |
GART | 5826 |
IMPDH1 | 11335 |
Early Phase of HIV Life Cycle
333 | |
---|---|
set | Early Phase of HIV Life Cycle |
setSize | 14 |
pANOVA | 0.00392 |
s.dist | -0.445 |
p.adjustANOVA | 0.0225 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PSIP1 | -8864 |
LIG1 | -8618 |
HMGA1 | -8468 |
XRCC6 | -7770 |
FEN1 | -7122 |
CCR5 | -5824 |
CD4 | -4882 |
PPIA | -4561 |
BANF1 | -4324 |
KPNA1 | -4278 |
XRCC5 | -2484 |
CXCR4 | -2277 |
XRCC4 | 6153 |
LIG4 | 8990 |
GeneID | Gene Rank |
---|---|
PSIP1 | -8864 |
LIG1 | -8618 |
HMGA1 | -8468 |
XRCC6 | -7770 |
FEN1 | -7122 |
CCR5 | -5824 |
CD4 | -4882 |
PPIA | -4561 |
BANF1 | -4324 |
KPNA1 | -4278 |
XRCC5 | -2484 |
CXCR4 | -2277 |
XRCC4 | 6153 |
LIG4 | 8990 |
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs
1035 | |
---|---|
set | SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
setSize | 11 |
pANOVA | 0.0107 |
s.dist | -0.445 |
p.adjustANOVA | 0.0495 |
Top enriched genes
GeneID | Gene Rank |
---|---|
LSM11 | -9482 |
ZNF473 | -8717 |
NCBP2 | -8212 |
SNRPE | -6979 |
SNRPF | -6725 |
SLBP | -4830 |
SNRPD3 | -4404 |
SNRPB | -3546 |
NCBP1 | -1125 |
SNRPG | 3835 |
LSM10 | 7576 |
GeneID | Gene Rank |
---|---|
LSM11 | -9482 |
ZNF473 | -8717 |
NCBP2 | -8212 |
SNRPE | -6979 |
SNRPF | -6725 |
SLBP | -4830 |
SNRPD3 | -4404 |
SNRPB | -3546 |
NCBP1 | -1125 |
SNRPG | 3835 |
LSM10 | 7576 |
Establishment of Sister Chromatid Cohesion
347 | |
---|---|
set | Establishment of Sister Chromatid Cohesion |
setSize | 11 |
pANOVA | 0.011 |
s.dist | -0.443 |
p.adjustANOVA | 0.0506 |
Top enriched genes
GeneID | Gene Rank |
---|---|
STAG1 | -6554 |
ESCO1 | -6521 |
RAD21 | -6258 |
SMC3 | -5758 |
PDS5A | -4597 |
CDCA5 | -3870 |
STAG2 | -2436 |
PDS5B | -2230 |
ESCO2 | -2104 |
WAPL | -1381 |
SMC1A | -662 |
GeneID | Gene Rank |
---|---|
STAG1 | -6554 |
ESCO1 | -6521 |
RAD21 | -6258 |
SMC3 | -5758 |
PDS5A | -4597 |
CDCA5 | -3870 |
STAG2 | -2436 |
PDS5B | -2230 |
ESCO2 | -2104 |
WAPL | -1381 |
SMC1A | -662 |
Synthesis of Leukotrienes (LT) and Eoxins (EX)
1166 | |
---|---|
set | Synthesis of Leukotrienes (LT) and Eoxins (EX) |
setSize | 15 |
pANOVA | 0.00306 |
s.dist | 0.442 |
p.adjustANOVA | 0.0184 |
Top enriched genes
GeneID | Gene Rank |
---|---|
GGT1 | 11721 |
CYP4F8 | 11319 |
PTGR1 | 11262 |
ALOX5 | 11153 |
LTA4H | 11060 |
ABCC1 | 7821 |
ALOX5AP | 7665 |
GGT5 | 6798 |
MAPKAPK2 | 6495 |
CYP4F22 | 3837 |
DPEP2 | 3646 |
CYP4F3 | 2865 |
DPEP3 | 74 |
LTC4S | -942 |
ALOX15 | -9193 |
GeneID | Gene Rank |
---|---|
GGT1 | 11721 |
CYP4F8 | 11319 |
PTGR1 | 11262 |
ALOX5 | 11153 |
LTA4H | 11060 |
ABCC1 | 7821 |
ALOX5AP | 7665 |
GGT5 | 6798 |
MAPKAPK2 | 6495 |
CYP4F22 | 3837 |
DPEP2 | 3646 |
CYP4F3 | 2865 |
DPEP3 | 74 |
LTC4S | -942 |
ALOX15 | -9193 |
Postmitotic nuclear pore complex (NPC) reformation
842 | |
---|---|
set | Postmitotic nuclear pore complex (NPC) reformation |
setSize | 27 |
pANOVA | 7.16e-05 |
s.dist | -0.441 |
p.adjustANOVA | 0.00091 |
Top enriched genes
GeneID | Gene Rank |
---|---|
NDC1 | -9817 |
NUP35 | -9626 |
NUP107 | -8801 |
SEH1L | -8792 |
NUP160 | -8699 |
RANGAP1 | -8224 |
NUP43 | -7792 |
NUP155 | -7633 |
RAN | -7577 |
NUP188 | -7295 |
NUP205 | -7051 |
NUP133 | -5674 |
NUP54 | -5340 |
AHCTF1 | -5169 |
TNPO1 | -3493 |
NUP93 | -3163 |
RCC1 | -3085 |
POM121 | -2295 |
NUP85 | -1717 |
NUP37 | -1424 |
GeneID | Gene Rank |
---|---|
NDC1 | -9817 |
NUP35 | -9626 |
NUP107 | -8801 |
SEH1L | -8792 |
NUP160 | -8699 |
RANGAP1 | -8224 |
NUP43 | -7792 |
NUP155 | -7633 |
RAN | -7577 |
NUP188 | -7295 |
NUP205 | -7051 |
NUP133 | -5674 |
NUP54 | -5340 |
AHCTF1 | -5169 |
TNPO1 | -3493 |
NUP93 | -3163 |
RCC1 | -3085 |
POM121 | -2295 |
NUP85 | -1717 |
NUP37 | -1424 |
KPNB1 | -109 |
NUP98 | 175 |
NUP62 | 395 |
UBE2I | 587 |
SUMO1 | 3612 |
SEC13 | 6793 |
NUP58 | 7628 |
Interactions of Vpr with host cellular proteins
546 | |
---|---|
set | Interactions of Vpr with host cellular proteins |
setSize | 37 |
pANOVA | 3.55e-06 |
s.dist | -0.44 |
p.adjustANOVA | 6.81e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
NDC1 | -9817 |
NUP35 | -9626 |
NUP88 | -9430 |
PSIP1 | -8864 |
NUP107 | -8801 |
SEH1L | -8792 |
NUP160 | -8699 |
HMGA1 | -8468 |
NUP43 | -7792 |
NUP155 | -7633 |
SLC25A4 | -7576 |
NUP188 | -7295 |
NUP205 | -7051 |
POM121C | -6074 |
NUP133 | -5674 |
SLC25A6 | -5581 |
NUP54 | -5340 |
NUP153 | -4433 |
NUP210 | -4373 |
BANF1 | -4324 |
GeneID | Gene Rank |
---|---|
NDC1 | -9817 |
NUP35 | -9626 |
NUP88 | -9430 |
PSIP1 | -8864 |
NUP107 | -8801 |
SEH1L | -8792 |
NUP160 | -8699 |
HMGA1 | -8468 |
NUP43 | -7792 |
NUP155 | -7633 |
SLC25A4 | -7576 |
NUP188 | -7295 |
NUP205 | -7051 |
POM121C | -6074 |
NUP133 | -5674 |
SLC25A6 | -5581 |
NUP54 | -5340 |
NUP153 | -4433 |
NUP210 | -4373 |
BANF1 | -4324 |
KPNA1 | -4278 |
TPR | -4127 |
NUP93 | -3163 |
RANBP2 | -3109 |
NUP42 | -2718 |
SLC25A5 | -2499 |
POM121 | -2295 |
NUP85 | -1717 |
NUP37 | -1424 |
NUP50 | -1242 |
NUP98 | 175 |
NUP62 | 395 |
AAAS | 627 |
RAE1 | 5040 |
SEC13 | 6793 |
NUP58 | 7628 |
NUP214 | 10124 |
Diseases associated with the TLR signaling cascade
287 | |
---|---|
set | Diseases associated with the TLR signaling cascade |
setSize | 23 |
pANOVA | 0.000281 |
s.dist | 0.437 |
p.adjustANOVA | 0.00263 |
Top enriched genes
GeneID | Gene Rank |
---|---|
MYD88 | 11614 |
BTK | 11379 |
CD36 | 11354 |
UNC93B1 | 11011 |
TLR5 | 10992 |
TLR2 | 10761 |
CD14 | 10542 |
LY96 | 10002 |
TICAM1 | 9637 |
TLR4 | 9355 |
IKBKG | 8902 |
TLR1 | 8749 |
TLR6 | 7631 |
CHUK | 7179 |
TIRAP | 6862 |
IKBKB | 5156 |
NFKBIA | 3946 |
NFKB2 | 1272 |
NFKB1 | -2166 |
RELA | -2563 |
GeneID | Gene Rank |
---|---|
MYD88 | 11614 |
BTK | 11379 |
CD36 | 11354 |
UNC93B1 | 11011 |
TLR5 | 10992 |
TLR2 | 10761 |
CD14 | 10542 |
LY96 | 10002 |
TICAM1 | 9637 |
TLR4 | 9355 |
IKBKG | 8902 |
TLR1 | 8749 |
TLR6 | 7631 |
CHUK | 7179 |
TIRAP | 6862 |
IKBKB | 5156 |
NFKBIA | 3946 |
NFKB2 | 1272 |
NFKB1 | -2166 |
RELA | -2563 |
TRAF3 | -5198 |
TLR10 | -6794 |
TLR3 | -9494 |
Diseases of Immune System
289 | |
---|---|
set | Diseases of Immune System |
setSize | 23 |
pANOVA | 0.000281 |
s.dist | 0.437 |
p.adjustANOVA | 0.00263 |
Top enriched genes
GeneID | Gene Rank |
---|---|
MYD88 | 11614 |
BTK | 11379 |
CD36 | 11354 |
UNC93B1 | 11011 |
TLR5 | 10992 |
TLR2 | 10761 |
CD14 | 10542 |
LY96 | 10002 |
TICAM1 | 9637 |
TLR4 | 9355 |
IKBKG | 8902 |
TLR1 | 8749 |
TLR6 | 7631 |
CHUK | 7179 |
TIRAP | 6862 |
IKBKB | 5156 |
NFKBIA | 3946 |
NFKB2 | 1272 |
NFKB1 | -2166 |
RELA | -2563 |
GeneID | Gene Rank |
---|---|
MYD88 | 11614 |
BTK | 11379 |
CD36 | 11354 |
UNC93B1 | 11011 |
TLR5 | 10992 |
TLR2 | 10761 |
CD14 | 10542 |
LY96 | 10002 |
TICAM1 | 9637 |
TLR4 | 9355 |
IKBKG | 8902 |
TLR1 | 8749 |
TLR6 | 7631 |
CHUK | 7179 |
TIRAP | 6862 |
IKBKB | 5156 |
NFKBIA | 3946 |
NFKB2 | 1272 |
NFKB1 | -2166 |
RELA | -2563 |
TRAF3 | -5198 |
TLR10 | -6794 |
TLR3 | -9494 |
CD22 mediated BCR regulation
121 | |
---|---|
set | CD22 mediated BCR regulation |
setSize | 59 |
pANOVA | 6.94e-09 |
s.dist | -0.436 |
p.adjustANOVA | 2.31e-07 |
Top enriched genes
GeneID | Gene Rank |
---|---|
IGKV3-11 | -9443 |
IGLV6-57 | -8979 |
CD79A | -8733 |
IGLV2-14 | -8599 |
IGHV3-33 | -8574 |
IGKV1-16 | -8350 |
IGLV3-21 | -8327 |
IGLV3-1 | -8150 |
IGKV3-15 | -7683 |
IGHV1-69 | -7589 |
IGLV2-8 | -7468 |
IGKV1-5 | -7365 |
IGLV3-19 | -7358 |
IGKV4-1 | -7302 |
CD79B | -7082 |
CD22 | -6705 |
IGHV3-53 | -6692 |
IGHV4-34 | -6614 |
IGHV2-5 | -6583 |
IGHV3-48 | -5881 |
GeneID | Gene Rank |
---|---|
IGKV3-11 | -9443 |
IGLV6-57 | -8979 |
CD79A | -8733 |
IGLV2-14 | -8599 |
IGHV3-33 | -8574 |
IGKV1-16 | -8350 |
IGLV3-21 | -8327 |
IGLV3-1 | -8150 |
IGKV3-15 | -7683 |
IGHV1-69 | -7589 |
IGLV2-8 | -7468 |
IGKV1-5 | -7365 |
IGLV3-19 | -7358 |
IGKV4-1 | -7302 |
CD79B | -7082 |
CD22 | -6705 |
IGHV3-53 | -6692 |
IGHV4-34 | -6614 |
IGHV2-5 | -6583 |
IGHV3-48 | -5881 |
IGLC7 | -5764 |
IGLV3-27 | -5637 |
IGHV3-23 | -5636 |
IGHV1-2 | -5526 |
IGLV1-51 | -5296 |
IGKC | -5232 |
IGHV3-7 | -5228 |
IGHD | -5224 |
IGHM | -5149 |
IGLC2 | -5138 |
IGKV3-20 | -5082 |
IGKV1-33 | -4953 |
IGHV4-39 | -4884 |
IGHV3-30 | -4685 |
IGLV1-47 | -4485 |
IGKV1-12 | -4392 |
IGKV2-28 | -4281 |
IGLC1 | -4280 |
IGHV2-70 | -4223 |
IGHV3-11 | -3626 |
IGHV1-46 | -3558 |
IGLV1-40 | -3024 |
IGKV2-30 | -2958 |
IGKV1-17 | -2929 |
IGHV4-59 | -2340 |
IGLV3-25 | -1935 |
IGHV3-13 | -1600 |
IGLV1-44 | -1090 |
IGKV2D-28 | -728 |
IGLC3 | -403 |
IGKV3D-20 | -305 |
IGLV2-23 | 1244 |
IGKV5-2 | 3051 |
IGLV2-11 | 3601 |
IGKV1D-39 | 3771 |
IGLV7-43 | 7123 |
IGKV1-39 | 9771 |
LYN | 10893 |
PTPN6 | 11254 |
SLBP independent Processing of Histone Pre-mRNAs
1036 | |
---|---|
set | SLBP independent Processing of Histone Pre-mRNAs |
setSize | 10 |
pANOVA | 0.017 |
s.dist | -0.436 |
p.adjustANOVA | 0.0704 |
Top enriched genes
GeneID | Gene Rank |
---|---|
LSM11 | -9482 |
ZNF473 | -8717 |
NCBP2 | -8212 |
SNRPE | -6979 |
SNRPF | -6725 |
SNRPD3 | -4404 |
SNRPB | -3546 |
NCBP1 | -1125 |
SNRPG | 3835 |
LSM10 | 7576 |
GeneID | Gene Rank |
---|---|
LSM11 | -9482 |
ZNF473 | -8717 |
NCBP2 | -8212 |
SNRPE | -6979 |
SNRPF | -6725 |
SNRPD3 | -4404 |
SNRPB | -3546 |
NCBP1 | -1125 |
SNRPG | 3835 |
LSM10 | 7576 |
Translesion synthesis by REV1
1275 | |
---|---|
set | Translesion synthesis by REV1 |
setSize | 16 |
pANOVA | 0.00258 |
s.dist | -0.435 |
p.adjustANOVA | 0.0161 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPA1 | -9657 |
RPS27A | -8722 |
RFC3 | -8694 |
RPA3 | -8069 |
RFC4 | -7736 |
REV1 | -7246 |
PCNA | -6841 |
RFC1 | -5493 |
RPA2 | -4620 |
REV3L | -4275 |
RFC5 | -3986 |
UBB | -2442 |
UBA52 | -1437 |
RFC2 | 4835 |
UBC | 4874 |
MAD2L2 | 9187 |
GeneID | Gene Rank |
---|---|
RPA1 | -9657 |
RPS27A | -8722 |
RFC3 | -8694 |
RPA3 | -8069 |
RFC4 | -7736 |
REV1 | -7246 |
PCNA | -6841 |
RFC1 | -5493 |
RPA2 | -4620 |
REV3L | -4275 |
RFC5 | -3986 |
UBB | -2442 |
UBA52 | -1437 |
RFC2 | 4835 |
UBC | 4874 |
MAD2L2 | 9187 |
Interactions of Rev with host cellular proteins
545 | |
---|---|
set | Interactions of Rev with host cellular proteins |
setSize | 37 |
pANOVA | 4.77e-06 |
s.dist | -0.435 |
p.adjustANOVA | 8.66e-05 |
Top enriched genes
GeneID | Gene Rank |
---|---|
NPM1 | -9836 |
NDC1 | -9817 |
NUP35 | -9626 |
NUP88 | -9430 |
NUP107 | -8801 |
SEH1L | -8792 |
NUP160 | -8699 |
RANGAP1 | -8224 |
NUP43 | -7792 |
NUP155 | -7633 |
RAN | -7577 |
NUP188 | -7295 |
NUP205 | -7051 |
RANBP1 | -6221 |
POM121C | -6074 |
NUP133 | -5674 |
NUP54 | -5340 |
NUP153 | -4433 |
NUP210 | -4373 |
XPO1 | -4204 |
GeneID | Gene Rank |
---|---|
NPM1 | -9836 |
NDC1 | -9817 |
NUP35 | -9626 |
NUP88 | -9430 |
NUP107 | -8801 |
SEH1L | -8792 |
NUP160 | -8699 |
RANGAP1 | -8224 |
NUP43 | -7792 |
NUP155 | -7633 |
RAN | -7577 |
NUP188 | -7295 |
NUP205 | -7051 |
RANBP1 | -6221 |
POM121C | -6074 |
NUP133 | -5674 |
NUP54 | -5340 |
NUP153 | -4433 |
NUP210 | -4373 |
XPO1 | -4204 |
TPR | -4127 |
NUP93 | -3163 |
RANBP2 | -3109 |
RCC1 | -3085 |
NUP42 | -2718 |
POM121 | -2295 |
NUP85 | -1717 |
NUP37 | -1424 |
NUP50 | -1242 |
KPNB1 | -109 |
NUP98 | 175 |
NUP62 | 395 |
AAAS | 627 |
RAE1 | 5040 |
SEC13 | 6793 |
NUP58 | 7628 |
NUP214 | 10124 |
Dissolution of Fibrin Clot
300 | |
---|---|
set | Dissolution of Fibrin Clot |
setSize | 12 |
pANOVA | 0.0097 |
s.dist | 0.431 |
p.adjustANOVA | 0.0464 |
Top enriched genes
GeneID | Gene Rank |
---|---|
ANXA2 | 11174 |
PLAUR | 10834 |
SERPINB2 | 10828 |
SERPINB6 | 9209 |
SERPINB8 | 7711 |
S100A10 | 6864 |
SERPINE2 | 5551 |
SERPINF2 | 3535 |
PLAU | 2369 |
PLG | 1297 |
SERPINE1 | -1083 |
PLAT | -1179 |
GeneID | Gene Rank |
---|---|
ANXA2 | 11174 |
PLAUR | 10834 |
SERPINB2 | 10828 |
SERPINB6 | 9209 |
SERPINB8 | 7711 |
S100A10 | 6864 |
SERPINE2 | 5551 |
SERPINF2 | 3535 |
PLAU | 2369 |
PLG | 1297 |
SERPINE1 | -1083 |
PLAT | -1179 |
Extension of Telomeres
354 | |
---|---|
set | Extension of Telomeres |
setSize | 51 |
pANOVA | 1.09e-07 |
s.dist | -0.43 |
p.adjustANOVA | 2.87e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
DKC1 | -9835 |
POLD2 | -9742 |
POLA1 | -9660 |
RPA1 | -9657 |
STN1 | -9499 |
WRN | -9097 |
CHTF18 | -8785 |
RFC3 | -8694 |
LIG1 | -8618 |
PRIM1 | -8268 |
RPA3 | -8069 |
CTC1 | -8006 |
SHQ1 | -7860 |
RUVBL1 | -7856 |
RFC4 | -7736 |
DSCC1 | -7671 |
FEN1 | -7122 |
PCNA | -6841 |
GAR1 | -6696 |
POLA2 | -6222 |
GeneID | Gene Rank |
---|---|
DKC1 | -9835 |
POLD2 | -9742 |
POLA1 | -9660 |
RPA1 | -9657 |
STN1 | -9499 |
WRN | -9097 |
CHTF18 | -8785 |
RFC3 | -8694 |
LIG1 | -8618 |
PRIM1 | -8268 |
RPA3 | -8069 |
CTC1 | -8006 |
SHQ1 | -7860 |
RUVBL1 | -7856 |
RFC4 | -7736 |
DSCC1 | -7671 |
FEN1 | -7122 |
PCNA | -6841 |
GAR1 | -6696 |
POLA2 | -6222 |
TERT | -6124 |
POT1 | -5841 |
ANKRD28 | -5772 |
NHP2 | -5747 |
PRIM2 | -5653 |
RFC1 | -5493 |
TERF2 | -4926 |
RPA2 | -4620 |
BLM | -4432 |
WRAP53 | -4086 |
DNA2 | -4017 |
RFC5 | -3986 |
ACD | -3963 |
TERF1 | -3813 |
CDK2 | -3694 |
CCNA1 | -2231 |
CCNA2 | -1727 |
PPP6C | -1168 |
TERF2IP | -1108 |
CHTF8 | -503 |
PPP6R3 | -249 |
POLD1 | 646 |
TEN1 | 1027 |
PIF1 | 1616 |
RUVBL2 | 2364 |
RFC2 | 4835 |
TINF2 | 5948 |
RTEL1 | 7274 |
POLD4 | 10344 |
NOP10 | 10793 |
POLD3 | 11274 |
Vpr-mediated nuclear import of PICs
1319 | |
---|---|
set | Vpr-mediated nuclear import of PICs |
setSize | 34 |
pANOVA | 1.5e-05 |
s.dist | -0.429 |
p.adjustANOVA | 0.000232 |
Top enriched genes
GeneID | Gene Rank |
---|---|
NDC1 | -9817 |
NUP35 | -9626 |
NUP88 | -9430 |
PSIP1 | -8864 |
NUP107 | -8801 |
SEH1L | -8792 |
NUP160 | -8699 |
HMGA1 | -8468 |
NUP43 | -7792 |
NUP155 | -7633 |
NUP188 | -7295 |
NUP205 | -7051 |
POM121C | -6074 |
NUP133 | -5674 |
NUP54 | -5340 |
NUP153 | -4433 |
NUP210 | -4373 |
BANF1 | -4324 |
KPNA1 | -4278 |
TPR | -4127 |
GeneID | Gene Rank |
---|---|
NDC1 | -9817 |
NUP35 | -9626 |
NUP88 | -9430 |
PSIP1 | -8864 |
NUP107 | -8801 |
SEH1L | -8792 |
NUP160 | -8699 |
HMGA1 | -8468 |
NUP43 | -7792 |
NUP155 | -7633 |
NUP188 | -7295 |
NUP205 | -7051 |
POM121C | -6074 |
NUP133 | -5674 |
NUP54 | -5340 |
NUP153 | -4433 |
NUP210 | -4373 |
BANF1 | -4324 |
KPNA1 | -4278 |
TPR | -4127 |
NUP93 | -3163 |
RANBP2 | -3109 |
NUP42 | -2718 |
POM121 | -2295 |
NUP85 | -1717 |
NUP37 | -1424 |
NUP50 | -1242 |
NUP98 | 175 |
NUP62 | 395 |
AAAS | 627 |
RAE1 | 5040 |
SEC13 | 6793 |
NUP58 | 7628 |
NUP214 | 10124 |
Rev-mediated nuclear export of HIV RNA
1013 | |
---|---|
set | Rev-mediated nuclear export of HIV RNA |
setSize | 35 |
pANOVA | 1.17e-05 |
s.dist | -0.428 |
p.adjustANOVA | 0.000193 |
Top enriched genes
GeneID | Gene Rank |
---|---|
NDC1 | -9817 |
NUP35 | -9626 |
NUP88 | -9430 |
NUP107 | -8801 |
SEH1L | -8792 |
NUP160 | -8699 |
RANGAP1 | -8224 |
NUP43 | -7792 |
NUP155 | -7633 |
RAN | -7577 |
NUP188 | -7295 |
NUP205 | -7051 |
RANBP1 | -6221 |
POM121C | -6074 |
NUP133 | -5674 |
NUP54 | -5340 |
NUP153 | -4433 |
NUP210 | -4373 |
XPO1 | -4204 |
TPR | -4127 |
GeneID | Gene Rank |
---|---|
NDC1 | -9817 |
NUP35 | -9626 |
NUP88 | -9430 |
NUP107 | -8801 |
SEH1L | -8792 |
NUP160 | -8699 |
RANGAP1 | -8224 |
NUP43 | -7792 |
NUP155 | -7633 |
RAN | -7577 |
NUP188 | -7295 |
NUP205 | -7051 |
RANBP1 | -6221 |
POM121C | -6074 |
NUP133 | -5674 |
NUP54 | -5340 |
NUP153 | -4433 |
NUP210 | -4373 |
XPO1 | -4204 |
TPR | -4127 |
NUP93 | -3163 |
RANBP2 | -3109 |
RCC1 | -3085 |
NUP42 | -2718 |
POM121 | -2295 |
NUP85 | -1717 |
NUP37 | -1424 |
NUP50 | -1242 |
NUP98 | 175 |
NUP62 | 395 |
AAAS | 627 |
RAE1 | 5040 |
SEC13 | 6793 |
NUP58 | 7628 |
NUP214 | 10124 |
Uptake and function of anthrax toxins
1306 | |
---|---|
set | Uptake and function of anthrax toxins |
setSize | 10 |
pANOVA | 0.0192 |
s.dist | 0.428 |
p.adjustANOVA | 0.0756 |
Top enriched genes
GeneID | Gene Rank |
---|---|
FURIN | 10311 |
MAP2K6 | 10292 |
MAP2K1 | 10244 |
MAP2K3 | 9766 |
PDCD6IP | 8553 |
MAP2K2 | 5079 |
MAP2K4 | 4579 |
MAP2K7 | 1099 |
ANTXR2 | 775 |
CALM1 | -5150 |
GeneID | Gene Rank |
---|---|
FURIN | 10311 |
MAP2K6 | 10292 |
MAP2K1 | 10244 |
MAP2K3 | 9766 |
PDCD6IP | 8553 |
MAP2K2 | 5079 |
MAP2K4 | 4579 |
MAP2K7 | 1099 |
ANTXR2 | 775 |
CALM1 | -5150 |
Detoxification of Reactive Oxygen Species
277 | |
---|---|
set | Detoxification of Reactive Oxygen Species |
setSize | 32 |
pANOVA | 3.05e-05 |
s.dist | 0.426 |
p.adjustANOVA | 0.000433 |
Top enriched genes
GeneID | Gene Rank |
---|---|
NCF2 | 11041 |
NCF4 | 10873 |
GSR | 10772 |
PRDX3 | 10709 |
CYBA | 10617 |
CYBB | 10196 |
P4HB | 9433 |
CAT | 9425 |
GPX3 | 9342 |
PRDX5 | 8681 |
TXN | 8653 |
SOD2 | 8563 |
TXNRD1 | 8216 |
NOX4 | 8004 |
NOX5 | 7998 |
TXNRD2 | 7888 |
NCF1 | 7481 |
ATOX1 | 6597 |
ERO1A | 6518 |
GPX2 | 6305 |
GeneID | Gene Rank |
---|---|
NCF2 | 11041 |
NCF4 | 10873 |
GSR | 10772 |
PRDX3 | 10709 |
CYBA | 10617 |
CYBB | 10196 |
P4HB | 9433 |
CAT | 9425 |
GPX3 | 9342 |
PRDX5 | 8681 |
TXN | 8653 |
SOD2 | 8563 |
TXNRD1 | 8216 |
NOX4 | 8004 |
NOX5 | 7998 |
TXNRD2 | 7888 |
NCF1 | 7481 |
ATOX1 | 6597 |
ERO1A | 6518 |
GPX2 | 6305 |
PRDX1 | 5934 |
TXN2 | 5240 |
GPX1 | 5066 |
ATP7A | 2494 |
CCS | 2233 |
NUDT2 | 1834 |
GSTP1 | 1776 |
PRDX6 | -823 |
PRDX2 | -4140 |
CYCS | -4630 |
SOD1 | -5860 |
GPX7 | -9452 |
G1/S-Specific Transcription
418 | |
---|---|
set | G1/S-Specific Transcription |
setSize | 29 |
pANOVA | 7.21e-05 |
s.dist | -0.426 |
p.adjustANOVA | 0.00091 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RBL2 | -9700 |
POLA1 | -9660 |
TFDP2 | -9444 |
FBXO5 | -9228 |
LIN9 | -8001 |
E2F6 | -7656 |
PCNA | -6841 |
RBL1 | -6718 |
TYMS | -5813 |
RRM2 | -5738 |
CDC45 | -5643 |
CDK1 | -5568 |
LIN52 | -5480 |
CDC6 | -5479 |
E2F5 | -5304 |
ORC1 | -5158 |
RBBP4 | -4658 |
CDT1 | -4032 |
LIN54 | -3805 |
CCNE1 | -2791 |
GeneID | Gene Rank |
---|---|
RBL2 | -9700 |
POLA1 | -9660 |
TFDP2 | -9444 |
FBXO5 | -9228 |
LIN9 | -8001 |
E2F6 | -7656 |
PCNA | -6841 |
RBL1 | -6718 |
TYMS | -5813 |
RRM2 | -5738 |
CDC45 | -5643 |
CDK1 | -5568 |
LIN52 | -5480 |
CDC6 | -5479 |
E2F5 | -5304 |
ORC1 | -5158 |
RBBP4 | -4658 |
CDT1 | -4032 |
LIN54 | -3805 |
CCNE1 | -2791 |
CDC25A | -2547 |
CCNA1 | -2231 |
E2F1 | -108 |
TK1 | 2257 |
HDAC1 | 2347 |
TFDP1 | 4357 |
LIN37 | 5346 |
E2F4 | 5439 |
DHFR | 5520 |
Signal transduction by L1
1072 | |
---|---|
set | Signal transduction by L1 |
setSize | 20 |
pANOVA | 0.00101 |
s.dist | 0.424 |
p.adjustANOVA | 0.00772 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RAC1 | 10907 |
MAPK1 | 10847 |
PAK1 | 10704 |
MAP2K1 | 10244 |
ITGA5 | 10158 |
FGFR1 | 10016 |
MAPK3 | 9636 |
ITGAV | 8115 |
CSNK2A1 | 7984 |
ITGA9 | 7799 |
VAV2 | 7476 |
CSNK2B | 6563 |
NRP1 | 5491 |
MAP2K2 | 5079 |
CSNK2A2 | 4323 |
ITGA2B | 1927 |
L1CAM | -1644 |
ITGB3 | -2871 |
ITGB1 | -4850 |
NCAM1 | -7535 |
GeneID | Gene Rank |
---|---|
RAC1 | 10907 |
MAPK1 | 10847 |
PAK1 | 10704 |
MAP2K1 | 10244 |
ITGA5 | 10158 |
FGFR1 | 10016 |
MAPK3 | 9636 |
ITGAV | 8115 |
CSNK2A1 | 7984 |
ITGA9 | 7799 |
VAV2 | 7476 |
CSNK2B | 6563 |
NRP1 | 5491 |
MAP2K2 | 5079 |
CSNK2A2 | 4323 |
ITGA2B | 1927 |
L1CAM | -1644 |
ITGB3 | -2871 |
ITGB1 | -4850 |
NCAM1 | -7535 |
RHO GTPases Activate NADPH Oxidases
886 | |
---|---|
set | RHO GTPases Activate NADPH Oxidases |
setSize | 21 |
pANOVA | 0.000813 |
s.dist | 0.422 |
p.adjustANOVA | 0.0066 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PRKCD | 11506 |
S100A9 | 11432 |
S100A8 | 11315 |
NCF2 | 11041 |
RAC1 | 10907 |
NCF4 | 10873 |
MAPK1 | 10847 |
CYBA | 10617 |
MAPK14 | 10466 |
CYBB | 10196 |
MAPK3 | 9636 |
NCF1 | 7481 |
PRKCB | 7102 |
RAC2 | 5082 |
PIN1 | 202 |
MAPK11 | -273 |
NOXA1 | -3249 |
PIK3C3 | -3291 |
PIK3R4 | -4411 |
PRKCA | -5667 |
GeneID | Gene Rank |
---|---|
PRKCD | 11506 |
S100A9 | 11432 |
S100A8 | 11315 |
NCF2 | 11041 |
RAC1 | 10907 |
NCF4 | 10873 |
MAPK1 | 10847 |
CYBA | 10617 |
MAPK14 | 10466 |
CYBB | 10196 |
MAPK3 | 9636 |
NCF1 | 7481 |
PRKCB | 7102 |
RAC2 | 5082 |
PIN1 | 202 |
MAPK11 | -273 |
NOXA1 | -3249 |
PIK3C3 | -3291 |
PIK3R4 | -4411 |
PRKCA | -5667 |
PRKCZ | -6483 |
Metabolism of non-coding RNA
644 | |
---|---|
set | Metabolism of non-coding RNA |
setSize | 53 |
pANOVA | 1.11e-07 |
s.dist | -0.421 |
p.adjustANOVA | 2.87e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
NDC1 | -9817 |
GEMIN4 | -9746 |
NUP35 | -9626 |
NUP88 | -9430 |
DDX20 | -9102 |
NUP107 | -8801 |
SEH1L | -8792 |
NUP160 | -8699 |
PHAX | -8612 |
NCBP2 | -8212 |
NUP43 | -7792 |
NUP155 | -7633 |
GEMIN5 | -7299 |
NUP188 | -7295 |
NUP205 | -7051 |
SNRPE | -6979 |
WDR77 | -6973 |
SNRPF | -6725 |
GEMIN8 | -6108 |
POM121C | -6074 |
GeneID | Gene Rank |
---|---|
NDC1 | -9817 |
GEMIN4 | -9746 |
NUP35 | -9626 |
NUP88 | -9430 |
DDX20 | -9102 |
NUP107 | -8801 |
SEH1L | -8792 |
NUP160 | -8699 |
PHAX | -8612 |
NCBP2 | -8212 |
NUP43 | -7792 |
NUP155 | -7633 |
GEMIN5 | -7299 |
NUP188 | -7295 |
NUP205 | -7051 |
SNRPE | -6979 |
WDR77 | -6973 |
SNRPF | -6725 |
GEMIN8 | -6108 |
POM121C | -6074 |
CLNS1A | -5864 |
NUP133 | -5674 |
TGS1 | -5399 |
NUP54 | -5340 |
SNRPD2 | -4757 |
SMN1 | -4719 |
NUP153 | -4433 |
SNRPD3 | -4404 |
NUP210 | -4373 |
TPR | -4127 |
SNRPD1 | -3757 |
SNRPB | -3546 |
NUP93 | -3163 |
RANBP2 | -3109 |
GEMIN6 | -2834 |
NUP42 | -2718 |
POM121 | -2295 |
NUP85 | -1717 |
NUP37 | -1424 |
NUP50 | -1242 |
NCBP1 | -1125 |
GEMIN2 | -805 |
NUP98 | 175 |
NUP62 | 395 |
AAAS | 627 |
PRMT5 | 1768 |
SNRPG | 3835 |
GEMIN7 | 4800 |
SNUPN | 4907 |
RAE1 | 5040 |
SEC13 | 6793 |
NUP58 | 7628 |
NUP214 | 10124 |
snRNP Assembly
1356 | |
---|---|
set | snRNP Assembly |
setSize | 53 |
pANOVA | 1.11e-07 |
s.dist | -0.421 |
p.adjustANOVA | 2.87e-06 |
Top enriched genes
GeneID | Gene Rank |
---|---|
NDC1 | -9817 |
GEMIN4 | -9746 |
NUP35 | -9626 |
NUP88 | -9430 |
DDX20 | -9102 |
NUP107 | -8801 |
SEH1L | -8792 |
NUP160 | -8699 |
PHAX | -8612 |
NCBP2 | -8212 |
NUP43 | -7792 |
NUP155 | -7633 |
GEMIN5 | -7299 |
NUP188 | -7295 |
NUP205 | -7051 |
SNRPE | -6979 |
WDR77 | -6973 |
SNRPF | -6725 |
GEMIN8 | -6108 |
POM121C | -6074 |
GeneID | Gene Rank |
---|---|
NDC1 | -9817 |
GEMIN4 | -9746 |
NUP35 | -9626 |
NUP88 | -9430 |
DDX20 | -9102 |
NUP107 | -8801 |
SEH1L | -8792 |
NUP160 | -8699 |
PHAX | -8612 |
NCBP2 | -8212 |
NUP43 | -7792 |
NUP155 | -7633 |
GEMIN5 | -7299 |
NUP188 | -7295 |
NUP205 | -7051 |
SNRPE | -6979 |
WDR77 | -6973 |
SNRPF | -6725 |
GEMIN8 | -6108 |
POM121C | -6074 |
CLNS1A | -5864 |
NUP133 | -5674 |
TGS1 | -5399 |
NUP54 | -5340 |
SNRPD2 | -4757 |
SMN1 | -4719 |
NUP153 | -4433 |
SNRPD3 | -4404 |
NUP210 | -4373 |
TPR | -4127 |
SNRPD1 | -3757 |
SNRPB | -3546 |
NUP93 | -3163 |
RANBP2 | -3109 |
GEMIN6 | -2834 |
NUP42 | -2718 |
POM121 | -2295 |
NUP85 | -1717 |
NUP37 | -1424 |
NUP50 | -1242 |
NCBP1 | -1125 |
GEMIN2 | -805 |
NUP98 | 175 |
NUP62 | 395 |
AAAS | 627 |
PRMT5 | 1768 |
SNRPG | 3835 |
GEMIN7 | 4800 |
SNUPN | 4907 |
RAE1 | 5040 |
SEC13 | 6793 |
NUP58 | 7628 |
NUP214 | 10124 |
Transcription of E2F targets under negative control by DREAM complex
1249 | |
---|---|
set | Transcription of E2F targets under negative control by DREAM complex |
setSize | 19 |
pANOVA | 0.00151 |
s.dist | -0.42 |
p.adjustANOVA | 0.0102 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RBL2 | -9700 |
TFDP2 | -9444 |
MYC | -9418 |
LIN9 | -8001 |
PCNA | -6841 |
RBL1 | -6718 |
LIN52 | -5480 |
CDC6 | -5479 |
E2F5 | -5304 |
RBBP4 | -4658 |
MAX | -4483 |
TOP2A | -4125 |
LIN54 | -3805 |
CDC25A | -2547 |
E2F1 | -108 |
HDAC1 | 2347 |
TFDP1 | 4357 |
LIN37 | 5346 |
E2F4 | 5439 |
GeneID | Gene Rank |
---|---|
RBL2 | -9700 |
TFDP2 | -9444 |
MYC | -9418 |
LIN9 | -8001 |
PCNA | -6841 |
RBL1 | -6718 |
LIN52 | -5480 |
CDC6 | -5479 |
E2F5 | -5304 |
RBBP4 | -4658 |
MAX | -4483 |
TOP2A | -4125 |
LIN54 | -3805 |
CDC25A | -2547 |
E2F1 | -108 |
HDAC1 | 2347 |
TFDP1 | 4357 |
LIN37 | 5346 |
E2F4 | 5439 |
WNT5A-dependent internalization of FZD4
1324 | |
---|---|
set | WNT5A-dependent internalization of FZD4 |
setSize | 13 |
pANOVA | 0.00874 |
s.dist | 0.42 |
p.adjustANOVA | 0.0434 |
Top enriched genes
GeneID | Gene Rank |
---|---|
AP2A1 | 11707 |
ARRB2 | 11021 |
AP2A2 | 10434 |
AP2S1 | 9504 |
CLTC | 9346 |
CLTB | 8275 |
CLTA | 7680 |
AP2M1 | 7323 |
PRKCB | 7102 |
FZD4 | 3002 |
AP2B1 | -3690 |
DVL2 | -4905 |
PRKCA | -5667 |
GeneID | Gene Rank |
---|---|
AP2A1 | 11707 |
ARRB2 | 11021 |
AP2A2 | 10434 |
AP2S1 | 9504 |
CLTC | 9346 |
CLTB | 8275 |
CLTA | 7680 |
AP2M1 | 7323 |
PRKCB | 7102 |
FZD4 | 3002 |
AP2B1 | -3690 |
DVL2 | -4905 |
PRKCA | -5667 |
RHO GTPases Activate WASPs and WAVEs
888 | |
---|---|
set | RHO GTPases Activate WASPs and WAVEs |
setSize | 35 |
pANOVA | 2.11e-05 |
s.dist | 0.415 |
p.adjustANOVA | 0.000316 |
Top enriched genes
GeneID | Gene Rank |
---|---|
WASF1 | 11510 |
NCKAP1L | 11401 |
BTK | 11379 |
WAS | 11238 |
ARPC1A | 11206 |
CYFIP1 | 11117 |
ARPC1B | 10956 |
GRB2 | 10925 |
RAC1 | 10907 |
MAPK1 | 10847 |
ACTB | 10419 |
WASF2 | 10259 |
ARPC5 | 10048 |
MAPK3 | 9636 |
ARPC3 | 9484 |
ARPC4 | 9223 |
ARPC2 | 9212 |
ACTG1 | 8547 |
NCKAP1 | 7871 |
ABI1 | 7663 |
GeneID | Gene Rank |
---|---|
WASF1 | 11510 |
NCKAP1L | 11401 |
BTK | 11379 |
WAS | 11238 |
ARPC1A | 11206 |
CYFIP1 | 11117 |
ARPC1B | 10956 |
GRB2 | 10925 |
RAC1 | 10907 |
MAPK1 | 10847 |
ACTB | 10419 |
WASF2 | 10259 |
ARPC5 | 10048 |
MAPK3 | 9636 |
ARPC3 | 9484 |
ARPC4 | 9223 |
ARPC2 | 9212 |
ACTG1 | 8547 |
NCKAP1 | 7871 |
ABI1 | 7663 |
ACTR2 | 7352 |
CDC42 | 7337 |
WIPF2 | 6706 |
ACTR3 | 6644 |
ABL1 | 4039 |
BAIAP2 | -1231 |
WASL | -1370 |
BRK1 | -2011 |
PTK2 | -3332 |
WIPF1 | -3530 |
CYFIP2 | -4772 |
WASF3 | -6482 |
NCKIPSD | -6991 |
ABI2 | -7811 |
NCK1 | -8821 |
Polymerase switching on the C-strand of the telomere
835 | |
---|---|
set | Polymerase switching on the C-strand of the telomere |
setSize | 26 |
pANOVA | 0.000249 |
s.dist | -0.415 |
p.adjustANOVA | 0.00245 |
Top enriched genes
GeneID | Gene Rank |
---|---|
POLD2 | -9742 |
POLA1 | -9660 |
STN1 | -9499 |
CHTF18 | -8785 |
RFC3 | -8694 |
PRIM1 | -8268 |
CTC1 | -8006 |
RFC4 | -7736 |
DSCC1 | -7671 |
PCNA | -6841 |
POLA2 | -6222 |
POT1 | -5841 |
PRIM2 | -5653 |
RFC1 | -5493 |
TERF2 | -4926 |
RFC5 | -3986 |
ACD | -3963 |
TERF1 | -3813 |
TERF2IP | -1108 |
CHTF8 | -503 |
GeneID | Gene Rank |
---|---|
POLD2 | -9742 |
POLA1 | -9660 |
STN1 | -9499 |
CHTF18 | -8785 |
RFC3 | -8694 |
PRIM1 | -8268 |
CTC1 | -8006 |
RFC4 | -7736 |
DSCC1 | -7671 |
PCNA | -6841 |
POLA2 | -6222 |
POT1 | -5841 |
PRIM2 | -5653 |
RFC1 | -5493 |
TERF2 | -4926 |
RFC5 | -3986 |
ACD | -3963 |
TERF1 | -3813 |
TERF2IP | -1108 |
CHTF8 | -503 |
POLD1 | 646 |
TEN1 | 1027 |
RFC2 | 4835 |
TINF2 | 5948 |
POLD4 | 10344 |
POLD3 | 11274 |
Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
345 | |
---|---|
set | Erythropoietin activates Phosphoinositide-3-kinase (PI3K) |
setSize | 11 |
pANOVA | 0.0172 |
s.dist | 0.415 |
p.adjustANOVA | 0.0707 |
Top enriched genes
GeneID | Gene Rank |
---|---|
LYN | 10893 |
EPOR | 10373 |
GAB1 | 9727 |
IRS2 | 9312 |
PIK3R5 | 6963 |
PIK3CD | 6507 |
PIK3CG | 6350 |
PIK3CB | 6109 |
JAK2 | 3783 |
PIK3CA | -1131 |
PIK3R1 | -9306 |
GeneID | Gene Rank |
---|---|
LYN | 10893 |
EPOR | 10373 |
GAB1 | 9727 |
IRS2 | 9312 |
PIK3R5 | 6963 |
PIK3CD | 6507 |
PIK3CG | 6350 |
PIK3CB | 6109 |
JAK2 | 3783 |
PIK3CA | -1131 |
PIK3R1 | -9306 |
Nuclear import of Rev protein
752 | |
---|---|
set | Nuclear import of Rev protein |
setSize | 34 |
pANOVA | 2.89e-05 |
s.dist | -0.414 |
p.adjustANOVA | 0.000414 |
Top enriched genes
GeneID | Gene Rank |
---|---|
NPM1 | -9836 |
NDC1 | -9817 |
NUP35 | -9626 |
NUP88 | -9430 |
NUP107 | -8801 |
SEH1L | -8792 |
NUP160 | -8699 |
NUP43 | -7792 |
NUP155 | -7633 |
RAN | -7577 |
NUP188 | -7295 |
NUP205 | -7051 |
POM121C | -6074 |
NUP133 | -5674 |
NUP54 | -5340 |
NUP153 | -4433 |
NUP210 | -4373 |
TPR | -4127 |
NUP93 | -3163 |
RANBP2 | -3109 |
GeneID | Gene Rank |
---|---|
NPM1 | -9836 |
NDC1 | -9817 |
NUP35 | -9626 |
NUP88 | -9430 |
NUP107 | -8801 |
SEH1L | -8792 |
NUP160 | -8699 |
NUP43 | -7792 |
NUP155 | -7633 |
RAN | -7577 |
NUP188 | -7295 |
NUP205 | -7051 |
POM121C | -6074 |
NUP133 | -5674 |
NUP54 | -5340 |
NUP153 | -4433 |
NUP210 | -4373 |
TPR | -4127 |
NUP93 | -3163 |
RANBP2 | -3109 |
RCC1 | -3085 |
NUP42 | -2718 |
POM121 | -2295 |
NUP85 | -1717 |
NUP37 | -1424 |
NUP50 | -1242 |
KPNB1 | -109 |
NUP98 | 175 |
NUP62 | 395 |
AAAS | 627 |
RAE1 | 5040 |
SEC13 | 6793 |
NUP58 | 7628 |
NUP214 | 10124 |
Platelet sensitization by LDL
832 | |
---|---|
set | Platelet sensitization by LDL |
setSize | 16 |
pANOVA | 0.0042 |
s.dist | 0.413 |
p.adjustANOVA | 0.0236 |
Top enriched genes
GeneID | Gene Rank |
---|---|
FGR | 11610 |
PECAM1 | 11314 |
PTPN6 | 11254 |
PPP2R5B | 10579 |
MAPK14 | 10466 |
LRP8 | 10317 |
PLA2G4A | 9943 |
PPP2R5A | 7512 |
PPP2CB | 5377 |
PPP2CA | 4882 |
PPP2R1A | 4593 |
PTPN11 | 2859 |
PPP2R5D | 2555 |
PPP2R1B | -2904 |
PPP2R5E | -6283 |
PPP2R5C | -7679 |
GeneID | Gene Rank |
---|---|
FGR | 11610 |
PECAM1 | 11314 |
PTPN6 | 11254 |
PPP2R5B | 10579 |
MAPK14 | 10466 |
LRP8 | 10317 |
PLA2G4A | 9943 |
PPP2R5A | 7512 |
PPP2CB | 5377 |
PPP2CA | 4882 |
PPP2R1A | 4593 |
PTPN11 | 2859 |
PPP2R5D | 2555 |
PPP2R1B | -2904 |
PPP2R5E | -6283 |
PPP2R5C | -7679 |
NEP/NS2 Interacts with the Cellular Export Machinery
695 | |
---|---|
set | NEP/NS2 Interacts with the Cellular Export Machinery |
setSize | 32 |
pANOVA | 6.13e-05 |
s.dist | -0.409 |
p.adjustANOVA | 0.000811 |
Top enriched genes
GeneID | Gene Rank |
---|---|
NDC1 | -9817 |
NUP35 | -9626 |
NUP88 | -9430 |
NUP107 | -8801 |
SEH1L | -8792 |
NUP160 | -8699 |
NUP43 | -7792 |
NUP155 | -7633 |
RAN | -7577 |
NUP188 | -7295 |
NUP205 | -7051 |
POM121C | -6074 |
NUP133 | -5674 |
NUP54 | -5340 |
NUP153 | -4433 |
NUP210 | -4373 |
XPO1 | -4204 |
TPR | -4127 |
NUP93 | -3163 |
RANBP2 | -3109 |
GeneID | Gene Rank |
---|---|
NDC1 | -9817 |
NUP35 | -9626 |
NUP88 | -9430 |
NUP107 | -8801 |
SEH1L | -8792 |
NUP160 | -8699 |
NUP43 | -7792 |
NUP155 | -7633 |
RAN | -7577 |
NUP188 | -7295 |
NUP205 | -7051 |
POM121C | -6074 |
NUP133 | -5674 |
NUP54 | -5340 |
NUP153 | -4433 |
NUP210 | -4373 |
XPO1 | -4204 |
TPR | -4127 |
NUP93 | -3163 |
RANBP2 | -3109 |
NUP42 | -2718 |
POM121 | -2295 |
NUP85 | -1717 |
NUP37 | -1424 |
NUP50 | -1242 |
NUP98 | 175 |
NUP62 | 395 |
AAAS | 627 |
RAE1 | 5040 |
SEC13 | 6793 |
NUP58 | 7628 |
NUP214 | 10124 |
Hyaluronan metabolism
503 | |
---|---|
set | Hyaluronan metabolism |
setSize | 15 |
pANOVA | 0.00674 |
s.dist | 0.404 |
p.adjustANOVA | 0.0351 |
Top enriched genes
GeneID | Gene Rank |
---|---|
HYAL2 | 11702 |
SLC9A1 | 11489 |
GUSB | 11435 |
LYVE1 | 10683 |
CHP1 | 9397 |
HYAL1 | 8617 |
CD44 | 8470 |
HEXB | 6925 |
STAB2 | 5526 |
ABCC5 | 1819 |
HYAL3 | 304 |
HAS3 | 259 |
HEXA | -442 |
CEMIP | -3222 |
HMMR | -3479 |
GeneID | Gene Rank |
---|---|
HYAL2 | 11702 |
SLC9A1 | 11489 |
GUSB | 11435 |
LYVE1 | 10683 |
CHP1 | 9397 |
HYAL1 | 8617 |
CD44 | 8470 |
HEXB | 6925 |
STAB2 | 5526 |
ABCC5 | 1819 |
HYAL3 | 304 |
HAS3 | 259 |
HEXA | -442 |
CEMIP | -3222 |
HMMR | -3479 |
Translesion synthesis by POLI
1273 | |
---|---|
set | Translesion synthesis by POLI |
setSize | 17 |
pANOVA | 0.00441 |
s.dist | -0.399 |
p.adjustANOVA | 0.0248 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPA1 | -9657 |
RPS27A | -8722 |
RFC3 | -8694 |
RPA3 | -8069 |
RFC4 | -7736 |
REV1 | -7246 |
PCNA | -6841 |
RFC1 | -5493 |
RPA2 | -4620 |
REV3L | -4275 |
RFC5 | -3986 |
UBB | -2442 |
UBA52 | -1437 |
POLI | 2898 |
RFC2 | 4835 |
UBC | 4874 |
MAD2L2 | 9187 |
GeneID | Gene Rank |
---|---|
RPA1 | -9657 |
RPS27A | -8722 |
RFC3 | -8694 |
RPA3 | -8069 |
RFC4 | -7736 |
REV1 | -7246 |
PCNA | -6841 |
RFC1 | -5493 |
RPA2 | -4620 |
REV3L | -4275 |
RFC5 | -3986 |
UBB | -2442 |
UBA52 | -1437 |
POLI | 2898 |
RFC2 | 4835 |
UBC | 4874 |
MAD2L2 | 9187 |
Translation
1268 | |
---|---|
set | Translation |
setSize | 295 |
pANOVA | 4.36e-32 |
s.dist | -0.398 |
p.adjustANOVA | 9.91e-30 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL3 | -9701 |
RPS2 | -9635 |
RPL14 | -9390 |
EEF1A1 | -9389 |
RPL23A | -9382 |
RPL5 | -9359 |
EIF4A2 | -9355 |
NARS2 | -9337 |
GFM1 | -9259 |
RPS3A | -9257 |
MRPS30 | -9238 |
MRPS6 | -9227 |
RPS6 | -9170 |
RPL7 | -9134 |
EEF1B2 | -9090 |
RPL4 | -9065 |
EARS2 | -8978 |
EEF1G | -8961 |
RPL22 | -8915 |
N6AMT1 | -8889 |
GeneID | Gene Rank |
---|---|
RPL3 | -9701 |
RPS2 | -9635 |
RPL14 | -9390 |
EEF1A1 | -9389 |
RPL23A | -9382 |
RPL5 | -9359 |
EIF4A2 | -9355 |
NARS2 | -9337 |
GFM1 | -9259 |
RPS3A | -9257 |
MRPS30 | -9238 |
MRPS6 | -9227 |
RPS6 | -9170 |
RPL7 | -9134 |
EEF1B2 | -9090 |
RPL4 | -9065 |
EARS2 | -8978 |
EEF1G | -8961 |
RPL22 | -8915 |
N6AMT1 | -8889 |
LARS1 | -8879 |
EIF3B | -8874 |
MRPS33 | -8868 |
RPS3 | -8856 |
RPS25 | -8832 |
MRPL50 | -8779 |
RPL21 | -8773 |
RPS27A | -8722 |
IARS1 | -8710 |
RPS5 | -8698 |
RPLP0 | -8691 |
RPL12 | -8689 |
RPL13A | -8688 |
EIF3E | -8600 |
SRPRB | -8515 |
FARS2 | -8512 |
RPL6 | -8498 |
RPL34 | -8489 |
RPS20 | -8476 |
RPL17 | -8462 |
RPL27A | -8420 |
RPS12 | -8401 |
EIF1AX | -8394 |
MRPS18B | -8387 |
MRPS27 | -8372 |
RPS14 | -8337 |
GSPT2 | -8336 |
RPS23 | -8334 |
EIF4B | -8328 |
RPL10 | -8318 |
LARS2 | -8305 |
RPS27 | -8260 |
RPLP2 | -8255 |
RPL36A | -8130 |
MARS2 | -8117 |
RPS7 | -8047 |
RPL35A | -8046 |
RPL10A | -7989 |
RPL29 | -7954 |
MRPL17 | -7946 |
RPL11 | -7928 |
RPL32 | -7914 |
RPS15A | -7912 |
TRAM1 | -7911 |
RPL22L1 | -7828 |
MRPS25 | -7801 |
RPL30 | -7783 |
RPL18 | -7781 |
MRPL46 | -7776 |
EIF3L | -7766 |
RPL35 | -7710 |
AARS2 | -7669 |
RPL26 | -7648 |
KARS1 | -7645 |
RPS4X | -7636 |
RPS10 | -7629 |
RPL24 | -7626 |
FARSB | -7620 |
RPS16 | -7617 |
RPL18A | -7609 |
WARS2 | -7547 |
RPL31 | -7521 |
MRPS17 | -7515 |
MRPL49 | -7488 |
RPL9 | -7451 |
AARS1 | -7422 |
RPL15 | -7380 |
RPS13 | -7375 |
MRPL24 | -7374 |
RPL7A | -7296 |
RPS18 | -7288 |
MRPL48 | -7205 |
RPS8 | -7161 |
RPS17 | -7134 |
EEF2 | -7073 |
RPL19 | -7006 |
RPL23 | -6933 |
EPRS1 | -6849 |
RPS29 | -6791 |
MRPL3 | -6766 |
DARS1 | -6758 |
RPS11 | -6742 |
RPS21 | -6706 |
RPL37 | -6660 |
EEF1A1P5 | -6596 |
RPL38 | -6589 |
GSPT1 | -6576 |
MRPL38 | -6536 |
MT-RNR1 | -6484 |
MRPL1 | -6477 |
MRPS9 | -6468 |
MRPS14 | -6456 |
RPS28 | -6429 |
SARS1 | -6425 |
RPL36 | -6343 |
MRPL35 | -6300 |
RPL8 | -6274 |
MRPL45 | -6248 |
MRPS2 | -6123 |
RPL27 | -6068 |
RPL41 | -6065 |
SARS2 | -6041 |
EIF3J | -6001 |
MRPL9 | -5999 |
DAP3 | -5995 |
EIF5B | -5931 |
EIF3H | -5894 |
RPL39 | -5790 |
EIF3M | -5620 |
RPS19 | -5616 |
MRPL32 | -5558 |
RPL13 | -5550 |
RPS26 | -5524 |
PPA1 | -5482 |
RPS15 | -5342 |
RPS24 | -5310 |
MRPL42 | -5308 |
SEC11C | -5303 |
MRPL54 | -5211 |
AIMP1 | -5088 |
MRPL11 | -5071 |
MRPS7 | -5007 |
EEF1D | -4995 |
EIF2B3 | -4898 |
SRP72 | -4824 |
HARS1 | -4780 |
RPL37A | -4774 |
IARS2 | -4691 |
PTCD3 | -4586 |
RPSA | -4559 |
MRPL14 | -4414 |
SRP9 | -4398 |
MRPL39 | -4366 |
MRPS12 | -4356 |
VARS2 | -4343 |
EIF3D | -4337 |
RPL36AL | -4148 |
MRPL30 | -4147 |
MRPS31 | -4116 |
MRPL19 | -4110 |
MRPS28 | -3921 |
MRPL34 | -3892 |
RPLP1 | -3887 |
EIF3C | -3750 |
EIF3F | -3748 |
PARS2 | -3729 |
MRPL43 | -3700 |
MRPL55 | -3601 |
PABPC1 | -3482 |
TSFM | -3472 |
MRPL12 | -3417 |
MRPL15 | -3362 |
EIF2S1 | -3350 |
MRPS10 | -3348 |
SEC61A2 | -3262 |
QARS1 | -3062 |
MRPS35 | -3044 |
MRPL41 | -2920 |
PPA2 | -2874 |
MRPS21 | -2793 |
EIF3I | -2671 |
SSR1 | -2645 |
AIMP2 | -2623 |
MRPL57 | -2601 |
YARS2 | -2577 |
SRP68 | -2562 |
SPCS2 | -2449 |
EIF2B5 | -2425 |
MRRF | -2404 |
SSR2 | -2362 |
SEC61G | -2328 |
MRPS22 | -2326 |
MRPL37 | -2251 |
MRPS26 | -2022 |
SPCS1 | -2007 |
RPL28 | -1952 |
EEF1A2 | -1947 |
SPCS3 | -1816 |
VARS1 | -1755 |
GADD45GIP1 | -1746 |
EIF3G | -1676 |
MRPS23 | -1564 |
EIF3A | -1537 |
FARSA | -1474 |
MRPL47 | -1448 |
UBA52 | -1437 |
RARS1 | -1110 |
FAU | -1029 |
MRPL58 | -1009 |
MRPS34 | -978 |
MRPL2 | -971 |
TARS1 | -811 |
MRPL27 | -697 |
SSR3 | -664 |
SRP19 | -483 |
EIF5 | -416 |
TRMT112 | -370 |
GFM2 | -362 |
MRPS16 | -360 |
EIF3K | -298 |
MT-RNR2 | -141 |
RARS2 | -78 |
RPL39L | -69 |
NARS1 | -55 |
MTFMT | 190 |
MRPL18 | 194 |
MRPL40 | 273 |
EIF2S2 | 297 |
MRPS18C | 334 |
MTIF2 | 475 |
MRPS15 | 1207 |
MRPL21 | 1215 |
EIF2S3 | 1308 |
MRPS36 | 1368 |
RPS4Y1 | 1461 |
EIF2B1 | 1607 |
MRPL13 | 1696 |
MRPL20 | 1881 |
MRPL22 | 1912 |
SSR4 | 1961 |
EIF4E | 2104 |
EEF1E1 | 2209 |
MRPL44 | 2241 |
MRPL36 | 2321 |
YARS1 | 2340 |
RPS9 | 2392 |
MRPS18A | 2478 |
MRPS24 | 2522 |
MRPL4 | 2604 |
RPS27L | 2784 |
DARS2 | 2882 |
ERAL1 | 3081 |
MRPL16 | 3317 |
SEC61A1 | 3976 |
MTIF3 | 3990 |
RPN1 | 4038 |
MRPL51 | 4065 |
ETF1 | 4300 |
OXA1L | 4368 |
MTRF1L | 4426 |
APEH | 4454 |
MT-TV | 4515 |
SEC61B | 4523 |
MRPS11 | 4616 |
MRPL33 | 4926 |
SRP14 | 5005 |
HARS2 | 5027 |
EIF2B2 | 5069 |
GARS1 | 5314 |
MRPL10 | 5324 |
EIF4EBP1 | 5335 |
TARS2 | 5460 |
AURKAIP1 | 5462 |
SRPRA | 5496 |
RPL3L | 5700 |
MRPS5 | 5888 |
EIF4A1 | 5928 |
CHCHD1 | 6111 |
RPL26L1 | 6187 |
TUFM | 6200 |
SRP54 | 6468 |
EIF2B4 | 6686 |
MRPL23 | 6696 |
RPN2 | 7108 |
SEC11A | 7174 |
WARS1 | 7325 |
EIF4H | 7435 |
MRPL53 | 7456 |
DDOST | 7465 |
MRPL52 | 8490 |
MARS1 | 9700 |
CARS2 | 9768 |
EIF4G1 | 9922 |
MRPL28 | 10313 |
CARS1 | 10957 |
Processive synthesis on the C-strand of the telomere
858 | |
---|---|
set | Processive synthesis on the C-strand of the telomere |
setSize | 19 |
pANOVA | 0.00278 |
s.dist | -0.396 |
p.adjustANOVA | 0.017 |
Top enriched genes
GeneID | Gene Rank |
---|---|
POLD2 | -9742 |
RPA1 | -9657 |
WRN | -9097 |
LIG1 | -8618 |
RPA3 | -8069 |
FEN1 | -7122 |
PCNA | -6841 |
POT1 | -5841 |
TERF2 | -4926 |
RPA2 | -4620 |
BLM | -4432 |
DNA2 | -4017 |
ACD | -3963 |
TERF1 | -3813 |
TERF2IP | -1108 |
POLD1 | 646 |
TINF2 | 5948 |
POLD4 | 10344 |
POLD3 | 11274 |
GeneID | Gene Rank |
---|---|
POLD2 | -9742 |
RPA1 | -9657 |
WRN | -9097 |
LIG1 | -8618 |
RPA3 | -8069 |
FEN1 | -7122 |
PCNA | -6841 |
POT1 | -5841 |
TERF2 | -4926 |
RPA2 | -4620 |
BLM | -4432 |
DNA2 | -4017 |
ACD | -3963 |
TERF1 | -3813 |
TERF2IP | -1108 |
POLD1 | 646 |
TINF2 | 5948 |
POLD4 | 10344 |
POLD3 | 11274 |
Pre-NOTCH Processing in Golgi
846 | |
---|---|
set | Pre-NOTCH Processing in Golgi |
setSize | 18 |
pANOVA | 0.00381 |
s.dist | 0.394 |
p.adjustANOVA | 0.022 |
Top enriched genes
GeneID | Gene Rank |
---|---|
NOTCH3 | 11733 |
NOTCH4 | 11483 |
FURIN | 10311 |
ATP2A2 | 9686 |
ATP2A1 | 8605 |
NOTCH2 | 8499 |
ST3GAL4 | 8130 |
RAB6A | 7579 |
NOTCH1 | 6982 |
LFNG | 6750 |
B4GALT1 | 5109 |
SEL1L | 4716 |
RFNG | 4234 |
ST3GAL6 | 3540 |
TMED2 | 965 |
ATP2A3 | -2610 |
ST3GAL3 | -5182 |
MFNG | -7131 |
GeneID | Gene Rank |
---|---|
NOTCH3 | 11733 |
NOTCH4 | 11483 |
FURIN | 10311 |
ATP2A2 | 9686 |
ATP2A1 | 8605 |
NOTCH2 | 8499 |
ST3GAL4 | 8130 |
RAB6A | 7579 |
NOTCH1 | 6982 |
LFNG | 6750 |
B4GALT1 | 5109 |
SEL1L | 4716 |
RFNG | 4234 |
ST3GAL6 | 3540 |
TMED2 | 965 |
ATP2A3 | -2610 |
ST3GAL3 | -5182 |
MFNG | -7131 |
G0 and Early G1
414 | |
---|---|
set | G0 and Early G1 |
setSize | 27 |
pANOVA | 0.000438 |
s.dist | -0.391 |
p.adjustANOVA | 0.00378 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RBL2 | -9700 |
TFDP2 | -9444 |
MYC | -9418 |
LIN9 | -8001 |
PCNA | -6841 |
RBL1 | -6718 |
CDK1 | -5568 |
LIN52 | -5480 |
CDC6 | -5479 |
E2F5 | -5304 |
MYBL2 | -4826 |
RBBP4 | -4658 |
MAX | -4483 |
TOP2A | -4125 |
LIN54 | -3805 |
CDK2 | -3694 |
DYRK1A | -3079 |
CCNE1 | -2791 |
CDC25A | -2547 |
CCNA1 | -2231 |
GeneID | Gene Rank |
---|---|
RBL2 | -9700 |
TFDP2 | -9444 |
MYC | -9418 |
LIN9 | -8001 |
PCNA | -6841 |
RBL1 | -6718 |
CDK1 | -5568 |
LIN52 | -5480 |
CDC6 | -5479 |
E2F5 | -5304 |
MYBL2 | -4826 |
RBBP4 | -4658 |
MAX | -4483 |
TOP2A | -4125 |
LIN54 | -3805 |
CDK2 | -3694 |
DYRK1A | -3079 |
CCNE1 | -2791 |
CDC25A | -2547 |
CCNA1 | -2231 |
CCNA2 | -1727 |
E2F1 | -108 |
HDAC1 | 2347 |
CCNE2 | 3704 |
TFDP1 | 4357 |
LIN37 | 5346 |
E2F4 | 5439 |
PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases
800 | |
---|---|
set | PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases |
setSize | 13 |
pANOVA | 0.015 |
s.dist | 0.39 |
p.adjustANOVA | 0.0635 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RAC1 | 10907 |
ELMO2 | 9846 |
CRK | 9373 |
PTK6 | 8980 |
RHOA | 8752 |
DOCK1 | 8538 |
PXN | 8537 |
RASA1 | 6726 |
KRAS | 3113 |
NRAS | 1826 |
ELMO1 | -1412 |
HRAS | -3116 |
ARHGAP35 | -5181 |
GeneID | Gene Rank |
---|---|
RAC1 | 10907 |
ELMO2 | 9846 |
CRK | 9373 |
PTK6 | 8980 |
RHOA | 8752 |
DOCK1 | 8538 |
PXN | 8537 |
RASA1 | 6726 |
KRAS | 3113 |
NRAS | 1826 |
ELMO1 | -1412 |
HRAS | -3116 |
ARHGAP35 | -5181 |
Transport of Ribonucleoproteins into the Host Nucleus
1284 | |
---|---|
set | Transport of Ribonucleoproteins into the Host Nucleus |
setSize | 32 |
pANOVA | 0.000146 |
s.dist | -0.388 |
p.adjustANOVA | 0.00167 |
Top enriched genes
GeneID | Gene Rank |
---|---|
NDC1 | -9817 |
NUP35 | -9626 |
NUP88 | -9430 |
NUP107 | -8801 |
SEH1L | -8792 |
NUP160 | -8699 |
NUP43 | -7792 |
NUP155 | -7633 |
NUP188 | -7295 |
NUP205 | -7051 |
POM121C | -6074 |
NUP133 | -5674 |
NUP54 | -5340 |
NUP153 | -4433 |
NUP210 | -4373 |
KPNA1 | -4278 |
TPR | -4127 |
NUP93 | -3163 |
RANBP2 | -3109 |
NUP42 | -2718 |
GeneID | Gene Rank |
---|---|
NDC1 | -9817 |
NUP35 | -9626 |
NUP88 | -9430 |
NUP107 | -8801 |
SEH1L | -8792 |
NUP160 | -8699 |
NUP43 | -7792 |
NUP155 | -7633 |
NUP188 | -7295 |
NUP205 | -7051 |
POM121C | -6074 |
NUP133 | -5674 |
NUP54 | -5340 |
NUP153 | -4433 |
NUP210 | -4373 |
KPNA1 | -4278 |
TPR | -4127 |
NUP93 | -3163 |
RANBP2 | -3109 |
NUP42 | -2718 |
POM121 | -2295 |
NUP85 | -1717 |
NUP37 | -1424 |
NUP50 | -1242 |
KPNB1 | -109 |
NUP98 | 175 |
NUP62 | 395 |
AAAS | 627 |
RAE1 | 5040 |
SEC13 | 6793 |
NUP58 | 7628 |
NUP214 | 10124 |
Classical antibody-mediated complement activation
188 | |
---|---|
set | Classical antibody-mediated complement activation |
setSize | 69 |
pANOVA | 2.98e-08 |
s.dist | -0.386 |
p.adjustANOVA | 9.02e-07 |
Top enriched genes
GeneID | Gene Rank |
---|---|
IGKV3-11 | -9443 |
IGLV6-57 | -8979 |
IGLV5-45 | -8955 |
IGLV2-18 | -8778 |
IGLV2-14 | -8599 |
IGHV3-33 | -8574 |
IGKV1-16 | -8350 |
IGLV3-21 | -8327 |
IGLV3-1 | -8150 |
IGKV3-15 | -7683 |
IGHV1-69 | -7589 |
IGLV3-12 | -7540 |
IGLV2-8 | -7468 |
IGKV1-5 | -7365 |
IGLV3-19 | -7358 |
IGKV4-1 | -7302 |
IGLV7-46 | -6955 |
IGHV3-53 | -6692 |
IGHV4-34 | -6614 |
IGHV2-5 | -6583 |
GeneID | Gene Rank |
---|---|
IGKV3-11 | -9443 |
IGLV6-57 | -8979 |
IGLV5-45 | -8955 |
IGLV2-18 | -8778 |
IGLV2-14 | -8599 |
IGHV3-33 | -8574 |
IGKV1-16 | -8350 |
IGLV3-21 | -8327 |
IGLV3-1 | -8150 |
IGKV3-15 | -7683 |
IGHV1-69 | -7589 |
IGLV3-12 | -7540 |
IGLV2-8 | -7468 |
IGKV1-5 | -7365 |
IGLV3-19 | -7358 |
IGKV4-1 | -7302 |
IGLV7-46 | -6955 |
IGHV3-53 | -6692 |
IGHV4-34 | -6614 |
IGHV2-5 | -6583 |
IGHV3-48 | -5881 |
IGLC7 | -5764 |
IGLV3-27 | -5637 |
IGHV3-23 | -5636 |
IGLV8-61 | -5601 |
IGHV1-2 | -5526 |
IGLV1-51 | -5296 |
IGKC | -5232 |
IGHV3-7 | -5228 |
IGLC2 | -5138 |
IGKV3-20 | -5082 |
IGKV1-33 | -4953 |
IGHV4-39 | -4884 |
IGHV3-30 | -4685 |
IGLV1-47 | -4485 |
IGKV1-12 | -4392 |
IGKV2-28 | -4281 |
IGLC1 | -4280 |
IGHV2-70 | -4223 |
IGHG3 | -4128 |
IGHV3-11 | -3626 |
IGHV1-46 | -3558 |
IGLV4-69 | -3305 |
IGHG2 | -3113 |
IGLV1-40 | -3024 |
IGKV2-30 | -2958 |
IGKV1-17 | -2929 |
IGHV4-59 | -2340 |
IGLV1-36 | -2214 |
IGLV3-25 | -1935 |
IGHV3-13 | -1600 |
IGHG1 | -1504 |
IGLV1-44 | -1090 |
IGHG4 | -760 |
IGKV2D-28 | -728 |
IGLC3 | -403 |
IGKV3D-20 | -305 |
IGLV10-54 | -276 |
IGLV2-23 | 1244 |
C1S | 2813 |
IGKV5-2 | 3051 |
IGLV2-11 | 3601 |
IGKV1D-39 | 3771 |
C1R | 4413 |
IGLV7-43 | 7123 |
IGKV1-39 | 9771 |
C1QA | 11453 |
C1QC | 11693 |
C1QB | 11723 |
Scavenging of heme from plasma
1056 | |
---|---|
set | Scavenging of heme from plasma |
setSize | 71 |
pANOVA | 2.01e-08 |
s.dist | -0.385 |
p.adjustANOVA | 6.23e-07 |
Top enriched genes
GeneID | Gene Rank |
---|---|
IGKV3-11 | -9443 |
IGLV6-57 | -8979 |
IGLV5-45 | -8955 |
IGLV2-18 | -8778 |
IGLV2-14 | -8599 |
IGHV3-33 | -8574 |
IGKV1-16 | -8350 |
IGLV3-21 | -8327 |
IGLV3-1 | -8150 |
IGKV3-15 | -7683 |
JCHAIN | -7676 |
IGHV1-69 | -7589 |
IGLV3-12 | -7540 |
IGLV2-8 | -7468 |
IGKV1-5 | -7365 |
IGLV3-19 | -7358 |
IGKV4-1 | -7302 |
IGLV7-46 | -6955 |
IGHV3-53 | -6692 |
IGHV4-34 | -6614 |
GeneID | Gene Rank |
---|---|
IGKV3-11 | -9443 |
IGLV6-57 | -8979 |
IGLV5-45 | -8955 |
IGLV2-18 | -8778 |
IGLV2-14 | -8599 |
IGHV3-33 | -8574 |
IGKV1-16 | -8350 |
IGLV3-21 | -8327 |
IGLV3-1 | -8150 |
IGKV3-15 | -7683 |
JCHAIN | -7676 |
IGHV1-69 | -7589 |
IGLV3-12 | -7540 |
IGLV2-8 | -7468 |
IGKV1-5 | -7365 |
IGLV3-19 | -7358 |
IGKV4-1 | -7302 |
IGLV7-46 | -6955 |
IGHV3-53 | -6692 |
IGHV4-34 | -6614 |
IGHV2-5 | -6583 |
IGHV3-48 | -5881 |
IGLC7 | -5764 |
IGLV3-27 | -5637 |
IGHV3-23 | -5636 |
IGLV8-61 | -5601 |
IGHV1-2 | -5526 |
IGLV1-51 | -5296 |
IGHA1 | -5247 |
IGKC | -5232 |
IGHV3-7 | -5228 |
IGLC2 | -5138 |
IGKV3-20 | -5082 |
IGKV1-33 | -4953 |
IGHV4-39 | -4884 |
IGHV3-30 | -4685 |
IGLV1-47 | -4485 |
IGKV1-12 | -4392 |
IGKV2-28 | -4281 |
IGLC1 | -4280 |
IGHV2-70 | -4223 |
IGHV3-11 | -3626 |
IGHV1-46 | -3558 |
IGLV4-69 | -3305 |
IGLV1-40 | -3024 |
IGKV2-30 | -2958 |
IGKV1-17 | -2929 |
HPX | -2463 |
IGHV4-59 | -2340 |
IGLV1-36 | -2214 |
IGHA2 | -2084 |
IGLV3-25 | -1935 |
IGHV3-13 | -1600 |
IGLV1-44 | -1090 |
HBA1 | -867 |
IGKV2D-28 | -728 |
IGLC3 | -403 |
IGKV3D-20 | -305 |
IGLV10-54 | -276 |
HBB | -79 |
IGLV2-23 | 1244 |
APOL1 | 1736 |
IGKV5-2 | 3051 |
IGLV2-11 | 3601 |
IGKV1D-39 | 3771 |
IGLV7-43 | 7123 |
ALB | 9450 |
IGKV1-39 | 9771 |
LRP1 | 11120 |
CD163 | 11297 |
HP | 11572 |
Leading Strand Synthesis
595 | |
---|---|
set | Leading Strand Synthesis |
setSize | 14 |
pANOVA | 0.0126 |
s.dist | -0.385 |
p.adjustANOVA | 0.0558 |
Top enriched genes
GeneID | Gene Rank |
---|---|
POLD2 | -9742 |
POLA1 | -9660 |
RFC3 | -8694 |
PRIM1 | -8268 |
RFC4 | -7736 |
PCNA | -6841 |
POLA2 | -6222 |
PRIM2 | -5653 |
RFC1 | -5493 |
RFC5 | -3986 |
POLD1 | 646 |
RFC2 | 4835 |
POLD4 | 10344 |
POLD3 | 11274 |
GeneID | Gene Rank |
---|---|
POLD2 | -9742 |
POLA1 | -9660 |
RFC3 | -8694 |
PRIM1 | -8268 |
RFC4 | -7736 |
PCNA | -6841 |
POLA2 | -6222 |
PRIM2 | -5653 |
RFC1 | -5493 |
RFC5 | -3986 |
POLD1 | 646 |
RFC2 | 4835 |
POLD4 | 10344 |
POLD3 | 11274 |
Here is the session info with all the versions of packages used.
sessionInfo()
## R version 4.0.3 (2020-10-10)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 20.04.2 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.9.0
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.9.0
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## attached base packages:
## [1] parallel stats4 stats graphics grDevices utils datasets
## [8] methods base
##
## other attached packages:
## [1] pkgload_1.2.0 GGally_2.1.1
## [3] beeswarm_0.3.1 gtools_3.8.2
## [5] echarts4r_0.4.0 topconfects_1.6.0
## [7] limma_3.46.0 eulerr_6.1.0
## [9] mitch_1.2.2 MASS_7.3-53.1
## [11] fgsea_1.16.0 gplots_3.1.1
## [13] DESeq2_1.30.0 SummarizedExperiment_1.20.0
## [15] Biobase_2.50.0 MatrixGenerics_1.2.0
## [17] matrixStats_0.58.0 GenomicRanges_1.42.0
## [19] GenomeInfoDb_1.26.0 IRanges_2.24.0
## [21] S4Vectors_0.28.0 BiocGenerics_0.36.0
## [23] reshape2_1.4.4 forcats_0.5.1
## [25] stringr_1.4.0 dplyr_1.0.5
## [27] purrr_0.3.4 readr_1.4.0
## [29] tidyr_1.1.3 tibble_3.1.0
## [31] ggplot2_3.3.3 tidyverse_1.3.0
## [33] zoo_1.8-9
##
## loaded via a namespace (and not attached):
## [1] colorspace_2.0-0 ellipsis_0.3.1 rprojroot_2.0.2
## [4] XVector_0.30.0 fs_1.5.0 rstudioapi_0.13
## [7] farver_2.1.0 bit64_4.0.5 AnnotationDbi_1.52.0
## [10] fansi_0.4.2 lubridate_1.7.10 xml2_1.3.2
## [13] splines_4.0.3 cachem_1.0.4 geneplotter_1.68.0
## [16] knitr_1.31 polyclip_1.10-0 jsonlite_1.7.2
## [19] broom_0.7.5 annotate_1.68.0 dbplyr_2.1.0
## [22] shiny_1.6.0 compiler_4.0.3 httr_1.4.2
## [25] backports_1.2.1 assertthat_0.2.1 Matrix_1.3-2
## [28] fastmap_1.1.0 cli_2.3.1 later_1.1.0.1
## [31] htmltools_0.5.1.1 tools_4.0.3 gtable_0.3.0
## [34] glue_1.4.2 GenomeInfoDbData_1.2.4 fastmatch_1.1-0
## [37] Rcpp_1.0.6 cellranger_1.1.0 jquerylib_0.1.3
## [40] vctrs_0.3.6 polylabelr_0.2.0 xfun_0.22
## [43] ps_1.6.0 testthat_3.0.2 rvest_1.0.0
## [46] mime_0.10 lifecycle_1.0.0 XML_3.99-0.6
## [49] zlibbioc_1.36.0 scales_1.1.1 promises_1.2.0.1
## [52] hms_1.0.0 RColorBrewer_1.1-2 yaml_2.2.1
## [55] memoise_2.0.0 gridExtra_2.3 sass_0.3.1
## [58] reshape_0.8.8 stringi_1.5.3 RSQLite_2.2.4
## [61] highr_0.8 genefilter_1.72.0 desc_1.3.0
## [64] caTools_1.18.1 BiocParallel_1.24.1 rlang_0.4.10
## [67] pkgconfig_2.0.3 bitops_1.0-6 evaluate_0.14
## [70] lattice_0.20-41 labeling_0.4.2 htmlwidgets_1.5.3
## [73] bit_4.0.4 tidyselect_1.1.0 plyr_1.8.6
## [76] magrittr_2.0.1 R6_2.5.0 generics_0.1.0
## [79] DelayedArray_0.16.0 DBI_1.1.1 pillar_1.5.1
## [82] haven_2.3.1 withr_2.4.1 survival_3.2-10
## [85] RCurl_1.98-1.3 modelr_0.1.8 crayon_1.4.1
## [88] KernSmooth_2.23-18 utf8_1.2.1 rmarkdown_2.7
## [91] locfit_1.5-9.4 grid_4.0.3 readxl_1.3.1
## [94] data.table_1.14.0 blob_1.2.1 reprex_1.0.0
## [97] digest_0.6.27 xtable_1.8-4 httpuv_1.5.5
## [100] munsell_0.5.0 bslib_0.2.4
END of report